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VPreface
Though a relatively young discipline, bioinformatics is finding increasing 
importance in many life science disciplines, including biology, biochemistry, 
medicine, and chemistry. Since its beginnings in the late 1980s, the success of 
bioinformatics has been associated with rapid developments in computer sci-
ence, not least in the relevant hardware and software. In addition, biotechno-
logical advances, such as have been witnessed in the fields of genome 
sequencing, microarrays, and proteomics, have contributed enormously to the 
bioinformatics boom. Finally, the simultaneous breakthrough and success of 
the World Wide Web has facilitated the worldwide distribution of and easy 
access to bioinformatics tools.
Today, bioinformatics techniques, such as the Basic Local Alignment Search 
Tool (BLAST) algorithm, pairwise and multiple sequence comparisons, queries 
of biological databases, and phylogenetic analyses, have become familiar tools 
to the natural scientist. Many of the software products that were initially unin-
tuitive and cryptic have matured into relatively simple and user-friendly prod-
ucts that are easily accessible over the Internet. One no longer needs to be a 
computer scientist to proficiently operate bioinformatics tools with respect to 
complex scientific questions. Nevertheless, what remains important is an 
understanding of fundamental biological principles, together with a knowledge 
of the appropriate bioinformatics tools available and how to access them. Also 
and not least important is the confidence to apply these tools correctly in order 
to generate meaningful results.
The present, comprehensively revised second English edition of this book is 
based on a lecture series of Paul M.  Selzer, professor of biochemistry at the 
Interfaculty Institute for Biochemistry, Eberhard-Karls-University, Tübingen, 
Germany, as well as on multiple international teaching events within the frame-
works of the EU FP7 and Horizon 2020 programs. The book is unique in that it 
includes both exercises and their solutions, thereby making it suitable for class-
room use. Based on both the huge national success of the first German edition 
from 2004 and the subsequently overwhelming international success of the first 
English edition from 2008, the authors decided to produce a second German 
and English edition in close proximity to each other. Working on the same 
team, each of the three authors had many years of accumulated expertise in 
research and development within the pharmaceutical industry, specifically in 
the area of bioinformatics and cheminformatics, before they moved to different 
career opportunities to widen their individual industrial and academic scien-
tific areas of expertise. The aim of this book is both to introduce the daily appli-
cation of a variety of bioinformatics tools and provide an overview of a complex 
field. However, the intent is neither to describe nor even derive formulas or 
algorithms, but rather to facilitate rapid and structured access to applied bioin-
VI
formatics by interested students and scientists. Therefore, detailed knowledge 
in computer programming is not required to understand or apply this book’s 
contents.
Each of the seven chapters describes important fields in applied bioinformatics 
and provides both references and Internet links. Detailed exercises and solu-
tions are meant to encourage the reader to practice and learn the topic and 
become proficient in the relevant software. If possible, the exercises are chosen 
in such a way that examples, such as protein or nucleotide sequences, are inter-
changeable. This allows readers to choose examples that are closer to their sci-
entific interests based on a sound understanding of the underlying principles. 
Direct input required by the user, either through text or by pressing buttons, is 
indicated in Courier font and italics, respectively. Finally, the book con-
cludes with a detailed glossary of common definitions and terminology used in 
applied bioinformatics.
We would like to thank our former colleague and coauthor of the first edition, 
Dr. Andreas Rohwer, for his contributions, which are still of great importance 
in the second edition. We are very grateful to Ms. Christiane Ehrt and Ms. Lina 
Humbeck – TU Dortmund, Germany – for mindfully reading the book and 
actively verifying all exercises and solutions. We wish to thank Dr. Sandra 
Noack for her constructive contributions. Finally, we wish to thank Ms. Ste-
fanie Wolf and Ms. Sabine Schwarz from the publisher Springer for their con-
tinuous support in producing the second edition.
Paul M. Selzer 
Ingelheim am Rhein, Germany
Richard J. Marhöfer 
Worms, Germany
Oliver Koch 
Dortmund, Germany
May 2018
 Preface
VII
The Circulation of Genetic Information
Genetic information is encoded by a 4-letter alphabet, which in turn is trans-
lated into proteins using a 20-letter alphabet. Proteins fold into three- 
dimensional structures that perform essential functions in single-celled or 
multicellular organisms. These organisms are under constant selection pres-
sure, which in turn leads to changes in their genetic information.
Cover Image
The three-dimensional molecular structure of a protein-DNA complex is 
depicted. The transcription activator Gal4 from Saccharomyces cerevisiae is 
shown bound to a DNA oligomer (PDB-ID: 1D66). Gal4 is represented by a 
ribbon model in which α-helices and loops are drawn in red and yellow, respec-
tively. The side chains of the amino acids in the loops are not shown. For the 
DNA oligomer, local bending of the molecular surface is color-coded where 
darker colors represent increased bending [Brickmann J, Exner TE, Keil M, 
Marhöfer RJ (2000) Molecular graphics - trends and perspectives. J Mol Mod 
6:328-340]. The structure was produced on a Silicon Graphics Octane 2 work-
station using the software package MOLCAD/Sybyl (Tripos Inc.) [Brickmann 
J, Goetze T, Heiden W, Moeckel G, Reiling S, Vollhardt H, Zachmann CD 
(1995) Interactive visualization of molecular scenarios with MOLCAD/Sybyl. 
In: Bowie JE (Hrsg) Data visualization in molecular science - tools for insight 
and innovation. Addison-Wesley Publishing Company Inc, Reading, Massa-
chusetts, USA, S 83-97].
IX
A Short History of Bioinformatics
The first algorithm for comparing protein or DNA sequences was published by 
Needleman and Wunsch in 1970 (7 Chap. 3). Bioinformatics is thus only 1 year 
younger than the Internet progenitor ARPANET and 1 year older than e-mail, 
which was invented by Ray Thomlinson in 1971. However, the term bioinfor-
matics was only coined in 1978 (Hogeweg 1978) and was defined as the “study 
of informatic processes in biotic systems.” The Brookhaven Protein Data Bank 
(PDB) was also founded in 1971. The PDB is a database for the storage of crys-
tallographic data of proteins (7 Chap. 2). The development of bioinformatics 
proceeded very slowly at first until the complete gene sequence of the bacterio-
phage virus ϕX174 was published in 1977 (Sanger et al. 1977). Shortly after, the 
IntelliGenetics Suite, the first software package for the analysis of DNA and 
protein sequences, was used (1980). In the following year, Smith and Waterman 
published another algorithm for sequence comparison, and IBM marketed the 
first personal computer (7 Chap. 3). In 1982, a spin-off of the University of 
Wisconsin – the Genetics Computer Group – marketed a software package for 
molecular biology, the Wisconsin Suite. At first, both the IntelliGenetics and 
the Wisconsin Suite were packages of single, relatively small programs that 
were controlled via the command line. A graphical user interface was later 
developed for the Wisconsin Suite, which made for more convenient operation 
of the programs. The IntelliGenetics suite has since disappeared from the mar-
ket, but the Wisconsin Suite was available under the name GCG until the 2000s.
The publication of the polymerase chain reaction (PCR) process by Mullis and 
colleagues in 1986 represented a milestone in molecular biology and, concur-
rently, bioinformatics (Mullis et al. 1986). In the same year, the SWISS- PROT 
database was founded, and Thomas Roderick coined the term genomics, 
describing the scientific discipline of sequencing and description of whole 
genomes (Kuska 1998). Two years later, the National Center for Biotechnology 
Information (NCBI) was established; today, it operates one of the most impor-
tant primary databases (. Fig. 1; see 7 Chap. 2). The same year also saw the 
start of the Human Genome Initiative and the publication of the FASTA algo-
rithm (7 Chap. 3). In 1991, CERN released the protocols that made possible the 
World Wide Web (7 https://home.cern/topics/birth-web; 7 https://timeline.
web.cern.ch/timelines/The-birth-of-the-World-Wide-Web). The Web made it pos-
sible, for the first time, to provide easy access to bioinformatics tools. However, 
it took a few years until such tools actually became available. Also, in 1991 Greg 
Venter published the use of Expressed Sequence Tags (ESTs) (7 Chap. 4). By 
the next year, Venter and his wife, Claire Fraser, had founded The Institute for 
Genomics Research (TIGR). With the publication of GeneQuiz in 1994, a fully 
integrated sequence analysis tool appeared that, in 1996, was used in the 
GeneCrunch project for the first automatic analysis of the over 6000 proteins of 
baker’s yeast, Saccharomyces cerevisiae (Goffeau et al. 1996). In the same year, 
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the launch of the Prosite database (7 Chap. 2) was announced. One year after 
the successful implementation of the GeneQuiz package for automatic sequence 
analysis, LION Biosciences AG was founded in Heidelberg, Germany. The basis 
for one of LION’s main products, the integrated sequence analysis package, 
termed bioSCOUT, was GeneQuiz. Together with other products of the 
Sequence-Retrieval System (SRS) package, LION Biosciences AG quickly 
became a very successful bioinformatics company with a worldwide presence. 
This did not last for long, however, and in 2006 the bioinformatics division was 
sold to BioWisdom, which continued to modify and sell SRS. At this time, SRS 
was certainly one of the most important systems for the indexing and manag-
ing of flat file databases. The importance of SRS has steadily declined in recent 
years; nevertheless, a few installations can still be found on the Web.
Twenty years after the term bioinformatics had been coined, another term, che-
moinformatics, was published (Brown 1998). Up till that time, the terms chemo-
metrics, computer chemistry, and computational chemistry were common and 
are still in use today. The term chemoinformatics, sometimes also cheminfor-
matics, is used as an umbrella term that sometimes even includes additional 
terms like molecular modeling. Note that : traditionalists still use the term only 
for the representation and handling of chemical structures in databases.
The 1990s saw additional milestones in bioinformatics and molecular biology. 
The genomes of three important model organisms were published: Haemophi-
lus influenzae (Fleischmann et al. 1995), S. cerevisiae (1996), and Caenorhabdi-
tis elegans (C. elegans Sequencing Consortium 1998). Also, in 1998, Greg Ventor 
founded his company Celera, and in 2000 the genomes of two additional model 
organisms followed, Arabidopsis thaliana and Drosophila melanogaster. The 
next year saw the publication of the first draft of the human genome, which 
officially was declared to be completed in 2003. In 2002 three important insti-
tutes, the European Bioinformatics Institute (EMB-EBI), the Swiss Institute of 
Bioinformatics (SIB), and the Protein Information Resource (PIR), founded 
the UniProt Consortium and combined their databases Swiss- Prto, TrEMBL, 
and PIR-PSD in the UniProt database (7 Chap. 2). The same year saw the pub-
lication of the mouse (mus musculus) genome, the genome of the causative 
agent of human malaria, Plasmodium falciparum, and its vector, the mosquito 
Anopheles gambiae. Shortly after, in 2004, the genome of the brown rat (Rattus 
norvegicus) was published, followed by the genome of the chimpanzee (Pan 
troglodytes) in 2005. The sequencing of other genomes is an ongoing process, 
and to list them all would go beyond the scope of this short survey. An over-
view of the completed and ongoing genome projects can be found in the 
Genomes OnLine Database GOLD: 7 http://www.genomesonline.org/.
In 2005, 454 sequencing – the first technique of the Next-Generation Sequenc-
ing (NGS, see 7 Chap. 4)  – was presented, followed shortly  – in 2006  – by 
Solexa sequencing. NGS was nominated method of the year by the journal 
Nature Methods already 1  year later. Another year later, in 2008, RNA-Seq, 
A Short History of Bioinformatics
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which is based on NGS, was introduced and led to a number of new disciplines, 
for example, pharmacogenetics and proteogenomics (7 Chap. 4). NGS has also 
taken on an important role in medical practice, where it is extensively used in 
the field of personalized medicine. As a matter of course, new Web services and 
new databases are developed and published constantly, in part for highly spe-
cialized purposes. It would go far beyond the scope of this book to list all of 
those purposes. A comprehensive list of databases, however, can be found once 
a year in the January issue of the journal Nucleic Acids Research (database 
issue), and a listing of Web services is published also ones a year in the July 
issue (software issue): NAR: https://nar.oxfordjournals.org/.
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1.1  Nucleic Acids and Proteins
Nucleic acids and proteins are two important classes of macromolecules that play cru-
cial roles in nature and form the basis of all life. Deoxyribonucleic acid (DNA) is the car-
rier of genetic information, and ribonucleic acid (RNA) is involved in the biosynthesis 
of proteins that control the cellular processes of life. The basic monomer constituents of 
nucleic acids are nucleotides, while those of proteins are amino acids.
1.2  Structure of the Nucleic Acids DNA and RNA
The structure of nucleotides is the same in DNA and RNA (Alberts et al. 2014). Nucleotides 
consist of a pentose, a phosphoric acid residue, and a heterocyclic base. In a DNA or 
RNA strand, nucleotides are linked via chemical bonds between the pentose sugar of 
one nucleotide and the phosphoric acid residue of the next (. Fig. 1.1). Accordingly, the 
basic framework of nucleic acids is a polynucleotide where the phosphoric acid forms 
an ester bond between the 3′ OH group of the sugar residue of one nucleotide and the 
5′ OH group of the sugar of the next nucleotide. At one end of the polynucleotide chain, 
therefore, a phosphate group is connected to the 5′ oxygen of a pentose sugar, whereas at 
the other end, a free 3′ hydroxyl group is present (. Fig. 1.1).
Each unit of the basic ribose/phosphoric acid residue structure carries a hetero-
cyclic nucleobase that is connected to the sugar residue via an N-glycosidic linkage. 
The nucleic acids consist of five different bases (cytosine, uracil, thymine, adenine, and 
guanine), whereby uracil occurs only in RNA and thymine only in DNA. Nucleotides 
may be abbreviated using the first letter of the corresponding base, and their succession 
indicates the nucleotide sequence of the nucleic acid strand. DNA and RNA not only 
differ in their bases, but their respective sugar residues also differ in chemical composi-
tion. In RNA, the sugar is a ribose, whereas DNA incorporates 2-deoxyribose.
DNA consists of two nucleotide strands that combine in an antiparallel orientation so 
that hydrogen bonds are formed between the bases of each strand, resulting in a ladder-
like structure. The bases are paired so that a purine ring on one strand interacts with a 
pyrimidine ring on the opposite strand. Two hydrogen bonds exist between A and T and 
three between G and C. The two nucleotide strands making up DNA are “complementary” 
to one another. Therefore, the sequential succession of bases on one strand determines the 
base sequence on the other strand. Under physiological conditions, DNA exists as a double 
helix in which the two polynucleotide strands wind right- handedly around a common axis 
(. Fig. 1.2). The diameter of the double helix is 2 nm. Along the double helix, opposing 
bases are 0.34 nm apart and rotated at an angle of 36° to one other. The helical structure 
recurs every 3.4 nm and corresponds to 10 base pairs (Watson and Crick 1953a, b).
1.3  The Storage of Genetic Information
DNA consists of four nucleotides that store genetic information. The base sequence is 
the only variable element on the nucleotide strand and, therefore, encodes the necessary 
information to generate proteins. Proteins are composed of varying amounts of up to 
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20 amino acids, and each amino acid is encoded by a triplet of bases, termed codons. 
If doublet codons were to be used to encode proteins, the resulting 42 = 16 possible 
combinations would be insufficient to generate 20 amino acids. On the other hand, 
triplet codons give 43 = 64 possibilities, allowing for more combinations than necessary 
to encode 20 amino acids. From these theoretical calculations one can infer that an 
individual amino acid may be encoded by more than one codon. Therefore, the result-
ing genetic code is described as being degenerate. The genetic code shown in . Fig. 1.3 
applies universally to all living organisms; however, some exceptions can be found in 
mitochondria and ciliates.
The relationship between DNA, RNA, and proteins has been described as the central 
dogma of molecular biology (Crick 1970) (. Fig. 1.4). Genetic information is encoded 
in the DNA as the sequence of its bases. This information is transferred to messenger 
RNA (mRNA) during the process of transcription, whereas the unambiguous transfer 
of information is guaranteed by the pairing of complementary bases. The final process 
of building proteins from mRNA is called translation. Overall, the amino acid compo-
sition of proteins is determined by the genetic information of the DNA sequence. Thus, 
the flow of information generally proceeds from the genome over the transcriptome 
to the proteome. However, RNA viruses are an exception. They can transcribe their 
RNA into DNA with the help of a reverse transcriptase and replicate RNA by means of 
a replicase. The entirety of genomic DNA in any organism is known as a genome, and 
the total pool of mRNA in any organism is referred to as a transcriptome. Analogously, 
the entire pool of proteins in any organism is referred to as the proteome.
Thus, a genome comprises genes that contain the information to build proteins. The 
organization of a gene region, however, is different in prokaryotes than in eukaryotes 
(. Fig. 1.5). The most striking difference is that prokaryotic gene information is encoded 
on a continuous DNA stretch, whereas in eukaryotes, coding exons are interrupted by 
noncoding introns (Krebs et al. 2014). Eukaryotic transcription of DNA to mature mRNA 
(containing information derived only from exons) requires several steps. The introns are 
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removed during the process of splicing. Through alternative splicing (removing and join-
ing different introns and exons), different mRNAs and, consequently, different proteins can 
result from one gene (7 Chap. 4, . Fig. 4.7). Alternative splicing, among other mechanisms, 
explains why a relatively low number of genes are found in the human genome compared 
to the greater number of proteins actually produced (Claverie 2001; Venter et al. 2001).
1.4  The Structure of Proteins
1.4.1  Primary Structure
As mentioned, proteins are macromolecules that are composed of the 20 naturally 
occurring amino acids (. Fig. 1.6). The primary structure is the amino acid sequence. 
Under physiological conditions, proteins fold into characteristic three-dimensional 
structures that dictate their biological properties and functions (Berg et al. 2015). The 
common configuration of natural amino acids is characterized by an amino and a car-
boxyl group around a central α-carbon atom.
The corresponding side chain of each amino acid determines the chemical properties, 
such as hydrophobic, polar, acidic, or basic (. Fig. 1.7). Due to the limitation of just 20 
amino acids, denatured (unfolded) proteins have very similar properties that correspond 
essentially to a homogeneous cross section of randomly distributed side chains. The dif-
ferent properties of functional proteins are based on the three-dimensional conformation 
(folding) of the protein. Nevertheless, the primary structure is essential for determining 
secondary and tertiary structures and, with that, the three-dimensional folding.
Peptide bonds connect individual amino acids in a polypeptide chain. Each amino 
acid is linked via the acid amide bond of its α-carboxyl group to the α-amino group of 
the next amino acid. Consequently, polypeptides have free N- and C-termini. The con-
nection of this main part of amino acids is called the protein backbone. The primary 
structure of a polypeptide, i.e., the amino acid sequence from the N- to the C-terminus, 
can contain between three and several hundred amino acids. Each amino acid in the 
polypeptide chain is abbreviated by either a three-letter or one-letter code (. Fig. 1.6).
1.4.2  Secondary Structure
The term secondary structure describes the local conformation of the backbone of 
any polymer. In the case of proteins, the secondary structure describes the ordered 
folding patterns of a polypeptide chain into regular helices (α-helix) and sheet struc-
tures (β-strand) and irregular turns. Turns are built up from three up to six amino 
acids and cover a huge conformational space of the protein backbone. Therefore, turns 
are important for the protein globularity since helices and sheets are linear structural 
elements. These three secondary structure elements represent the building blocks 
of the three- dimensional folding pattern of proteins (Koch and Klebe 2009). Loops 
are another structural element that consist of multiple turns and connect helices and 
sheets.
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The key to understanding these more complex structures lies in the geometric prop-
erties of the peptide group. Linus Pauling and Robert Corey demonstrated in the 1930s 
and 1940s that the peptide bond is a rigid, planar structure that can be attributed to 
the 40% double-bond character of the peptide bond. Accordingly, a polypeptide chain 
can be regarded as a sequentially linked chain of rigid and planar peptide groups. The 
chain conformation of a polypeptide can therefore be determined by the torsion angles 
around the Cα–N binding (ϕ) and the Cα–C binding (ψ) of the constituent amino acid 
residues. In the planar and fully stretched (all trans) conformation, all angles are 180°. 
Viewed from the Cα atom, the angles increase with a clockwise rotation. Not all con-
ceivable values for ϕ and ψ are possible, however, owing mainly to steric hindrance 
caused by the side chains of the amino acids. A Ramachandran plot is a conformation 
chart of those values that are sterically possible for ϕ and ψ (. Fig. 2.6). Areas in the 
Ramachandran plot that correspond to sterically possible values of angles ϕ and ψ are 
called permissible areas; those corresponding to values that are not possible are called 
forbidden areas (. Fig. 1.8).
As already mentioned, three components in the secondary structure of proteins can 
be distinguished: the α-helix, the β-strand, and turns (. Fig. 1.9). The polypeptide chain 
of an α-helix displays a pitch of 0.54 nm with 3.6 residues per turn. As for α-helices, 
β-strands are stabilized by hydrogen bonds. However, they are found not within a local 
part of the polypeptide chain, as in the case of a helix, but between neighboring strands. 
Such β-strands exist in both parallel and antiparallel forms owing to the direction of 
the polypeptide chain. In β-strands, each successive side chain is on the opposite side of 
the plane of the sheet, with a repetition unit of two residues and at a distance of 0.7 nm. 
On average, a globular protein consists of approximately a half each of α-helices and 
β-sheets. The rest of the protein consists of nonrepetitive turns. They are responsible for 
the globularity of proteins since they allow a huge amount of different conformations. 
Overall, 158 different conformations of the protein backbone are described for turns 
(Koch and Klebe 2009).
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1.4.3  Tertiary and Quartanary Structure
The tertiary structure describes the three-dimensional arrangement and placement 
of secondary structural elements. Large polypeptide chains (>200 amino acids) fre-
quently fold themselves into several units termed domains. Normally such domains 
are composed of 100–200 amino acids with a diameter of approx. 2.5 nm. The tertiary 
structure specifies the protein properties, for example, whether a protein functions as 
an enzyme or a structural protein. Through the compaction of secondary structural ele-
ments and interactions between the amino acids of those elements, the structure of the 
protein is stabilized. The amino acid interactions include hydrogen bonds between pep-
tide groups, disulfide bonds between cysteine residues, ionic bonds between charged 
groups of amino acid side chains, and hydrophobic interactions. The quaternary struc-
ture is the arrangement of several polypeptide subunits. These are associated in a spe-
cific geometry so that a symmetrical complex is formed. The assembly of the individual 
subunits is carried out through noncovalent interactions.
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  . Fig. 1.8 Ramachandran plot of transcription regulator protein GAL4 from Saccharomyces cerevi-
siae. The amino acids are represented as small black squares. Evidently almost all amino acids lie in 
preferred, permissible areas (red and yellow). Two amino acids (LYS23 and ARG63) are found in slightly 
forbidden areas of the Ramachandran plot. This means that the combination of the values for ψ and 
ϕ would theoretically not be possible owing to the steric hindrance of the neighboring side chains. 
However, in practice, it can be observed. The plot was generated with the program PROCHECK (Las-
kowski et al. 1993; Rullmann 1996); plot statistics were deleted for clarity
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1.5 Exercises
 ? Exercise 1.1
What is the difference between the two polynucleotides DNA and RNA?
 ? Exercise 1.2
DNA consists of two complementary nucleotide strands. Which base pairings are 
observed between these two nucleotide strands?
 ? Exercise 1.3
What is the meaning of the terms genome, transcriptome, and proteome?
 ? Exercise 1.4
The 20 naturally occurring amino acids are encoded by base triplets (codons) of the 
genetic code. Which consideration led to the discovery of the triplet codon organi-
zation of the genetic code?
 ? Exercise 1.5
Build the genetic code of your name. If this is not possible, use the name CRICK.
 ? Exercise 1.6
What is meant by the central dogma of molecular biology?
  . Fig. 1.9 Secondary structure representation (ribbon model) of a horse pancreas lipase with two 
domains (left: only β-sheets, right: α-helices and β-sheets). Orange coils symbolize α-helices and pur-
ple arrows β-strands. The connections between these are loop regions that consist of turns. Disulfide 
bridges, which stabilize the three-dimensional structure of the protein, are represented in yellow
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 ? Exercise 1.7
What is meant by the term splicing, and how does this process contribute to the dis-
crepancy between the relatively low number of genes in the human genome but the 
larger number of proteins actually produced?
 ? Exercise 1.8
Which amino acids show the following properties: (A) hydrophobic, polar, and small 
and (B) hydrophobic and aliphatic?
 ? Exercise 1.9
In which direction is the primary structure of proteins read?
 ? Exercise 1.10
Which structural elements can be found in the secondary structure of proteins?
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2.1  Biological Knowledge is Stored in Global Databases
The most important basis for applied bioinformatics is the collection of sequence data 
and its associated biological information. For example, with genome sequencing projects 
such data are generated daily in very large quantities worldwide. In order to use these 
data appropriately, a structured filing system of the data is necessary, yet the data should 
also be accessible to those interested. Annually, the journal Nucleic Acids Research [nar] 
dedicates an entire issue (first issue in January) to all available biological databases that 
are recorded in tabular form with the respective URLs. Furthermore, for a number of 
databases, original articles describe their functions. This database issue, which is freely 
accessible also on the Web, is a good starting point for working with biological data-
bases. Depending on the kind of data included, different categories of biological data-
bases can be distinguished. Primary databases contain primary sequence information 
(nucleotide or protein) and accompanying annotation information regarding function, 
bibliographies, cross references to other databases, and so forth. Secondary biological 
databases, however, summarize the results from analyses of primary protein sequence 
databases. The aim of these analyses is to derive common features for sequence classes, 
which in turn can be used for the classification of unknown sequences (annotation). In 
addition, all other databases that save biological or medical information, for example, 
literature databases, are frequently classified as secondary databases.
The use of relational database systems (e.g., Oracle, MS Access, Informax, DB2) and 
their ability to manage large data sets would seem to make them ideal for the struc-
tured filing of data, yet these systems have not gained acceptance so far in the field of 
biological databases. Rather, sequence data and their accompanying information are 
usually filed in the form of flat file databases, that is, structured ASCII text files. This 
is for historical reasons and because ASCII text files offer the advantage of conferring 
the ability to manipulate data without requiring an expensive and complicated database 
system. ASCII text files also make data exchange between scientists relatively simple. 
One drawback, however, is that searching for certain keywords within a data set is both 
laborious and time-consuming. To minimize this disadvantage, various systems have 
been developed that can index flat file–based databases, that is, they come with an index 
register similar to that of a book, thus accelerating keyword-based searches.
2.2  Primary Databases
2.2.1  Nucleotide Sequence Databases
2.2.1.1  GenBank
The GenBank database [genbank] is perhaps the best-known nucleotide sequence data-
base available at the U.S. National Center for Biotechnology Information (NCBI) [ncbi]. 
GenBank is a public sequence database, which in its present version (217.00, December 
2016) contains roughly 199 million sequence entries. Sequences can be entered into 
GenBank by anyone via a Web page [bankit] or by e-mail [sequin] when working with 
larger sequence sets. Prior entry of sequence data into either GenBank or one of its 
associated databases, for example the European Nucleotide Archive (ENA) or the DNA 
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Database of Japan (DDBJ), is a prerequisite for the publication of new sequences in any 
scientific journal. Each single database entry is provided with a unique identification tag, 
the accession number (AN). The AN is a permanent record that remains unchanged even 
if changes are subsequently made to the database record. In some cases, a new AN can be 
assigned to an existing number if, for example, an author adds a new database record that 
combines existing sequences. Even then the old AN is retained as a secondary number. 
The AN is the only way to absolutely verify the identity of a sequence or database entry.
. Figure 2.1 shows a GenBank entry. The entry has been shortened at some points 
and these are indicated by [...]. The required structuring of the database record is per-
formed via defined keywords. Each entry starts with the keyword LOCUS followed by 
a locus name. Like the AN, the locus name is also unique; however, unlike the AN, it 
may change after revisions of the database. The locus name consists of eight characters, 
  . Fig. 2.1 Database record of GenBank database. The entry was shortened at some points, as indi-
cated by [...]
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including the first letter of the genus and species names, in addition to a six-digit 
AN. Newer entries have an eight-digit AN. In such cases, the locus name is identical 
to the AN. On the same line following the locus name, the length of the sequence is 
given. A sequence must have at least 50 base pairs to be entered into GenBank. This 
requirement was introduced only relatively recently, and therefore, some older entries 
do not fulfill this criterion. Column 3 denotes the type of molecule of the sequence 
entry. Every GenBank entry must contain coherent sequence information of a single 
molecule type, that is, an entry cannot contain sequence information of both genomic 
DNA and RNA.  The last column in the LOCUS line gives the date of the last entry 
modification. The end of the database record starts with the keyword ORIGIN. In newer 
entries, this field remains empty. The actual sequence information begins on the follow-
ing line and may contain many lines. A detailed description of all keywords is found on 
the GenBank sample page [gb-sample].
 z Entrez
Query of the GenBank database is carried out via the NCBI Entrez system [entrez], 
which is used to query all NCBI-associated databases (NCBI Resource Coordinators 
2016). Because search terms can be combined by means of logical operators (AND, OR, 
NOT) and single search terms restricted to certain database fields, Entrez is an important 
and effective tool for the execution of both simple and complicated searches. The restric-
tion of search terms to single database fields is generally performed by a field ID placed 
after the term: search term[field-id]. For example, the search for a sequence 
from Saccharomyces cerevisiae with a length of between 3260 and 3270 base pairs 
would require the following search syntax: (Saccharomyces cerevisiae[ORGN]) AND 
3260:3270[SLEN]. Representative field IDs for performing searches in GenBank are 
listed in . Table 2.1. Complete instructions for the use of Entrez are found on the Entrez 
help page [entrez-help]. To simplify the construction of complex queries, the advanced 
search was introduced. To use this search, follow the link beneath the Entrez search field. 
Field IDs and logical operators can be selected from list boxes and the respective query is 
constructed automatically and entered into the search text field. For better readability in 
this case, the field IDs are entered with their full name. The latter does also work in the 
generic search; it is therefore no longer necessary to remember the abbreviated field IDs.
  . Table 2.1 Field IDs to restrict search terms to certain database fields in the Entrez system
Field ID Database field
ACC Accession number
AU Author name
DP Publication date
GENES Gene name
ORGN Scientific and common name of the organism
PT Publication type, e.g., review, letter, technical publication
TA Journal name, official abbreviation, or ISSN number
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 z EMBL and DDBJ
The European counterpart to GenBank is the ENA [ena], located at the European 
Bioinformatics Institute (EBI) [ebi]. Another primary nucleotide sequence database, 
the DDBJ [ddbj], is operated by the National Institute of Genetics (NIG) [nig] in Japan 
and is the primary nucleotide sequence database for Asia. The three database opera-
tors, NCBI, EBI, and NIG, compose the International Nucleotide Sequence Database 
Collaboration and synchronize their databases every 24 h. A query of all three indi-
vidual databases is therefore not necessary, nor is it required to enter a new nucleotide 
sequence into all three databases.
While the database format of the DDBJ is identical to that of the NCBI, that of the 
ENA differs somewhat. . Figure 2.2 shows an entry in the EMBL database. The most 
obvious difference is the use of two-letter codes instead of full keywords. Furthermore, 
there are small changes in the organization of the individual data fields. For example, the 
date of the last modification is not listed in the field ID (corresponding to the LOCUS 
field in GenBank) but appears in the field DT (database field). A complete description of 
the EMBL format can be found on the ENA manual page [ebi-manual].
 z ENA Online Retrieval
The ENA offers several search forms. First is a simple search, which allows for text 
searches as well as for sequence retrieval (. Fig. 2.3). For text search, it is possible to 
search for accession numbers and for simple free text. The search is not limited to certain 
database fields and does not allow to restrict the search to certain text fields as the Entrez 
system does. Instead, all database entries that randomly contain the search term are 
retrieved. To use this kind of parameter, to search for a sequence from S. cerevisiae with 
a sequence length of 3270 base pairs for instance, the advanced search must be used. It 
can be reached by following the corresponding link beneath the simple search text field.
The advanced search form (. Fig.  2.4) starts with several rather coarse-grained 
categories of the database fields. Once one of these categories is selected, additional 
text fields and option boxes are displayed that make it possible to restrict the search to 
individual database fields or groups thereof. To retrieve our aforementioned S. cerevisiae 
sequence, we must select the category Sequence and enter the search term Saccharo-
myces cerevisiae into the field Taxon. The comparison operator is set to equal. 
Use of the other two operators does, of course, make sense only if we compare numeri-
cal values. In the field Base count, 3270 is entered and the comparison operator is set to 
less than or equal to (<=). While entered, all entries are translated into a 
query simultaneously, which is displayed in the gray text field at the head of the page. The 
retrieval is started by hitting the Search button. Unfortunately, this search form does not 
allow one to search for a range like we did in the NCBI Entrez example for the sequence 
length. However, it is possible to build the query in the query builder without a range 
first and then edit the resulting query manually. To do so, we click on the hyperlink Edit 
Query on the right of the text search field. Now we can modify the preconstructed query 
and add an additional restriction for the field ID base_count with a logical AND. The 
resulting query now is tax_eq(4932) AND (base_count > = 3260 AND 
base_count <= 3270). Sometimes it is necessary to use brackets to influence the 
precedence of the logical operators. Here this would not have been necessary; however, 
we used the brackets for readability reasons. If we had been interested in a S. cerevisiae 
sequence that is either shorter than 3260 base pairs or longer than 3270 base pairs, we 
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  . Fig. 2.2 Database record of EMBL database. The entry has been shortened at some points as indi-
cated by [...]
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would have had to use brackets to override the logical operator precedence. The query 
would have resulted in tax_eq(4932) AND (base_count <= 3260 OR 
base_count >= 3270).
In addition to a text search, the ENA also allows for sequence searches using sequence 
comparisons. Basically, this is a BLAST search, which can either be carried out using 
  . Fig. 2.3 Home page of ENA with simple search fields for text and sequence retrieval (Courtesy EMBL-EBI)
  . Fig. 2.4 Advanced ENA search form (Courtesy EMBL-EBI)
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standard BLAST parameters or which makes it possible to tweak BLAST parameters on 
the advanced search page. BLAST searches will be discussed in detail in the following 
chapter, so we will not cover this in more detail here.
2.2.2  Protein Sequence Databases
2.2.2.1  UniProt
The information available for proteins continues to grow rapidly. Besides sequence 
information, expression profiles can be examined, secondary structures predicted, and 
biological/biochemical function(s) analyzed. All these data are stored in databases, 
some of which are quite specialized. Therefore, it can be time consuming to collect all 
the relevant information regarding any given protein. For this reason, EBI, the Swiss 
Institute of Bioinformatics (SIB), and Georgetown University have built a consor-
tium with the aim of developing a central catalog for protein information. The result 
is the Universal Protein Resource (UniProt) [uniprot] (UniProt Consortium 2016), 
which unites the information in the three protein databases Swissprot, TrEMBL, and 
Protein Information Resource (PIR). UniProt consists of three parts, the UniProt 
Knowledgebase (UniProtKB), the UniProt Reference Clusters Database (UniRef), and 
the UniProt Archive (UniPArc), a collection of protein sequences and their history.
Protein sequences and their annotations are stored in the UniProt Knowledgebase 
(UniProtKB), which is divided into two realms. First is the UniProtKB/TrEMBL realm, 
which contains automatically annotated sequences, and there is the UniProtKN/Swis-
sProt realm, where manually curated and annotated sequences are stored. UniProtKB/
TrEMBL currently (June 2016) contains approx. 65 million entries and is thus around 
120 times larger than the realm UniProtKB/SwissProt, which contains approx. 550,000 
entries. Because of the manual curation, the UniprotKB/SwissProt realm is regarded as 
one of the most important protein databases. Quite often, it is also referred to as the gold 
standard of protein annotation.
The SwissProt database existed long before the UniProt database was founded and 
was located at the SIB. Because the team of specialists at the SIB was overwhelmed with 
the flood of new sequences being entered into the databases, a supplement to the Swis-
sProt database, the TrEMBL database, was introduced. TrEMBL stands for translated 
EMBL and contained all protein translations of the EMBL database, which had not yet 
been manually curated. The EMBL database is the predecessor of the ENA. All entries in 
TrEMBL (today UniProtKB/TrEMBL) are annotated automatically, that is, the quality of 
the annotations is not comparable to that of UniProtKB/SwissProt annotations.
. Figure 2.5 shows an entry in the UniProtKB/SwissProt database. At first glance 
the entry is similar to an ENA entry. Indeed, the two database formats are related. Both 
database schemes use two-letter identifiers, and most identifiers are identical for the 
two databases. Some identifiers, however, are modified for the UniProtKB and some 
are added. The raw database entry as shown in . Fig. 2.5 is rarely found. Most times, a 
graphical version is presented by UniProtKB, as shown in . Fig. 2.6.
The UniProtKB can be queried using simple full text search or using complex que-
ries with logical operators (. Fig. 2.7). For a simple full text search, the search term 
can simply be entered in the text field at the top of the page. For complex searches, 
an advanced search form is used. The search is initiated by clicking on the hyperlink 
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  . Fig. 2.5 Database entry in UniProtKB/SwissProt in raw format. The entry is shortened at various 
places, marked by [..] (Courtesy UniProt Consortium)
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  . Fig. 2.6 Database entry in UniProtKB/SwissProt in graphical format (Courtesy UniProt Consortium)
  . Fig. 2.7 Home page of UniProt with text field for a simple full text search, overlaid with advanced 
search form (Courtesy UniProt Consortium)
 Chapter 2 · Biological Databases
23 2
Advanced on the right of the text field. In the advanced search form the field IDs and 
the corresponding logical operators can be selected from drop-down menus. When 
started, the search query is displayed in the text field and can be tweaked manually if 
necessary.
UniRef is a nonredundant sequence database that allows for fast similarity searches. 
The database exists in three versions: UniRef100, UniRef90, and UniRef50. Each data-
base allows for the searching of sequences that are 100%, ≥ 90%, or ≥50% identical. The 
size of the database changes accordingly, making similarity searches, for example with 
BLAST, much faster.
2.2.2.2  NCBI Protein Database
Another well-known protein sequence database is maintained at the NCBI. This data-
base, however, is not a single database but a compilation of entries found in other 
protein sequence databases. For example, the NCBI database contains entries from 
Swissprot, the PIR database [pir], the Protein Data Bank (PDB) database [pdb], protein 
translations of the GenBank database, and several other sequence databases. Its format 
corresponds to that of GenBank, and queries are carried out analogously to those in 
GenBank via the Entrez system of NCBI.
2.3  Secondary Databases
2.3.1  Prosite
An important secondary biological database is Prosite [prosite] (Sigrist et  al. 2012), 
which resides at the SIB [expasy]. Classification of proteins in Prosite is determined 
using single conserved motifs, i.e., short sequence regions (10–20 amino acids) that are 
conserved in related proteins and usually have a key role in the protein’s function. The 
search for such sequence motifs in unknown proteins can provide a first hint of an affili-
ation to a protein family or function.
A motif is derived from multiple alignments (7 Chap. 3) and saved in the database 
as a regular expression (. Fig. 2.8). This is a formalized pattern for the description of 
a sequence of characters. In a regular expression in Prosite, individual amino acids are 
represented by a one-letter code and separated by hyphens. If a position can contain 
more than one residue, then these are written in square brackets. Positions that can 
be filled by any amino acid are marked by a lowercase letter x. Repetitions of the same 
amino acid are indicated in full brackets, followed by the number of repetitions. A typical 
regular expression in Prosite would have the following form: [GSTNE]-[GSTQCR]-
[FYW]-{ANW}-x(2)-P. This regular expression has seven amino acid positions. 
The first amino acid can be glycine, serine, threonine, asparagine, or glutamate; the 
second position glycine, serine, threonine, glutamine, cysteine or arginine; and the third 
position phenylalanine, tyrosine, or tryptophan. Position four can be any amino acid 
except alanine, asparagine, and tryptophan. In positions five and six, any amino acid 
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can follow, and position seven is occupied by proline. The Prosite user manual [prosite-
manual] contains a complete description of the Prosite database as well as the syntax 
of the  regular Prosite expressions. The Expasy Prosite Web server [prosite] offers dif-
ferent possibilities to query the Prosite database. Besides searching for keywords, one 
can examine a sequence for the presence of Prosite motifs. Furthermore, using the algo-
rithm ScanProsite, Prosite offers the possibility to search Swissprot, TrEMBL, and PDB 
for protein sequences that contain a user-defined pattern.
2.3.2  PRINTS
The PRINTS database [prints] (Attwood et  al. 2003) uses fingerprints to classify 
sequences. Fingerprints consist of several sequence motifs, represented in the PRINTS 
database by short, local, ungapped alignments (7 Chap. 3). The PRINTS database takes 
advantage of the fact that proteins usually contain functional regions that result in 
  . Fig. 2.8 NiceSite view of Prosite database record PS01159 (Printed with permission of Swiss Insti-
tute for Bioinformatics)
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several sequence motifs per protein. By using fingerprints the sensitivity of the analysis 
increases, i.e., it is possible to evaluate the affiliation of a protein to a protein family even 
in the absence of one of the surveyed motifs. Besides information on how to derive a 
fingerprint and judge its quality, PRINTS also offers cross references to entries in related 
databases, permitting access to more information regarding a given protein family. 
Like Prosite, PRINTS contains information about each protein family and, if available, 
the biological function of each motif in the fingerprint. Querying the database on the 
PRINTS Web server [prints] can be carried out via a keyword search. However, it can be 
more interesting to search for fingerprints in protein sequences. Like the Prosite server, 
the PRINTS server offers tools for sequence analysis.
2.3.3  Pfam
The Pfam database [pfam] (Finn et  al. 2016) classifies protein families according to 
profiles. A profile is a pattern that evaluates the probability of the appearance of a 
given amino acid, an insertion, or a deletion at every position in a protein sequence. 
Conserved positions are weighted more than less conserved positions, i.e., a weighted 
scoring scheme. Pfam is based on sequence alignments. High-quality, manually 
checked alignments serve as starting points for the automatic construction of hidden 
Markov models (HMMs). More sequences are then automatically added to the indi-
vidual alignments of the SwissProt database. The resulting alignments should repre-
sent functionally interesting structures and contain evolutionarily related sequences. 
Owing to the partly automatic construction of the alignments, however, it is also pos-
sible that sequence alignments will arise that have no evolutionary relationship to one 
other. Therefore, the results of a search against the Pfam database should be carefully 
reviewed.
2.3.4  Interpro
The Integrated Resource of Protein Families, Domains and Sites (Interpro) [interpro] 
(Mulder et  al. 2007) integrates important secondary databases into a comprehensive 
signature database. Interpro merges the databases Swissprot, TrEMBL, Prosite, Pfam, 
PRINTS, ProDom, Smart, and TIGRFAMs [tigr] and thereby allows a simple and simul-
taneous query of these databases. The result page combines the output of the individual 
queries. This makes for a fast comparison of the results while considering the strengths 
and weaknesses of the individual databases. The Interpro Web server offers a few intui-
tive query facilities for text and sequence searches.
2.4  Genotype-Phenotype Databases
For diseases to emerge and progress, several genes or their products are frequently 
required. The identification of genes relevant to disease is, therefore, of vital impor-
tance in a target-based approach to rational drug development. A number of 
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genotype- phenotype databases have been established that record relationships between 
genes and the biological properties of organisms. The Online Mendelian Inheritance 
in Man (OMIM) database of the NCBI [omim] is perhaps the best-known genotype-
phenotype database. A new database of this type, dbGaP [dbgap], was also recently 
established at the NCBI. The data in this database come with analyses of the statistical 
significance of the respective genotype-phenotype relationship. The Online Mendelian 
Inheritance in Animals (OMIA) database [omia] at the NCBI also contains genotype-
phenotype relationships of various animals, except mice and humans. For mice, 
the relevant database is in the Mouse Genome Database (MGD) [mgd]. Genotype-
phenotype relationships of the two important model organisms, D. melanogaster and 
C. elegans, are recorded in FlyBase [flybase] and WormBase [wormbase], respectively. 
Both databases also contain much more information than just genotype-phenotype 
data. A detailed description of all the aforementioned databases [nar] would be beyond 
the scope of this book. In what follows, therefore, only a genotype-phenotype database 
is discussed that semantically integrates the contents of the aforementioned databases.
2.4.1  PhenomicDB
The PhenomicDB database is a multiorganism genotype-phenotype database contain-
ing data from humans and other important organisms such as the mouse, zebra fish 
(Danio rerio), fruit fly (D. melanogaster), nematode (C. elegans), baker’s yeast (S. cere-
visiae), and cress plant (Arabidopsis thaliana). PhenomicDB integrates data from the 
aforementioned and other primary genotype-phenotype databases. A complete listing 
of all underlying data sources can be found on the home page [phenomicdb] and in 
Kahraman et al. (2005).
A characteristic of PhenomicDB is that cross-organism comparisons of genotype- 
phenotype relationships are possible. This is accomplished by incorporating orthology 
data and gene indices from the database HomoloGene [homologene] at the NCBI. For 
example, the cause of porphyria, an inherited or acquired enzyme defect of humans, 
is a nonfunctional δ-aminolevulinate dehydratase. The respective gene has the sym-
bol ALAD. As PhenomicDB indicates, a defect in the orthologous gene of baker’s yeast 
(gene symbol: HEM2) leads to a very similar phenotype, characterized by the keywords 
auxotrophies, carbon and nitrogen utilization defects, carbon utilization, and respira-
tory deficiency. Of course, one cannot expect that distantly related organisms such as 
baker’s yeast and humans show identical genotype-phenotype relationships in every 
case. Nevertheless, similar relationships can occur that might generate new hypoth-
eses regarding disease pathogenesis or that allow the advancement of a disease model, 
thereby supporting the development of new drugs.
PhenomicDB is queried via a simple search interface. Search terms can be comple-
mented automatically or manually by wildcards and restricted to certain database fields. 
Furthermore, it is possible to restrict the search to selected organisms. If orthologs of 
a given gene are found, the result page offers a hyperlink to the corresponding data-
base record, allowing for a fast comparison of the genotype-phenotype relationships 
across organisms (. Fig. 2.9). Owing to the semantic integration of the primary data-
bases, some detail information can be lost, however, but this is compensated for by the 
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interconnections of the primary data and the breadth of information included. Phe-
nomicDB can therefore be regarded as a metasearch engine for phenotypic information.
2.5  Molecular Structure Databases
2.5.1  Protein Data Bank
The PDB is a database of experimentally determined crystal structures of biological 
macromolecules and is coordinated by a consortium located in the USA, Europe, and 
Japan [wwpdb] (Berman et al. 2000). Probably the best-known Web page of the PDB 
is that of the Research Collaboratory for Structural Bioinformatics [pdb]. The PDB was 
founded at the Brookhaven National Laboratory in 1971, reflected in the frequent use of 
the name Brookhaven Protein Data Bank.
About 121,000 macromolecule structures are stored in the PDB database (as of July 
2016). These are predominantly proteins, but also include DNA and RNA structures 
and protein–nucleic acid complexes. Structures of other macromolecules, for example 
glycopeptides and polysaccharides, constitute only a very small proportion of the total 
structures. As of 2002, only those crystal structures that have been solved experimen-
tally are stored in the PDB database, whereas data of theoretical protein models are kept 
in their own section [pdb-models].
The PDB database offers several query options. A text-based search for a PDB ID or 
a keyword can be initiated on the main page. Furthermore, a number of search options 
  . Fig. 2.9 Start page of PhenomicDB (Printed with permission of Metalife AG)
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  . Fig. 2.10 Overview representation of PDB entry 2BTS (Printed courtesy of RCSB)
exist on the search database page, including detailed keyword and BLAST queries. A 
database record summarizes all of the information in the file and which is then detailed 
on subsequent pages. In addition, the molecular structure can be visualized by means of 
different applets (. Fig. 2.10).
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2.5.2  SCOP
Proteins that perform a similar biological function and are evolutionary related must 
have a similar structural organization, at least in the region of their active centers. It 
should, therefore, be possible to predict the function of an unknown protein by com-
parison of its structural organization with that of known proteins. Two databases, SCOP 
and CATH, provide such predictions. SCOP (Structural Classification Of Proteins) 
[scop] (Murzin et  al. 1995) classifies proteins of a known structure in a hierarchical 
manner. The three main classifications are families, superfamilies, and folds. Families 
describe proteins with a clear evolutionary relationship to each other and are limited by 
a sequence identity that must be at least 30% greater than the total length of the proteins. 
Nevertheless, proteins that fall below this limit can be included in a family if related-
ness can be shown owing to proven similar structures and functions. Proteins with very 
low sequence identities with respect to one other, even with suggested relations due to 
structural and functional properties, are put into superfamilies, however. Proteins that 
have the same arrangement of secondary structural elements in the same topology are 
classified into folds. It is unimportant whether the proteins have a functional relation-
ship or whether the similarity of folds is based on physicochemical principles. Recently, 
a new version, the SCOP2 database [scop2] (Andreeva et al. 2014), has been developed. 
Instead of displaying relations in simple tree structures, networks are used to do so.
2.5.3  CATH
The CATH database [cath] (Greene et al. 2007) classifies protein structures hierarchi-
cally into four categories: Class (C), Architecture (A), Topology (T), and Homologous 
Superfamily (H). The classification of proteins into the Class category is mainly auto-
matic, but it can be complemented by manual intervention when required. In the Class 
category, the proportion of secondary structural elements is taken into account without 
consideration of their arrangement or connections. Four classes of proteins are distin-
guished: proteins composed mainly of helices (mainly alpha), sheets (mainly beta), both 
helices and sheets (alpha-beta), and, finally, proteins with very few secondary structural 
elements. The Architecture category describes the arrangement of secondary structural 
elements to one another and is curated manually. Its categorization is performed via 
simple descriptors such as, for example, barrel, sandwich, and beta-propeller. In the 
Topology category, protein form and the interconnections of secondary structural ele-
ments are described. Its categorization is based on an algorithm that uses empirically 
derived parameters for domain classification. The Homologous Superfamily category 
encompasses homologous protein domains, i.e., domains with a common origin. The 
similarity of the sequences is determined by a sequence comparison followed by a struc-
tural comparison according to the classification in the Topology category. In addition 
to these four categories (whose first letters form the database name), a fifth category 
has been defined, the Sequence Families. Here, domains are classified based on high 
sequence identity (at least 35% identity over 60% of the length of the larger domain) and, 
thus, will likely possess similar functions.
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2.5.4  PubChem
The PubChem database at the NCBI [pubchem] stores small chemical molecules 
and information about their biological activities. It consists of three components, 
PubChem Compound, PubChem Substance, and PubChem BioAssay. PubChem 
Compound contains approx. 91 million molecules (July 2016) together with their 
two-dimensional (2D) molecular structures. A query is performed graphically via 
a molecular structure editor that allows the drawing of the desired (partial) struc-
ture (. Fig.  2.11). Furthermore, PubChem Compound makes possible a search for 
molecules that fulfill certain physicochemical parameters, for example, a particular 
molecular weight range, a given number of acceptors or donors for hydrogen bonds, 
and a certain logP range.
PubChem Substance permits the search for substances produced by various manu-
facturers, samples of unknown composition, and natural substances of unknown 2D 
molecular structure. The records of both databases are linked and include a link to the 
third database, PubChem BioAssay, if the corresponding data are present. Information 
on biological assays and molecules that have been tested in these systems is recorded 
in PubChem BioAssay, and this database can be queried via a text search in the Entrez 
system.
The PubChem databases have multiple applications thanks to internal and external 
database linking, including to PubMed. For example, with a known enzyme inhibitor 
it is possible to find other similar potential inhibitors. Furthermore, small chemical 
molecules can be identified that have different structures yet have been shown to have 
similar effects in a biological test system.
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  . Fig. 2.11 Two-dimensional molecular structure editor of PubChem database (Printed courtesy of 
NCBI)
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2.6 Exercises
 ? Exercise 2.1
Search for a protein (enzyme) from the organism Bacillus subtilis that hydrolyzes ter-
minal nonreducing arabinofuranoside residues. To do this, use the keyword search 
under Entrez (7 http://www.ncbi.nlm.nih.gov/entrez/). Note: hydrolysis, arabino-
furanoside, hydrolases, glycosyl, terminal, nonreducing. The Advanced search link 
leads you to an editor and your query history, so you can modify previous searches 
of the same session. Possible combinations are AND, OR, NOT.
 ? Exercise 2.2
Locate the gene for the enzyme IABF-BACSU from 7 Exercise 3.1 in the nucleotide 
database. If you are unable to find it, try to develop new search strategies from the 
results and hints provided.
 ? Exercise 2.3
Search for the protein with the following accession number in Entrez: P94552.
 ? Exercise 2.4
Search for the same accession number on the EBI home page (7 http://www.ebi.ac.uk/).
 ? Exercise 2.5
Take a closer look at the entry from 7 Exercise 2.4 and change it to the TextEntry 
view. Which information can you obtain from such an entry? Describe briefly the 
information found. It is not necessary to characterize IABF2-BACSU any further.
 ? Exercise 2.6
In the graphical representation, under Publications, in the panel on the left hand 
side, you will find a hyperlink to a publication in the journal Microbiology. Click on 
this hyperlink. What happens? Note: The hyperlink to the publication is also available 
in the TextEntry view.
 ? Exercise 2.7
In the literature, two genes for arfI and arfII are described that are homologous to 
α-L-arabinofuranosidase 1 and α-L-arabinofuranosidase 2. From which species are 
these two genes? Which other species are reported in the literature to have homolo-
gous genes that are very similar? To answer these questions, go again to the NCBI 
page (7 http://www.ncbi.nlm.nih.gov/) and search in the PubMed database. The 
History function that was mentioned earlier (7 Exercise 2.1) can also be used in 
PubMed and in all other database searches at NCBI.
 ? Exercise 2.8
In the PubMed database, look for a publication by an author with your own last 
name. How many do you find? Are there several authors with your name? If you find 
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nothing with your name, try it with the name Blobel. How can you restrict the results 
further using the name Günther Blobel, for example? How do you explain the differ-
ences with different search strategies?
 ? Exercise 2.9
Carry out a Prosite scan (7 http://www.expasy.org/prosite) with the sequence of the 
database entry IABF2-BACSU. You can enter the sequence by cutting and pasting or by 
entering the Swissprot accession number or ID. How many patterns are found? Which 
ones? What information about the motifs do you obtain on the results page? How can 
you obtain information about the biological role of the individual motifs in a simple way?
 ? Exercise 2.10
Go to the start page of the PRINTS database (7 http://bioinf.man.ac.uk/dbbrowser/
PRINTS/) and perform a Fingerprint search against the PRINTS database with the 
sequence IABF2_BACSU. Note that the sequence must be entered in raw format. When 
done, perform the same search with the sequence of the database record A1AB_
HUMAN.
 ? Exercise 2.11
Go to the Blocks server (7 http://blocks.fhcrc.org/) and initiate a database search 
with the Blocks Searcher using the sequence P35368. Because the search can take 
several minutes, possibly leading to a browser timeout, you should enter your e-mail 
address on the form. The results of the analysis will then be sent to you by e-mail. 
How many hits are found?
 ? Exercise 2.12
With the protein from 7 Exercise 2.11, query the Pfam database. The proteins of the 
Swissprot and TrEMBL databases are already present on the Pfam server. You can 
therefore either retrieve the previously obtained result with the accession number 
or protein ID or run a new analysis by providing the sequence in the FASTA format.
 ? Exercise 2.13
Repeat the preceding search (7 Exercise 2.12) using the Interpro database.
 ? Exercise 2.14
Retrieve the 3D structure of bovine rhodopsin (a GPCR) from the PDB database. 
How many entries do you find? Take a closer look at the entry with the best crystal-
lographic resolution for the complete protein (detailed in the overview). At what 
temperature was the crystallization carried out, and how many cysteine bonds does 
the protein have?
 ? Exercise 2.15
Is there an assay to check for the HERG channel activity of a molecule? How many 
compounds were tested in this assay, and how many of them were active? Use the 
PubChem database to answer this question.
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 ? Exercise 2.16
In how many assays was the molecule fenbendazole tested, and in how many of 
those assays was it active? What is fenbendazole used for, and how does the mol-
ecule differ from albendazole?
 ? Exercise 2.17
Is there a genotype-phenotype relationship in D. melanogaster that resembles the 
human genotype-phenotype relationship responsible for coproporphyria? Use 
PhenomicDB to answer this question.
References
Andreeva A, Howorth D, Chothia C, Kulesha E, Murzin AG (2014) SCOP2 prototype: a new approach to 
protein structure mining. Nucleic Acids Res 42(Databaseissue):D310–D314
Attwood TK, Bradley P, Flower DR, Gaulton A et al (2003) PRINTS and its automatic supplement, pre-
PRINTS. Nucleic Acids Res 31:400–402
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The 
Protein Data Bank. Nucleic Acids Res 28:235–242
Finn RD, Coggill P, Eberhardt RY, Eddy SR et al (2016) The Pfam protein families database: towards a 
more sustainable future. Nucleic Acids Res 44:D279–D285
Greene LH, Lewis TE, Addou S, Cuff A et al (2007) The CATH domain structure database: new protocols 
and classification levels give a more comprehensive resource for exploring evolution. Nucleic Acids 
Res 35:D291–D297
Kahraman A, Avramov A, Nashev L, Popov D et al (2005) PhenomicDB: a multi-species genotype/phe-
notype database for comparative phenomics. Bioinformatics 21:418–420
Kim KS, Lilburn TG, Renner MJ, Breznak JA (1998) arfI and arfII, two genes of encoding alpha-L-arabino-
furanosidases in Cytophaga xylanolytica. Appl Environ Microbiol 64:1919–1923
Mulder NJ, Apweiler R, Attwood TK, Bairoch A et al (2007) New developments in the InterPro database. 
Nucleic Acids Res 35:D224–D228
Murzin AG, Brenner SE, Hubbard T, Chothia C (1995) SCOP: a structural classification of proteins data-
base for the investigation of sequences and structures. J Mol Biol 247:536–540
NCBI Resource Coordinators (2016) Database resources of the National Center for Biotechnology 
Information. Nucleic Acids Res 45:D12–D17
Sigrist CJA, de Castro E, Cerutti L, Cuche BA, Bougueleret L, Xenarios I (2012) New and continuing devel-
opments at PROSITE. Nucleic Acids Res 41:D344–D347
The UniProt Consortium (2016) UniProt: the universal protein knowledgebase. Nucleic Acids Res 
45:D158–D169
Further Reading
bankit. http://www.ncbi.nlm.nih.gov/WebSub/?tool=genbank
cath. http://www.cathdb.info/
dbgap. http://www.ncbi.nlm.nih.gov/gap
ddbj. http://www.ddbj.nig.ac.jp/
ebi. http://www.ebi.ac.uk/
ebi-manual. http://www.ebi.ac.uk/embl/Documentation/User_manual/usrman.html
ena. http://www.ebi.ac.uk/ena/
entrez. http://www.ncbi.nlm.nih.gov/nucleotide
entrez-help. http://www.ncbi.nlm.nih.gov:80/entrez/query/static/help/helpdoc.html
expasy. http://www.expasy.org/
flybase. http://www.flybase.org/
gb-sample. http://www.ncbi.nlm.nih.gov/Sitemap/samplerecord.html
References
34
2
genbank. http://www.ncbi.nlm.nih.gov/Genbank/
homologene. http://www.ncbi.nlm.nih.gov/homologene
interpro. http://www.ebi.ac.uk/interpro/
mgd. http://www.informatics.jax.org/
nar. http://nar.oxfordjournals.org/
ncbi. http://www.ncbi.nlm.nih.gov/
nig. https://www.nig.ac.jp/nig/
omia. http://omia.angis.org.au/home/
omim. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM
pdb. http://www.rcsb.org/pdb/home/home.do
pdb-models. http://www.rcsb.org/pdb/search/searchModels.do
pfam. http://pfam.xfam.org/
phenomicdb. http://www.phenomicdb.de/
pir. http://pir.georgetown.edu/pirwww/dbinfo/pir_psd.shtml
prints. http://bioinf.man.ac.uk/dbbrowser/PRINTS/
prosite. http://prosite.expasy.org/
prosite-manual. http://prosite.expasy.org/prosuser.html
pubchem. http://pubchem.ncbi.nlm.nih.gov/
scop. http://scop.mrc-lmb.cam.ac.uk/scop/
scop2. http://scop2.mrc-lmb.cam.ac.uk/
sequin. http://www.ncbi.nlm.nih.gov/Sequin/
swissprot. http://www.expasy.org/sprot/
tigr. http://maize.jcvi.org/
uniprot. http://www.uniprot.org/
wormbase. http://www.wormbase.org/
wwpdb. http://www.wwpdb.org/
 Chapter 2 · Biological Databases
35
© Springer International Publishing AG, part of Springer Nature 2018
P.M. Selzer et al., Applied Bioinformatics, https://doi.org/10.1007/978-3-319-68301-0_3
3
Sequence Comparisons 
and Sequence-Based 
Database Searches
3.1  Pairwise and Multiple Sequence 
Comparisons – 36
3.2  Database Searches with Nucleotide and Protein 
Sequences – 42
3.2.1  Important Algorithms for Database Searching – 45
3.3  Software for Sequence Analysis – 46
3.4  Exercises – 48
 References – 49
36
3
3.1  Pairwise and Multiple Sequence Comparisons
The comparison of protein and DNA sequences is an important analytical method of 
applied bioinformatics. The annotations of new nucleotide and protein sequences, con-
struction of model structures for proteins, design and analysis of expression studies, 
and a variety of other bioinformatic and biological experiments are all based on these 
analyses. Nature acts conservatively, i.e., it does not develop a new kind of biology for 
every life form but continuously changes and adapts a proven general concept. Novel 
functionalities do not appear because a new gene has suddenly arisen but are devel-
oped and modified during evolution. Given this situation, therefore, one may transfer 
functional information from one protein to another if both possess a certain degree of 
similarity. However, this process must be carried out critically because similar proteins 
may yet perform different functions. The similarity of two proteins can arise based on 
evolution from a common ancestor (convergent evolution) or independently of each 
other based on different ancestor proteins (divergent evolution).
Before analyzing whether sequences are possibly related, it is first necessary to define 
some terms. Related sequences are designated as being homologous; however, the term 
homology often leads to confusion. Homology is not a measure of similarity, but rather 
signifies that sequences have a shared evolutionary history and, therefore, possess a 
common ancestral sequence (Tatusov et al. 1997). The definitions of the terms ortholog 
and paralog in combination with the function of a protein are, however, the subject of 
controversy (Jensen 2001; Gerlt and Babbitt 2001). In general, genome biologists define 
these terms as follows. Homologous proteins from different species that possess the 
same function (e.g., corresponding kinases in a signal transduction pathway in humans 
and mice) are called orthologs. In contrast, homologous proteins that have different 
functions in the same species (e.g., two kinases in different signal transduction path-
ways of humans) are termed paralogs.
Homology is not quantifiable – either two sequences are homologous or they are 
not. The identity or similarity of two sequences is, however, quantifiable. Identity is the 
ratio of the number of identical amino acids or nucleotides in a sequence to the total 
number of amino acids or nucleotides. Unlike identity, similarity is not as simple to 
calculate. Before similarity can be determined, the degree of similarity of the building 
blocks of sequences to each other must first be determined. This is done using similarity 
matrices that are also known as substitution or scoring matrices. Similarity matrices 
specify the probability that a sequence will transform into another sequence over time. 
Of course, this depends on the time elapsed and the mutational rate of nucleotides. 
Identity is an absolute measure that is, in contrast to similarity, not based on a specific 
defined model or a similarity matrix. Sequences of two homologous proteins can have 
a similarity of 60% and an identity of 40%. They do not show a 60% or 40% homology, 
a statement that can sometimes even be found in standard literature. It should be noted 
that similarity can be used only for amino acid sequences and not nucleotide sequences.
Before deciding upon the identity or similarity of two nucleotide or amino acid 
sequences, an alignment must first be calculated. The underlying principle of such an 
alignment is relatively simple (. Fig. 3.1). Two sequences are arbitrarily placed next to 
each other and the alignment judged according to the quality measure (e.g., a similarity 
matrix). The two sequences are then moved relative to one other, and for each position a 
score is calculated. This process is repeated until the best alignment is found.
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The determination of the quality measure is the real challenge for this process. For 
nucleotide sequences the simplest solution is an identity matrix (. Fig. 3.2a). Here, one 
assumes that the four nucleotides do not show any similarity to one other, and therefore, 
only identical nucleotides are factored into the similarity scoring. They are regarded as 
identical (match) or different (mismatch). For the final scoring only identical nucleo-
tides are added up.
For protein sequences, an identity matrix is not sufficient to describe biological and 
evolutionary processes. Amino acids are not exchanged with the same probability as 
might be conceived theoretically. For example, an exchange of aspartic acid for glutamic 
acid is frequently observed; however, a change from aspartic acid to tryptophan is rarely 
seen. One reason for this is the triplet-based genetic code (7 Chap. 1). For an exchange 
3 Reading frames
3 Reading frames
Identical sequences
Conservative mutation
Match and Mismatch
Insertion and Deletion
ATG
ATGGCATGCCTGATC
ATGGCATGCCTGATC
MSTPAGSDQERMILV
ACGGCTTACCTGGCC
ATGGCATGCCTGATC
MSTPAGSDQERMILV
TGC ATC GAT CTG GTA AGC CGA TGC GCA
MGTPAASFQERMSTV
MSTPAGSDQERMILV
ATGGC-TGCCTGATC
ATGGCATGCC-GATC
MSTPA-SDWERMILV
MSTPAGSDQE-MILV
MSKMAGSNVERMILV
MSRVAGSDIERMIMV
  . Fig. 3.1 Sequence align-
ments of nucleotide and amino 
acid sequences
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of aspartic acid to glutamic acid to occur only a mutation of the last nucleotide in the 
triplet codon is required (GAT/GAC to GAA/GAG). In contrast, a complete mutation 
of the whole triplet must occur in order for aspartic acid to be exchanged for tryptophan 
(GAT/GAC to TGG). Of course, such a complete mutational substitution has a much 
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  . Fig. 3.2 Scoring matrices allow the computation of optimal alignments. a Use of an identity 
matrix for the construction of an optimal nucleotide alignment. b Use of the BLOSUM62 matrix for the 
construction of an optimal amino acid alignment. Two potential alignments for each are represented; 
the optimal alignment is shown in green
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lower probability of occurring and needs a longer timeframe. A second reason for the 
mutation of aspartic acid to glutamic acid to occur more often is that both have similar 
properties (7 Chap. 1). In contrast, aspartic acid and tryptophan are chemically differ-
ent – the hydrophobic tryptophan is frequently found in the center of proteins, whereas 
the hydrophilic aspartic acid occurs more often at the surface. An exchange of aspartic 
acid for tryptophan, therefore, could greatly alter the tertiary structure of a protein and, 
consequently, its function. Such striking amino acid exchanges accompanied by a loss 
of function rarely happen.
Therefore, most algorithms use substitution matrices to align protein sequences. 
These amino acid substitution matrices describe the probability that amino acids will be 
exchanged in the course of evolution. These matrices contain a logarithm for the rela-
tionship of two probabilities that a couple of amino acids or nucleotides will appear in 
an alignment, i.e., both the probability of a coincidental concurrence and the probability 
of an evolutionary event responsible for the occurrence are taken into account. Negative 
values in the matrix mean that the occurrence is rather coincidental, whereas positive 
values suggest an evolutionary event. Because the matrix values are logarithms of rela-
tionships, addition of the numbers leads to a conclusion for the complete alignment. 
The most commonly used amino acid scoring matrices are the position accepted muta-
tion (PAM) (Dayhoff et  al. 1978) and blocks substitution matrix (BLOSUM) groups 
(Henikoff and Henikoff 1992) (. Fig. 3.2b).
Alignments can be carried out both globally and locally (. Fig. 3.3). In global align-
ments, complete nucleotide or protein sequences are compared to one another over the 
C
C
C
C
C
CN
N
N
N
N
N
Global alignment
Local alignment
  . Fig. 3.3 Global and local sequence alignment. Gaps can also appear in a global alignment, as seen 
in the lower local alignment
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entire length of the sequence. . Figure 3.4 shows the calculation of a global alignment. 
However, even very similar sequences can have single deletions or insertions and, con-
sequently, a different number of amino acids or nucleotides. To represent these align-
ments appropriately, gaps must be inserted into the sequences. Theoretically all possible 
sequences can be aligned by the introduction of gaps. To prevent this, fixed values (the 
scoring penalties) are given for the introduction of gaps (gap opening) and their exten-
sion (gap extension). These penalties are then subtracted from the alignment score to 
yield the total score. The alignment with the highest total score is considered the opti-
mal sequence comparison. This method is based on the algorithm of Needleman and 
Wunsch (1970).
Sometimes, interest may focus solely on aligning the most similar stretches within 
two sequences  – a local alignment (. Fig.  3.3). This approach makes it possible to 
identify protein domains and motifs (e.g., ATP binding sites, DNA binding domains, 
N-glycosylation sites). In principle, a local alignment is calculated in the same way as a 
global alignment using a substitution matrix and the introduction and extension of gaps. 
The difference lies in the score calculation and the path through the matrix. A negative 
score is replaced by a zero, and so the path through the matrix does not move from the 
lower right to the upper left but starts and ends at arbitrary places (. Fig. 3.4). The local 
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c
  . Fig. 3.4 Calculation of a global alignment of two similar protein sequences. a Both sequences are 
compared in a two-dimensional matrix, and the similarity of the amino acids is determined using simi-
larity matrices. Each alignment can be described as a path through the two-dimensional matrix, starting 
with the highest-scoring amino acid pair at the N-terminus. b Adding the values produces correspond-
ing scores for the different paths. The alignment with the highest score is considered optimal (red).  
c The optimal alignment is obtained by the introduction of a gap and contains 10 amino acids, of which 
7 are identical. Using the BLOSUM62 similarity matrix and a gap penalty of 1.0 a score of 31.0 is achieved
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alignment identified in the matrix with the highest score is regarded as optimal and the 
starting point. The alignment ends when a zero entry is reached. This method is based 
on the algorithm of Smith and Waterman (1981).
To compare more than two nucleotide or protein sequences, one could compare all 
sequences pairwise and then further examine these alignments. However, it is quicker 
to perform a multiple alignment (. Fig.  3.5) and analyze the overall alignment. One 
well-known program is ClustalW (Thompson et  al. 1994), which was subsequently 
superseded by Clustal Omega [clustalomega] (Sievers et  al. 2011). These programs 
utilize the fact that similar sequences are usually homologous. The basis for multiple 
sequence alignments are the pairwise alignments of all sequences. A phylogeny tree 
that represents the evolutionary relationship between the sequences in a tree structure 
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  . Fig. 3.5 Multiple-sequence alignment of four related proteins. Amino acids conserved in all four 
sequences (or with conservative changes) are highlighted in green; those conserved only in three of 
four sequences are shaded red
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is then constructed. The evolutionary distances correspond to the length of the hori-
zontal branches (. Fig. 3.6). The final multiple-sequence alignment starts with the two 
most similar sequences. Step by step, the next most similar sequence is then added and 
aligned until the final multiple alignment is retrieved.
3.2  Database Searches with Nucleotide and Protein Sequences
A frequently used application of pairwise alignments is the search for similar protein or 
nucleotide sequences in sequence databases. With older dynamic alignment algorithms 
such as those designed by Smith and Watermann (1981) or Needleman and Wunsch 
(1970), this is too slow to perform even on current computers. Instead, heuristic algo-
rithms like Basic Local Alignment Search Tool (BLAST) (Altschul et al. 1990; Boratyn 
et al. 2013) are employed (. Figs.  3.7 and 3.8). Heuristic methods make assessments 
DmHistamine
0.1
AgDopRll
AmDopRll
AmDopRl
AmDopRlll
DmDopRlllAgDopRlll
HsDopR4
HsDopR2
HsDopR3
AgDopRl
DmDopRl
DmDopRll
HsDopR1
HsDopR5
  . Fig. 3.6 Phylogenetic tree of dopamine receptor sequences. The evolutionary relationship 
between the sequences is reflected by the length of the branches. Dopamine receptor sequences of 
invertebrates (Dm, Drosophila melanogaster; Ag, Anopheles gambiae; Am, Apis mellifera) are compared 
with those of humans (Hs, Homo sapiens). Three clear clusters are formed. As a control, the phyloge-
netically distant sequence of the Dm histamine receptor was not found in any of the clusters
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to obtain almost exact results and utilize sequence and alignment statistics to make 
searches in large databases feasible. They do not guarantee an optimal alignment, how-
ever, but allow for sensitive and fast database searches. BLAST is provided as a Web ser-
vice at the NCBI [ncbi-blast], the EMBL-EBI [embl-blast], and the DDBJ [ddbj-blast]. 
BLAST is usually performed first against a nonredundant database, which is a compila-
tion of entries from different databases. In a nonredundant database, multiple entries 
are removed so that every record is available only once. These databases exist for both 
nucleotide and protein sequences.
To execute a meaningful search in a nucleotide or protein database, the correspond-
ing algorithm must be chosen from the BLAST group, and this depends on the aim of the 
search as well as the nature of the query sequence (nucleotide or protein) (. Table 3.1). 
For example, to query a nucleotide database with a protein sequence, every nucleo-
tide sequence of the database must be translated into all six theoretically possible pro-
tein sequences since the reading direction and the triplet starting point is unknown 
(. Fig.  3.1). Only then can the query sequence be compared with the database. This 
complex process is performed automatically by the algorithm tblastn. Depending on 
the nature of the query and the databases used, a total of five algorithms are possible 
(. Table 3.1).
In cases of a very low sequence identity, apparently meaningful but random align-
ments could be found that are not based on a common ancestor sequence. Therefore, 
the E-value is part of every BLAST result and can be used to assess the significance of 
an alignment. Pairwise alignments with an E-value < 0.02 are regarded as meaningful 
  . Fig. 3.7 Translated BLAST start page at NCBI. The blastx algorithm was used to compare a nucleo-
tide sequence with a protein sequence database (Printed with permission of NCBI)
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  . Fig. 3.8 Graphic representation of a BLAST result. The graph summarizes the number and length 
of hits with respect to the query sequence. The quality (alignment score) of the hits is represented by 
color coding (Printed with permission of NCBI)
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based on homologous sequences. A random alignment shows E-values > 1. The range 
in between needs further information (e.g., similar function) for a statement about 
homology.
Within the BLAST family of algorithms, Position-Specific Iterated BLAST (PSI-
BLAST) (Altschul et  al. 1997), Pattern-Hit Initiated BLAST (PHI-BLAST) (Zhang 
et  al. 1998), and bl2seq (blast two sequences) (Tatusova and Madden 1999) are 
particularly interesting. The bl2seq algorithm carries out a local alignment of two 
sequences. PHI-BLAST allows searching for proteins in a protein database with 
sequence motifs similar to those of the query. PSI-BLAST is a mixture of a pairwise 
and a multiple alignment. First, a normal BLAST search is executed. With the result-
ing multiple alignment of hits, a sequence profile is constructed, which is then used 
to continue the search for new sequences until no more are found. The interpreta-
tion of the results is frequently very difficult and occasionally misleading because 
sequences not directly related can also be taken into account. Therefore, PSI-BLAST 
results require careful examination. Hidden Markov models (HMMs) (Eddy 2004) 
operate in a similar fashion, but more slowly and with greater sensitivity. Again, 
results from HMMs must be checked critically. The Conserved Domains Search 
by NCBI recognizes conserved domains within the analyzed sequences (Marchler-
Bauer et al. 2015). There are also a number of species-specific BLAST applications 
for human, microbial, and other genomes as well as for the analysis of expression or 
immunological data and other special cases. These are available at the NCBI-BLAST 
Web page [ncbi-blast].
3.2.1  Important Algorithms for Database Searching
Needleman and Wunsch (1970) A global alignment that was first developed without 
gap functionality: The method uses a dynamic procedure, which is more efficient and 
faster in comparison with the calculation of all possible alignments. This calculation is 
still too time-consuming for the analysis of huge databases. It is very time intensive due 
  . Table 3.1 The most important algorithms of the BLAST group and their applications
Algorithm Query sequence Database Remarks
blastp Protein Protein –
blastn Nucleotides Nucleotides –
blastx Nucleotides Protein Query sequence is translated into all six 
reading frames
tblastn Protein Nucleotides Database is translated into all six reading 
frames
tblastx Nucleotides Nucleotides Query sequence and database are 
translated into all six reading frames
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to its dynamic procedure. A dynamic procedure is a solution to a problem that is broken 
down into subproblems, and the best results are then compared.
Smith and Waterman (1981) A local alignment that was originally developed without 
gap functionality: The method is very similar to that of Needleman and Wunsch and 
also quite time-consuming.
FastA (Pearson and Lipman 1988) A local alignment that is very fast due to the use of a 
heuristic method (making assessments to get almost exact results): The method identifies 
short word regions and then uses a dynamic procedure to obtain a gapped alignment.
BLAST (Altschul et al. 1990) A local alignment that can identify segment pairs of fixed 
length quickly due to the use of a heuristic method. Segments are then prolonged until 
preset threshold parameters are reached. BLAST is up to 100-fold faster than the Smith 
and Waterman algorithm.
Gapped BLAST (Altschul et al. 1997) A local alignment that looks only for a single seg-
ment pair: This segment pair is then prolonged by gaps in both directions. The gapped 
BLAST algorithm is three times faster than the ungapped BLAST algorithm.
3.3  Software for Sequence Analysis
Besides gene and protein sequences, NCBI, EBI, and other publicly accessible servers 
also provide genomic sequences. Such sequences are usually raw since they are published 
directly by sequencing units such as the Sanger Institute [sanger]. The advantage of raw 
sequence data is that predicted genes can be directly identified (. Fig. 3.9). A number 
of software solutions for gene predictions are offered on the Web. The Genscan server 
Genome
sequencing
Determination of the exon-intron
structure with
gene prediction software
Exon
Exon
Intron
Gene
  . Fig. 3.9 Identification of new genes and proteins by genome sequencing
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of the Massachusetts Institute of Technology [genscan] is particularly important and is 
based on neural networks that are trained to extract the exon–intron structure of eukary-
otic genes from genomic sequences. A typical result of a Genscan analysis is shown in 
. Fig. 3.10. Another software available for gene prediction in prokaryotic sequences is 
Glimmer from the TIGR institutes (now part of the J. Craig Venter Institute), which is 
available in its third version at the Center for Computational Biology of John Hopkins 
University [glimmer].
An interesting development in the area of sequence analysis is the European 
Molecular Biology Open Software Suite (EMBOSS) (Rice et  al. 2000) [emboss]. 
EMBOSS is an open-source project for different UNIX and Linux operating sys-
tems. The functional range of the software package grows steadily and is comparable 
with commercial packages such as that from GCG Wisconsin (Biova), the DNA-Star 
(DNASTAR Inc.), or Vector NTI software (Thermo Fischer Scientific Inc.). Expasy 
[expasy] and EMBnet [embnet] should also be mentioned. Besides databases, Expasy 
offers a number of hyperlinks to bioinformatic software. EMBnet is a worldwide 
association of different research groups and institutes and offers some free software 
for sequence analysis. In the exercise section below, we will identify other software 
packages and their applications. A comprehensive compilation of bioinformatic appli-
cations available on the Web is published once a year in the journal Nucleic Acids 
Research [nar] (Web server issue).
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0
5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
10.0 10.5 11.0 11.5 12.0 12.5 13.0 13.5 14.0 14.5 15.0
15.0
Initial
exon
Inernal
exon
Terminal
exon
Single-exon
gene
15.5 16.0 16.5
kb
kb
kb
kb
Key:
Optimal exon
Suboptimal exon
GENSCAN predicted genes in sequence embl:AC006676
  . Fig. 3.10 Graphic version of result of a Genscan analysis [genscan]
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3.4 Exercises
 ? Exercise 3.1
Calculate the optimal alignment for the following sequences (. Fig. 3.3):
Sequence 1: MTPARGSALS
Sequence 2: MTPVRRSLS
Use the EMBOSS application Needle (7 https://www.ebi.ac.uk/Tools/psa/emboss_
needle/) to do this. Calculate the scores for the similarity matrices BLOSUM62, 
PAM250, and PAM30 using a gap open penalty and a gap extend penalty of 1. Do the 
suggested similarity matrices lead to similar alignments, or are there differences?
 ? Exercise 3.2
Look for the Swiss-Prot database record for the human 5-hydroxytryptamine 2A 
receptor in the NCBI protein database [ncbi], and save the protein sequence in 
FASTA format.
 ? Exercise 3.3
With the saved sequence from 7 Exercise 3.2, perform a BLAST search for similar 
sequences in the nonredundant protein database of NCBI. Do this by going to the 
NCBI-BLAST page [ncbi-blast]. How many similar sequences are found? What infor-
mation can be extracted from the graph on the results page?
 ? Exercise 3.4
At the NCBI nucleotide database look for the entry with the AN AB037513 and save 
the nucleotide sequence in FASTA format. The sequence encodes a human 5HT2 
receptor. Then perform BLAST searches using blastn and tblastx against the genome 
database of the organism Drosophila melanogaster. How many similar sequences 
are found in each case? What can be stated regarding the quality of the hits? What 
are the differences between the two programs blastn and tblastx, and how do the 
respective search results originate?
 ? Exercise 3.5
Perform a local alignment of the protein sequences gi|543727 and gi|10726392 
using Global Align at Specialized Searches on the NCBI-BLAST page [blast]. The ANs 
can be entered directly after selecting Protein, so that no further database queries 
are required. The two sequences are the already mentioned human 5HT2 receptor 
and its ortholog in Drosophila melanogaster. How can the result be interpreted?
 ? Exercise 3.6
Perform a multiple alignment with the protein sequences gi|543727, gi|7296517 and 
NP_649806 using Clustal Omega [clustalomega]. How can the result be interpreted?
As a remark: You have to download the sequences from the NCBI database and store 
them in FASTA format. The input mask on the Clustal Omage page [clustalomega] 
can be used unchanged with standard settings. The sequences can be inserted into 
the text mask.
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 ? Exercise 3.7
Perform a multiple alignment with the following sequences analogously to 
7 Exercise 3.6 and calculate a phylogenetic tree for the proteins Q28944.1, 
P25975.3, NP_081182.2, NP_640355.1, NP_001903.1, AAH12612.1. How can the 
result be interpreted? To what kind of proteins do the sequences belong? Note: Save 
both the alignment (Download Alignment File) and phylogenetic tree (Download 
Phylogenetic Tree Data). Have a look at the alignment with a visualizer. One visualizer 
can be found on the Clustal Omega page (tab Phylogenetic Tree). Treeview [treeview] 
is another online visualizer. You can directly copy the results (Phylogenetic Tree tab at 
Tree Data) into the first text field Paste your tree in newick format. Delete the second 
text field and display the tree using ViewTree!.
 ? Exercise 3.8
Find an entry for a eukaryotic cosmid in the NCBI nucleotide database, e.g., AN: 
AC012088, and display the sequence in FASTA format. In a second browser window 
go to the Genscan server [genscan] and copy-paste the sequence into the corre-
sponding window. Then run Genscan. Try to interpret the result. Search for further 
cosmid sequences of different species and repeat the exercise.
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4.1  The Sequencing of Complete Genomes
A new era in genome research started in 1995 with the publication of the first com-
pletely sequenced bacterial genome from the human pathogen Haemophilus influen-
zae. For the first time one could analyze a complete genome, including both genes 
and their regulatory regions. Three years later, the sequencing of the first multicel-
lular eukaryotic genome, from the nematode Caenorhabditis elegans, was completed. 
Eukaryotic genomes are larger and far more complex than those from bacteria 
(7 Chap. 7). A comparison of eukaryotic and prokaryotic genomes demonstrated 
that genes encoding proteins constitute a much smaller proportion of the eukary-
otic genome. Thus, in humans and mice just 1.4% of the genome actually encodes 
genes, and only 5% of both genomes are highly conserved even though both share 
approximately 80% gene orthology. In addition to protein-encoding genes, con-
served regions contain important regulatory elements, non-protein-encoding genes, 
and regions important for chromosome structure. For the greater proportion of the 
genome, however, there are few data regarding function (Mouse Genome Sequencing 
Consortium 2002).
The relatively low number of genes identified in the human genome was at first sur-
prising. At the beginning of the human genome sequencing project, it had been esti-
mated that the number of genes would be on the order of 100,000–150,000. To date, 
however, only 19,000–20,000 genes have been demonstrated (Ezkurdia et  al. 2014). 
A similar number of genes were also estimated for the mouse genome. Interestingly, 
humans possess only about 3,000 genes more than the nematode C. elegans. In view of 
the fact that a human body contains several billion cells, whereas C. elegans has just 959 
somatic cells, this small difference in the number of genes is remarkable.
4.2  Characterization of Genomes Using STS and EST Sequences
4.2.1  Sequence-Tagged Sites are Landmarks 
in the Human Genome
Sequencing the entire human genome was a huge achievement. More than three billion 
nucleotides had to be sequenced and assembled in the right order. In a sense, the project 
could be compared to assembling a large jigsaw puzzle. It was first necessary to establish 
landmarks in the genome to allow for the correct placement of sequence regions. The 
most important landmarks in the genome are sequence-tagged sites (STSs), short DNA 
sequences 200–500 nucleotides long that are present only once in the genome of an 
organism. STSs are generated by the polymerase chain reaction (PCR), a method for 
the amplification of specific nucleotide sequences. Because STSs are unique, they can 
always be specifically amplified by PCR from genomic DNA.
DNA clones are examined by database searches for the existence of matching STS 
regions and then positioned on chromosomes or in genomes. Using this approach, a 
precise physical map of the humane genome could be generated.
A database dedicated to STSs has existed since 1994; this is the dbSTS [dbsts], which 
was transferred to a division of GenBank in 2013. Here, one can find all the information 
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available for individual STSs, including the STS name, sequences of the oligonucleotides 
necessary for PCR amplification, size of the PCR product, conditions for the PCR, and 
the nucleotide sequence of the STS.
Shortly following publication of the concept of STS-based mapping in 1989, it was 
recognized that STSs could also be generated from complementary DNA (cDNA) 
clones. Such cDNA clones originate from cellular mRNA and, thus, correspond to the 
expressed genes of a cell. In addition to genome mapping, STSs derived from cDNA can 
also be used to localize genes within a genome. Indeed, by 1996, a genetic map of the 
human genome had been assembled.
4.2.2  Expressed Sequence Tags
It was soon realized that partial sequences of cDNA clones could also be used in the 
discovery of new genes (Adams et al. 1991). Because cDNA clones are derived from 
expressed genes, the sequences were called expressed sequence tags (ESTs). ESTs are 
generated by the end-sequencing of cDNAs (. Fig. 4.1). ESTs are easy to produce at 
a reasonable price, and many EST projects have resulted in the identification of new 
genes. However, the concept of EST sequencing also met with opposition. Critics noted 
that sequencing just cDNA would miss important and nonexpressed gene regulatory 
regions. Second, some ESTs are just too short to assign a gene function, and, finally, 
  . Fig. 4.1 Section of electropherogram from dideoxy DNA sequencing reaction with corresponding 
nucleotide sequence of expressed sequence tag (Clipping from Ensembl database, printed with kind 
permission from EBI, Hinxton, UK)
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ESTs, being automatically generated, can be of poor sequence quality. Frequently, not 
just nucleotide changes occur, but also base insertions and deletions that lead to frame-
shift errors. Simply, it was feared that many public EST databases would be of poor 
quality.
Despite these criticisms, EST projects became widely accepted. In particular, the 
speed with which ESTs could be generated on a high-throughput scale (owing to the 
automation of DNA sequencing technology and plasmid DNA production) resulted 
in a real boom for EST projects. Important EST projects were initiated at Washington 
University (WU) [washington], for example. In collaboration with the American phar-
maceutical company Merck & Co., Inc., in Kenilworth, New Jersey, USA, WU sequenced 
580,000 human ESTs between 1995 and 1997. These ESTs were generated from cDNA 
libraries that had been made available by the Integrated Molecular Analysis of Genomes 
and their Expression (IMAGE) consortium, which is a merger of several academic 
research groups that produce high-quality cDNA libraries and make them available for 
other research, such as EST projects. The IMAGE consortium has the largest collection 
of publicly available cDNA libraries worldwide [image].
As a reaction to the huge increase in EST data, dbEST [dbest] was established at 
NCBI to collect all publicly accessible ESTs. In 1993, less than 50,000 sequences were 
stored in dbEST; today, however, more than 74 million ESTs from over 2,400 organ-
isms are stored in this database (dbEST release 130101, January 2017). One drawback 
of dbEST is that it contains redundant ESTs, especially for strongly expressed genes 
like actin. For this reason, the UniGene database [unigene] was established in which 
all cDNAs and ESTs that originate from an identical gene are combined into a group or 
cluster. The result is a reduction in the number of entries down to the actual number of 
proteins produced in an organism. Because of its nonredundancy, UniGene is a useful 
basis for other databanks such as ProtEST and HomoloGene [homologene]. ProtEST is 
integrated into UniGene and provides information on whether cDNAs and ESTs that 
are assigned to a UniGene cluster are similar to known protein sequences upon trans-
lation. In contrast, the independent database HomoloGene provides information on 
whether human UniGene clusters have homologs in other species.
Another NCBI database, dbGSS [dbgss], stores Genome Survey Sequences (GSSs). 
Like ESTs, GSSs are partial nucleotide sequences with a length of up to 1,000 bases and 
generated by end-sequencing individual clones. The difference between GSSs and ESTs 
is the nucleic acid source material: GSSs are prepared from genomic libraries, whereas 
cDNA libraries are used for ESTs. Thus, GSSs differ from ESTs by potentially contain-
ing DNA fragments that lie outside of areas encoding genes. More than 35 million 
sequences from more than 1,000 organisms are stored in dbGSS (dbGSS release 130101, 
January 2017).
Although the importance of EST projects has diminished over the years, we 
will present a brief overview of how an EST project was done because the principal 
approach is similar to the modern high-throughput sequencing (7 Sect. 4.6.3). The 
similarity of the two approaches is easy to see if we compare an EST project to whole 
transcriptome shotgun sequencing, also known as RNA-Seq (Wang et al. 2009). Both 
approaches start with the generation of a cDNA library. In addition, the following steps 
of high-throughput sequencing are easier to understand if we keep in mind how an 
EST project works.
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4.3  EST Project Implementation
At the beginning of an EST project, the starting material for the construction of a 
cDNA library is selected. This can be cells, specific tissues, or even whole organisms 
(. Fig. 4.2). From this material total RNA is isolated, which predominantly comprises 
ribosomal RNA (rRNA), transfer RNA (tRNA), and messenger RNA (mRNA).  The most 
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interesting of these in the construction of a cDNA library is mRNA because it represents 
all active genes of a given cell or tissue. It is present only in very small amounts (approx. 
3% of the total RNA). The very unstable mRNA is transcribed into the considerably more 
stable cDNA by the viral enzyme reverse transcriptase. The cDNA is then cloned into 
plasmids that serve as vectors. Usually cDNAs are cloned directionally, i.e., it is known 
at which end of the vector the 5′ and 3′ ends of the cDNA are located. Plasmids are 
amplified by transforming the bacterium Escherichia coli, resulting in the desired cDNA 
library, which can then provide the basis for generating EST sequences. The transformed 
bacteria are plated and grown on nutrient media, and plasmid DNA is isolated from ran-
domly selected individual clones. The cloned cDNA can then be sequenced either from 
the 5′ or 3′ end or from both ends simultaneously. The identified nucleotide sequence is 
then exported to a computer, and the raw data are bioinformatically processed.
The quality of the data is first checked in a process called quality trimming. For 
example, quality trimming defines the minimum length that an EST must have and what 
number of ambiguous nucleotides (variable N) is allowed relative to the nonambiguous 
nucleotides (A/T/G/C). Modern sequencers permit the computation of quality scores 
that are a measure of the quality of the sequencing of each individual nucleotide. Using 
these values, sequence regions of poor quality, e.g., the ends of sequences, are removed. 
Finally, any contamination with sequences from vector and bacteria are also removed.
Curated ESTs are a collection of random cDNA sequences of different lengths, and 
many are derived from identical transcripts. Many ESTs will be found particularly for 
highly expressed genes. To eliminate redundancy, therefore, alignments of these ESTs 
are generated to form overlapping sequences that are as long as possible (. Fig. 4.3). 
These consensus sequences are compared again to other ESTs so that further identical 
ESTs are incorporated into the alignment. This iterative process is described as sequence 
assembly. Often sequence assembly programs such as CAP3 [cap] and Phrap [phrap] 
are used. Sequence assemblies are either contigs whose sequences correspond to the 
consensus sequences of the alignments or singletons that are not similar to other ESTs 
and, therefore, cannot be grouped into contigs.
For large EST data sets, it can be useful to subdivide ESTs into groups or clusters first. 
Those clusters displaying identical nucleotides for a given region are summarized into 
groups. Finally, within these groups, a more stringent sequence assembly is performed 
to generate consensus sequences. Thus, ESTs that descend from alternatively spliced 
forms are arranged into the same clusters, but different contigs,  better depicting the EST 
relationships. One useful program for sequence clustering is stackPACK [stackpack].
4.4  Identification of Unknown Genes
Once ESTs are arranged into contigs, the corresponding consensus sequences can be 
used to identify unknown genes. For this purpose, annotation and sequence searches 
are carried out against various databases.
ESTs are usually first annotated, i.e., a potential function is assigned to both the level 
of the single ESTs and the assembled contigs by comparison with existing proteins of 
known function. Usually the BLASTx algorithm is applied whereby the EST nucleo-
tide sequences are first translated into all six reading frames. This process is shown in 
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. Fig. 4.4 using an EST sequence obtained from bovine intestine. The EST was anno-
tated by BLASTx against a nonredundant protein database and shows high similarity 
with part of murine caspase 6. Caspases are proteases that function during programmed 
cell death (apoptosis). Because of the similarity to caspase, it can be inferred that the 
gene transcript from which the EST is derived encodes either a true caspase or a protein 
containing a caspase domain. It is important to state that ESTs are usually partial gene 
sequences, and therefore, alignments may not contain the entire length of a deduced 
protein. Indeed, ESTs often encode only the untranslated region (UTR) of mRNA, 
and such ESTs are known as nonencoding ESTs (. Fig. 4.5). These difficulties can be 
avoided, however, when ESTs are extended by sequence assembly, sometimes to the 
point where the entire protein can be identified.
By direct comparison of EST sequences between different organisms, similar or even 
new genes or proteins may also be identified. Generally, however, it is not advisable to 
attempt this at the nucleotide level (e.g., with BLASTn) because little similarity exists 
between species due to species-dependent codon usage (7 Chaps. 1 and 7). However, 
sequences normally show greater conservation at the amino acid level. Therefore, 
sequences should be compared after translation of the nucleotide sequence into all six 
reading frames. For this, tBLASTx, which automatically carries out both the transla-
tion and the database comparison, is a good choice (7 Chap. 3). However, when large 
EST library
Sequence Assembly
Consensus sequence 1 Consensus sequence 2 Singleton
Contig 1 Contig 2 Singleton 1
  . Fig. 4.3 Classification of ESTs into contigs and the formation of consensus sequences
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  . Fig. 4.5 EST sequences are derived from coding and noncoding segments of an mRNA
b
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  . Fig. 4.4 Annotation of an EST sequence from bovine intestine. a The translated EST has an identity 
of 89% over a length of 175 amino acids (525 nucleotides) with murine caspase 6. Sequence differ-
ences are highlighted in red. The numbering of the EST sequence from 1 to 525 refers to nucleotides. 
In contrast, the numbering of the caspase 6 protein from 22 to 195 refers to amino acids. b Schematic 
of alignment of EST sequence with sequence of murine caspase 6
databases are being queried, some time may be needed. An interesting example of a 
large-scale comparison is the evaluation of EST sequences from different parasitic 
worms. At WU in St. Louis, a parasitic nematode sequencing project is under way in 
which more than 300,000 ESTs of different parasitic threadworms are being sequenced 
[nematode]. By comparison of these data sets it will be possible to find genes that are 
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ubiquitous in all nematodes. Such an approach has been used to clarify evolutionary 
relationships within the phylum Nematoda (Blaxter 1998).
Using EST data, new members of a protein family can also be identified. The 
procedure to identify new protein kinases in the nematode EST data set is shown in 
. Fig.  4.6. To start, one compares the peptide sequence of a known protein kinase 
(e.g., from mouse) with an EST database (e.g., dbEST). If a nematode EST sequence 
How can a novel
protein kinase be identified
in EST data from nematodes?
Compare the peptide sequence of a known
protein kinase (e.g. from mouse) with EST
data from nematodes
Are EST sequences
from nematodes with
high identity to protein
kinases of mouse
availabel?
EST database
e.g. dbEST
Compare EST sequences of
protein kinases from nematodes with a
non redundant protein database
non redundant database
If no identical protein can be
detected in the database, a noval
protein kinase has been identified.
Are the identified
protein kinases from
nematodes already
stored in nr-DB?
  . Fig. 4.6 Strategy for identification of new members of protein families
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of high identity to the mouse kinase is found, then it is likely that the EST encodes a 
protein kinase. To determine whether the identified protein kinase is novel, the ESTs 
must be compared with a nonredundant protein or nucleotide database. If no identical 
sequences are identified, then a new member of the protein kinase family has indeed 
been found.
4.5  The Discovery of Splice Variants
In addition to helping identify new genes, ESTs can also identify alternative gene 
splice variants. Alternative splice variants can arise upon gene transcription and dur-
ing the processing of the RNA primary transcript. During splicing, noncoding introns 
are removed from the primary transcript and the remaining exons joined to form the 
mature mRNA (7 Chap. 1). During alternative splicing, one exon can be replaced by 
another, thereby creating a new mRNA. In this way, different mRNAs, encoding differ-
ent proteins, can arise from a single primary RNA transcript (. Fig. 4.7). Alternative 
splicing, therefore, is an efficient strategy for producing several proteins from one 
gene. It is believed that alternative splice forms exist for one-third to two-thirds of all 
human genes (Yeo et al. 2004). For example, two mRNA transcripts are known for the Fc 
receptor that is important in immunology. During alternative splicing the cytoplasmic 
domain of the receptor is exchanged for a second form. Because the individual cytoplas-
mic domains are crucial for signal transduction, alternative splicing generates domains 
with very different cellular functions.
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  . Fig. 4.7 Alternative splicing. The generation of several mRNA transcripts from a single gene by the 
combination of different exons (E) is called alternative splicing
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ESTs derived from fully processed mRNAs can give valuable hints as to the identi-
fication of unknown splice variants. ESTs are compared with nucleotide databases that 
contain information for mRNA transcripts (e.g., GenBank) or with protein databases 
(e.g., UniProt). In cases where otherwise identical sequences are found to differ in a few 
regions, e.g., by insertions or deletions, this can be evidence for alternatively spliced 
variants. Through such EST comparisons with known sequences in public databases, 
numerous alternatively spliced gene variants have already been discovered. At the 
University of California at Los Angeles, two databases called ASAP and ASAP2 of the 
Alternative Splicing Annotation Project have been established in which alternatively 
spliced genes, identified via EST sequences, are stored. Also, many gene prediction pro-
grams such as GrailEXP use EST sequences to correctly predict genes from sequenced 
genomes and derive information regarding splice sites [grailexp].
4.6  Genetic Causes for Individual Differences
A characteristic of eukaryotic genomes is the presence of mutations or genetic varia-
tions. These variations are responsible for the individual differences in a population. 
The most frequent variations are single-nucleotide polymorphisms (SNPs) caused by 
the exchange of a single nucleotide. Other polymorphisms are short deletions and inser-
tions (deletion insertion polymorphisms) and variations due to repetitive sequences 
(short tandem repeats).
A consortium of commercial and noncommercial institutions has identified almost 
1.8 million SNPs in the human genome (Thorisson and Stein 2003). Many of these SNPs 
lie outside genes and, therefore, do not alter cellular function. However, other SNPs lie 
within genes and are responsible for the occurrence of phenotypes. Example pheno-
types are the color of eyes or hair, but also disease conditions. Functionally important 
SNPs are discovered by comparing the appearance of a phenotype with the frequency 
of a specific SNP. If a correlation is found, it is likely that this SNP is responsible for the 
phenotype. Because individuals are randomly selected for these correlation analyses, 
the strategy is simpler and faster than classical pedigree analyses, in which the appear-
ance of phenotypes must be traced back in a family over several generations.
An example of a SNP-based disease is phenylketonuria in which the degradation 
of phenylalanine is disrupted. Point mutations in the enzyme phenylalanine hydroxy-
lase lead to inactivation of the enzyme. Many different SNPs have been discovered in 
the human phenylalanine hydroxylase enzyme, and these are collated in the database 
Phenylalanine Hydroxylase Locus Knowledgebase [pahdb]. Because of the missing 
enzyme activity, phenylalanine accumulates in the brain of newborns and infants and 
ultimately leads to a mental defect. Newborns are therefore examined in many coun-
tries for high blood levels of phenylalanine. Disease symptoms are preventable by a 
phenylalanine-poor diet, allowing those affected to live a normal life.
Genetic polymorphisms can also be an advantage. One example of this is the dif-
ferential susceptibility of individuals to infection by the human immunodeficiency 
virus 1 (HIV-1). In addition to the surface protein CD4, the virus requires additional 
coreceptors, such as the chemokine receptor CCR5, to enter the cell. A mutant of this 
receptor with a deletion of 32 nucleotides was discovered in 1996. This mutation leads 
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to a shift in the reading frame and subsequently to the translation of a nonfunctional 
protein that is no longer present at the cell surface. Humans who are homozygous for 
this mutation (both alleles disrupted) are more resistant to HIV-1 infection. Those 
who are heterozygous for the mutation (one functional allele) will develop AIDS 
later and have a longer life expectancy than those who lack the frame shift muta-
tion. In the Caucasian population of the USA, this polymorphism is homozygous 
at a frequency of 1%, with another 20% having a heterozygous allele. Unfortunately, 
among African and East Asian populations, this polymorphism is found only rarely 
(Berger et al. 1999).
SNPs are also excellent genomic markers because they are distributed over the entire 
genome and found at high density (on average every 300–500 nucleotides in the human 
genome). Moreover, SNPs have a low mutation frequency between generations and are 
detectable by high-throughput methods. SNPs, therefore, allow for the generation of 
precise genetic maps of high resolution. This resolution facilitates the discovery of dis-
ease genes, particularly if several genes are responsible for the emergence of complex 
illnesses like cancer or diabetes.
A number of methods exist for the detection of SNPs or genotyping. Microarray 
genotyping is based on the principle that the denaturation temperature of hybrid-
ized DNA strands will decrease if nonidentical nucleotides are present. The advan-
tage of this high-throughput method is that it allows for the simultaneous and 
parallel analysis of many sequences. Other techniques for identifying SNPs are 
based on enzymatic reactions that show a very high specificity for their substrate 
and are, thus, more accurate than hybridization-based methods. A commonly used 
enzyme-based genotyping technique is pyrosequencing [pyrosequencing]. Short 
DNA segments are sequenced in real time without the necessity for time-consum-
ing gel purification steps. The advantage of this method is that the entire vicin-
ity of the SNP is sequenced and serves as an internal control for the sequencing 
reaction. An alternative enzyme-based technology is single-base primer extension, 
which provides precise quantitative results at a moderate cost. Short oligonucleotide 
sequences hybridize exclusively next to the SNP. These oligonucleotides then serve 
as primers for polymerases that incorporate a labeled nucleotide at the position of 
the SNP. The incorporated nucleotide is then detected using colorimetric methods 
or by mass spectroscopy. Furthermore, SNPs can also be determined in silico, i.e., by 
graphically comparing similar EST sequences from different individuals. Using such 
multiple alignments, nucleotide exchanges are very easy to recognize. However, cau-
tion is advised when describing new SNPs using ESTs because these can contain 
sequencing errors interpretable as SNPs.
The dbSNP database is the NCBI repository for polymorphisms [dbsnp]. Each entry 
contains details of the genetic variation, adjacent nucleotides, and frequency of the poly-
morphisms. It also includes data about the experimental method and conditions used to 
identify the SNP. The dbSNP contains approximately 780 million polymorphisms from 
53 organisms, of which 545 million are human (September 2016). Moreover, a curated 
collection of human SNPs can be found in the GWAS Central, formerly known as the 
Human Genome Variation Database [gwas]. These SNP entries have been subjected to 
an additional quality check and are completely annotated.
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4.6.1  Pharmacogenetics
Pharmacogenetics (or pharmacogenomics) deals with genetic variations that are 
responsible for how patients differ in their reactions to drugs. A study in the USA in 
1994 reported that 2.2 million patients suffered from serious medication side effects and 
that over 100,000 patients died. Thus, there is a greater chance of dying from drug side 
effects than from most viral infections. Accordingly, the ability to predict how a patient 
might react to a drug prior to starting therapy would be a tremendous advance.
How a patient responds to drugs is a complex process involving many different pro-
teins including the receptors and enzymes that bind to and metabolize drugs, respec-
tively. Genetic variations in such proteins can result in decreased or absent drug binding 
or drug metabolism. Of particular importance are polymorphisms in proteins of the 
cytochrome P450 family. For example, the enzyme CYP2D6 is responsible for the metab-
olism of 20–25% of all prescription drugs. Mutations in CYP2D6 can influence the rate 
at which drugs are metabolized. Depending on the type of mutation, one can distinguish 
patients with ultrafast, extensive, medium, and slow drug metabolism. Clearly, therefore, 
genetic polymorphisms greatly influence the individual reactions of patients to drugs. 
Because SNPs represent by far the most frequent genetic variations, the search for SNPs 
that influence a drug’s effect or metabolism is of central importance to pharmacogenetics.
As stated, a major aim of pharmacogenetics is to predict unwanted side effects of a 
drug in advance of therapy. An important prerequisite for this is the development of diag-
nostic tests to understand the genetic predisposition of patients and how they might react 
to a specific drug. In such diagnostic tests the genotype of every patient is established, i.e., 
whether relevant proteins such as drug-metabolizing enzymes show distinct polymor-
phisms. Patients can then be classified into corresponding groups and a suitable therapy 
selected based on their genotype (. Figs. 4.8 and 4.9). This is also referred to as strati-
fied medicine because therapy is optimized and tailored to every patient belonging to a 
distinct responder group. An example already practiced in many countries is the chemo-
therapeutic treatment of patients with acute lymphatic leukemia (ALL). Mercaptopurine 
and thioguanine are frequently used as drugs that are incorporated into the DNA of 
proliferating cells (especially cancer cells), leading to their eventual death. One enzyme 
responsible for the metabolism of these compounds is thiopurine-S-methyltransferase. 
Clinical studies have shown that genetic polymorphisms greatly influence the activity of 
thiopurine-S-methyltransferase and, therefore, the toxicity and efficacy of mercaptopu-
rine and thioguanine. Patients deficient in thiopurine-S-methyltransferase accumulate 
these drugs in blood cells at high concentrations, which eventually causes death. By con-
trast, in patients with high thiopurine-S-methyltransferase activity, mercaptopurine and 
thioguanine must be used at higher doses. Therefore, each patient is examined for poly-
morphisms in the gene encoding thiopurine-S-methyltransferase and the most effective 
dose determined before treatment with mercaptopurine and thioguanine.
In addition to patients in the clinic, pharmacological research has also benefited 
from pharmacogenetics. Prior to approval for use in patients, every new drug candi-
date must be tested in extensive clinical studies using the strictest safety and efficacy 
criteria. Pharmacogenetics offers the possibility of excluding those patients unlikely to 
react to therapy or who might experience undesired side effects before the start of each 
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study. This process increases the chances that a drug will reach the market through the 
appropriate selection of patients who will benefit from the drug without unpleasant or 
even dangerous side effects. A list of drugs that cannot be used unless their suitability 
for individual patients is tested can be found at the Web site of the Verband Forschender 
Pharmaunternehmen [vfa-personalisiert]. Moreover, pharmacogenetics will allow the 
development of new drugs for patient groups that do not respond to existing therapies 
or will allow for the stratification of the therapy. Patients with an ultrafast metabolism 
who metabolize a given drug extremely fast could be given an alternative drug or a 
higher dose of the same drug. Accordingly, patients with a slow metabolism, where 
dangerous plasma levels of the drug could be reached, can be medicated using an alter-
native drug or a lower dose. Such drug incompatibilities can be observed relatively 
  . Fig. 4.8 Pharmacogenetics: Diagnosis and therapy are applied in tandem. A patient’s genetic pre-
disposition influences the effect of a given drug. Analysis of the patient’s genetic predisposition can 
help in choosing a reasonable drug
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often for prodrugs, i.e., drugs that are converted to active drugs by being metabolized 
(e.g., Tamoxifen), as well as for drugs that are not prodrugs (e.g., antidepressants like 
Mirtazapine). Some companies, like Humatrix AG [humatrix, stratipharm], specialize 
in diagnostic tests to evaluate the suitability of drugs for individual patients.
It should also be considered that individual reactions to drugs can only be partly 
explained by genetic variations and that other factors may also influence drug efficacy 
and safety (Everett 2016). These include the patient’s age and nutritional status, the con-
sumption of alcohol, the status of the patient’s microbiome, whether additional disease 
conditions coexist, and whether other drugs are being taken. Moreover, the existence of 
a genetic variation can, but need not, lead to a metabolic variation.
If we want to increase the success rate of individual medicines, we therefore need to 
keep in mind not only the patient’s genetic predisposition but also her individual meta-
bolic profile. Metabolic profiling using physicochemical methods has been going on 
for some 10 years now. In recent years, the terms metabonomics and metabolomics have 
been introduced. However, the initial studies showed that the metabolic profiles of two 
patients after medication with the same drug are critically dependent on the patients’ 
metabolic profiles before the medication. The microbiome of a patient’s gut influences 
the metabolism of the drug and, therefore, its effect. This knowledge led to a new disci-
pline, pharmacometabonomics. This discipline predicts the effect of a drug based on a 
patient’s metabolic profile before medication is administered using mathematical mod-
els. The application of pharmacogenomics and pharmacometabonomics should lead to 
a higher quality of individual medicine (Everett 2016).
4.6.2  Personalized Medicine and Biomarkers
The adjustment of a therapy to a patient’s genetic predisposition and individual meta-
bolic profile is often also referred to as personalized medicine. This term can be found 
quite often in the scientific literature starting around 2000, after which time it has gained 
  . Fig. 4.9 Genotyping of patients by detecting SNPs
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importance, although a clear definition of the term remains elusive, which leaves room 
for interpretation. Schleidgen and coworkers (Schleidgen et al. 2013) derived a common 
understanding by comparing 653 scientific publications defining the term using lexi-
cal approaches. Based on their investigation, personalized medicine strives to optimize 
stratification, i.e., the evaluation of current risk, and treatment on the basis of a knowl-
edge of biological information and knowledge of biomarkers on the level of molecular 
metabolic pathways, genetics, proteomics, and metabolomics. Indeed, this definition is 
somehow cumbersome. In the end, it just means that personal biological properties are 
considered for the therapy of each individual patient. Special attention is thereby paid to 
biomarkers, which, among other methods, are determined on a genetic basis.
Biomarkers are simply parameters that can be used for diagnosis, prognosis, and 
therapy. Commonly known examples are parameters in hemograms, which are used 
by physicians for diagnosis and to monitor therapeutic success or to modify therapy. 
Given the great complexity of diseases like cancer, such global biomarkers are no longer 
sufficient. Biomarkers are needed that allow for a finer-grained picture. Here we find a 
connection to pharmacogenetics, where knowledge of a patient’s genetic predisposition, 
e.g., a polymorphism in thiopurine-S-methyltransferase, is used as a biomarker to opti-
mize therapy. In a rather similar way, biomarker research looks for regions in genomic 
DNA, mRNA, or proteins that are correlated with diseases or that can be correlated to 
the reaction to some therapy. Once such biomarkers are established, they can be used 
for diagnosis, prognosis, and therapy. Knowledge of a patient’s genome is paramount for 
genetic biomarkers. Until recently, it was impossible to sequence individual genomes. 
Only with the emergence of next-generation sequencing (NGS) did the sequencing of 
genomes become a suitable diagnostic method that could be carried out in a few days 
at a cost of only a few thousand U.S. dollars, instead of taking 10 years and at a cost of 
approx. USD 3 billion.
How does one identify biomarkers? One possibility is a genome-wide association 
study (GWAS) [nhgri-gwas]. The goal of a GWAS is to identify alleles that are correlated 
with given diseases, i.e., alleles that are found if some disease is present and not found 
in the absence of the disease. If such a correlation is found, at first only an association 
is established. Whether it is a causative association must be determined by further bio-
chemical and molecular biological studies. For a GWAS, two study groups are formed, 
one with individuals possessing some special property, e.g., a disease, and one made 
up of individuals not possessing that property. DNA samples of both groups are then 
analyzed for genetic variations. Either the whole genome or just special marker areas, 
i.e., defined SNPs, are analyzed. Recent technical progress in DNA sequencing (7 Sect. 
4.6.3) and falling costs now allow for sequencing more patient genomes. This makes it 
possible to use GWASs for diagnostic purposes on the one hand, e.g., in pharmacoge-
netics (7 Sect. 4.6.1), and on the other hand for predictive purposes, e.g., to search for 
known allele-property associations in a given patient’s genome, even if the disease has 
not yet emerged. The identification of such an association however, does not mean that 
the disease must eventually emerge; it just means there is a certain probability that it will. 
For instance, consider hemochromatosis, which is connected to a homozygous mutation 
in the HFE gene. The probability that the disease will indeed emerge is only 30–50%, i.e., 
of 100 patents showing the mutation in the HFE gene, only 30–50 patients show clinical 
signs of the disease. That said, it becomes clear that the ever-growing number of known 
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human genomes not only has advantages for patients and society but also raises social 
and ethical questions. How does a patient cope with the knowledge of a risk factor, for 
instance, or what should insurance companies do with this information? This textbook 
is not the proper forum for answering such a question; however, it is important to keep 
in mind that despite all the euphoria over the technical possibilities, public dialog is 
necessary.
4.6.3  Next-Generation Sequencing (NGS)
As mentioned earlier, NGS allows for the rapid sequencing of whole genomes. Moreover, 
it is also possible to sequence RNA (RNA-Seq, see 7 Sect. 4.2.2), identify splice variants 
and splice sites, quantify mRNA very precisely. It also allows one to study the microbial 
diversity in humans or the environment. NGS, therefore, has become a very impor-
tant tool in everyday research. Several methods are available, which follow a similar 
basic principle. In a first step, a DNA library is created. This library consists of short 
DNA fragments (fragmentation), which are elongated by short DNA stretches of known 
sequence on both 5′ and 3′ ends (adaptation). These adapters are used in the next step to 
fix the DNA fragments to solid reaction media and to amplify them (amplification). In 
this step, several methods are used that in the end form clusters of identical DNA frag-
ments. The actual sequencing then takes place in the individual clusters. The last step 
is the data presentation, and all methods present the data in the form of a DNA chip.
The principal difference in the various systems lies in the technical details of the 
sequencing. In principle, four systems can be defined:
 5 Pyrosequencing: During the sequencing reaction, a pyrophosphate is set free, which 
via a sequence of chemical reactions leads to the emission of light. This light is 
detected by a camera. The bases are added subsequently, and the camera detects 
whther light is emitted. Before adding the next base, a wash step is carried out.
 5 Sequencing by synthesis: This method involves the use of nucleotides that are bound 
to a terminator and a fluorescent dye. After the nucleotide has been added, the 
fluorescent dye is excited and the emitted fluorescent wavelength is recorded. Sub-
sequently, the terminator is removed and the next nucleotide can be added.
 5 Sequencing by ligation: Instead of a DNA polymerase, 16 different oligonucleotide 
probes are used. Each of the nucleotide probes carries one of four different fluores-
cent dyes at its 5′ end. Each octamer consists of two specific and six general bases. 
For the sequencing a specific primer is bound to the adapter of the DNA sequence 
and a fitting probe is ligated using a DNA ligase. After a washing step, the fluo-
rescent signal is recorded and the last three DNA bases and the fluorescent dyes 
are removed. This is done seven times, followed by a denaturing step. The process 
is started anew with a primer that binds, shifted by one nucleotide. Five different 
primers are used in total.
 5 Ion semiconductor sequencing: This method is similar to pyrosequencing. Instead 
of recording the release of a pyrophosphate, the release of a proton is detected. The 
DNA clusters are bound to a semiconductor chip capable of measuring the sur-
rounding pH value. Once a nucleotide is added, a single proton is released, leading 
to a change in the pH value that can be detected by the semiconductor chip.
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Each of the methods has advantages and disadvantages, e.g., different read lengths, 
reagent costs, error rates, acquisition time, and coverage. Coverage means the number 
of reads in a sequence assembly necessary to reproduce a reference sequence. For a 
complete genome, the minimum coverage is 30. Today, only two methods can reach 
this level of coverage for a human genome – sequencing by synthesis and sequencing 
by ligation. Pyrosequencing is suitable for bacterial genomes and for simple eukaryotes, 
e.g., Arabidopsis thaliana [ngs-movie, ngs-knowledge-base].
The amount of data generated by NGS constitutes a formidable challenge. Even 
a compressed FASTQ file  – a specialized file format that per sequence contains the 
sequence identifier, the sequence itself as in a FASTA file, and two additional lines, one 
for comments and one for quality scores – easily reaches a size of 200 GB for a human 
genome with a coverage of 60. A project with 10–20 genomes therefore uses approxi-
mately 4 TB of disk space. Therefore, not only is storage not trivial, but transferring this 
amount of data between different research groups represents a challenge. A cloud solu-
tion seems appropriate. The National Institutes of Health (NIH) has two cloud systems 
called Biowolf and Helix [nih-biowolf]. In Europe, the EMBL is working on a cloud 
system based on the Helix Nebula cloud [helix-nebula].
Another challenge is the realignment or mapping of short reads to the reference 
genome. Because of the short length of the reads, they fit several positions of the refer-
ence genome. Moreover, the reference genome is large, and it can thus be difficult to 
find the correct position. Because of sequencing errors and the nature of SNPs, a certain 
variability of the mapping process is necessary. Errors can be distinguished from real 
variants later on. Several algorithms are available for read mapping, e.g., BWA, Bowtie, 
SNP-o-matic, NextGenMap, and BLAT, a far from comprehensive list; an exhaustive 
list of algorithms can be found at the HTS-Mapper Web site [hts-mapper]. The output 
of many mapper programs is in SAM/BAM format, where the BAM format is a com-
pressed binary version of the human-readable SAM format. BAM files can be indexed, 
allowing for rapid access to any region of a sequence. Special tools, e.g., SAM tools 
[sam-tools], allow for the analysis, modification, and visualization of sequences.
Once the mapping is complete, the genome information can be analyzed, e.g., single-
nucleotide variants like SNPs can be identified. Also for this step several tools are avail-
able, such as SAM tools MAQ, VariationHunter, and destruct, for instance. An overview 
of tools and methods can be found in the Wikibook Next Generation Sequencing (NGS), 
which is constantly being updated [wikibooks-ngs].
4.6.4  Proteogenomics
With the emergence of NGS it quickly became clear that the number of splice variants 
and nucleotide polymorphisms must lead to a much greater number of variations in 
the proteome than are stored in standard databases. The goal of proteogenomics is to 
study the actual connection between the genome and the proteome. For this, proteins are 
“sequenced” by generating a protein fingerprint using mass spectrometry (MS), which is 
compared to a database of theoretically derived protein fingerprints. If an experimentally 
derived fingerprint is identical to a theoretically derived one, the proteins are identi-
cal and the sequence of the unknown protein is revealed. The databases of theoretical 
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protein fingerprints are built based on NGS data connecting the genome to the pro-
teome. The method is much older than its name, which was coined only in 2004. Already 
in the 1990s and 2000s shotgun proteomics was being used, where MS data were used to 
search protein databases. In 2004, Jaffe and coworkers (Jaffe et al. 2004) used a six-frame 
translation of the Mycoplasma genome as the protein database and coined the term 
proteogenomics. The concept has quickly been used for more complex organisms and is 
nowadays, in combination with NGS, of crucial importance for identifying and studying 
human protein variants in biological and medical research (Sheynkman et al. 2016).
Different kinds of nucleotide data are suitable for this method. First EST data were 
used, which are either translated to three or six reading frames, depending on the 
knowledge of the actual orientation. If genomic data are used, they are translated to six 
potential reading frames. In addition, RNA-Seq data are used, as are data of ribosomal 
sequencing, where mRNA molecules bound to ribosomes are sequenced. Last but not 
least, special databases focused on specific variations, e.g., splice variants or SNPs, are 
used (Sheynkman et al. 2016; Nesvizhskii 2014).
Although a number of protein variants have been discovered so far, both methods 
are based on fragments, i.e., in the case of NGS, DNA or RNA fragments, and in the 
case of proteogenomics, enzymatically digested proteins. The complete and unimpaired 
sequence, therefore, cannot be revealed with 100% confidence. Therefore, it is at least 
possible that more variants remain undiscovered. However, both methods will improve 
over time, allowing for the discovery of intact sequences.
4.7 Exercises
 ? Exercise 4.1
How many ESTs does the database dbEST at NCBI contain (7 http://www.ncbi.nlm.
nih.gov/dbEST/index.html)? What two organisms have the most entries, and what is 
their percentage of the total number of entries?
 ? Exercise 4.2
Determine by querying dbEST how many Mangifera indica ESTs there are. Note: 
Enter the name Mangifera indica on the home page of dbEST, then repeat the 
search, this time entering Mangifera indica [ORGANISM]. Explain the differ-
ences between the two results.
 ? Exercise 4.3
Save the result of the second search in FASTA format.
 ? Exercise 4.4
Using the saved sequences perform a sequence assembly. Use the CAP3 sequence 
assembly program of the PRABI-Doua Institute (7 http://doua.prabi.fr/software/
cap3). Note: The server accepts a maximum of 50,000 bases. How many contigs 
are built?  How many ESTs do the contigs contain? Also, are there ESTs that are not 
grouped into contigs (singletons)?
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 ? Exercise 4.5
Annotate the ESTs by comparing the contigs with a nonredundant protein database 
using the BLASTx algorithm. To do this, go to the NCBI BLAST home page. Can reli-
able hits for all contigs in the protein database be found?
 ? Exercise 4.6
Search for an EST with the accession number (AN) AI590371 using the database 
query system Entrez at NCBI. Save the sequence in FASTA format.
 ? Exercise 4.7
Compare the saved EST sequence with the nonredundant nucleotide database of 
the NCBI. To do this, use the NCBI BLAST home page. How many reliable nucleotide 
sequence hits can be found in this database?
 ? Exercise 4.8
How many EST sequences are stored in the UniGene database for the first hit 
(sequence ID NM_080870.3)? In which disease is this protein involved and in which 
human population is this disease prevalent?
 ? Exercise 4.9
What can be learned about the expression of the protein from the EST of 7 Exercise 4.8?
 ? Exercise 4.10
Using the database query system Entrez at NCBI, locate the protein sequence of the 
mouse proto-oncogene c-myc with the AN P01108. Save the sequence in FASTA format.
 ? Exercise 4.11
Compare the saved sequence of the protein c-myc with an EST database from the mouse. 
Use the NCBI BLAST home page to do this. Are mouse ESTs found in the database? What 
is noticeable about the distribution of the ESTs, and how can this be explained?
 ? Exercise 4.12
In addition to very good hits (alignment score >200, red bars), many hits with an 
alignment score of 80–200 (magenta bars) are found. Do these ESTs also encode the 
protein c-myc? Give reasons for the result. Note: Compare the nucleotide sequences 
of this EST with the protein database UniProtKB.
 ? Exercise 4.13
At the NCBI book collection find Genes and Disease. In that book you will find infor-
mation about phenylketonuria. On which human chromosome is the gene for phe-
nylalanine hydroxylase found? Click on the hyperlink to the database Entrez Gene. 
What information does this database provide?
 ? Exercise 4.14
In the dbSNP database at NCBI (7 http://www.ncbi.nlm.nih.gov/SNP/) search for the 
reference cluster with the ID rs334. In which organism is this SNP found? Examine 
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the category GeneView. Compared to the reference sequence (contig reference), 
which nucleotide exchange is found? Does it result in an amino acid exchange? If so, 
which one? What gene is affected by this SNP? Follow the link of the gene name to 
the database Entrez Gene. What disease is caused by the mutation?
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5.1  Protein Structure
Proteins are macromolecules whose monomeric subunits are the naturally occurring 20 
amino acids. The amino acids are linked via peptide bonds (generated upon water 
release) to form a polypeptide (7 Chap. 1). Polypeptides can range in length from three 
to several hundred amino acids. The amino acid sequence of a given protein, also known 
as the primary structure, is genetically determined. It becomes fixed during translation 
based on the information encoded in the mRNA.
The properties of an extended  polypeptide chain correspond to a cross section of 
those of the corresponding amino acids, i.e., the function of the corresponding protein 
cannot be determined solely from the primary structure. It also depends on the spatial 
arrangement of the amino acids to one another. Stretched polypeptide chains  fold spon-
taneously into secondary structures and then into three-dimensional (3D) structures. 
The secondary structure can comprise two main structural features, the α-helix and the 
β-sheet. These structural elements are connected via nonrepetitive elements called 
loops, which consist of irregular turns as third secondary structural elements. It is the 
combination of the positioning of the amino acid side chains and the peptide backbone 
of the secondary structure that forms the protein tertiary structure. If a protein consists 
of several subunits, then the association of these subunits to form the functional protein 
is called the quaternary structure.
The function of a protein is mediated by its 3D structure, which, if known, can allow 
the inference of function. A reliable ab initio prediction of protein tertiary structure 
based solely on the primary structure is not yet possible, at least in the near future. Also, 
the experimental determination of structure is still difficult and the number of known 
protein structures comparatively small. Therefore, the prediction of the protein function 
based on the tertiary or quaternary structure is limited. However, proteins show a vari-
ety of structural and topological features that can be used to predict their properties and 
functions. Many of these features can be inferred or predicted from the primary struc-
ture by computational methods. Some of these properties and their predictions are dis-
cussed in what follows.
5.2  Signal Peptides
For many proteins the site of synthesis is not the site of action. This applies to trans-
membrane proteins, proteins within the endoplasmic reticulum, and proteins that are 
secreted or imported into lysosomes. Prior to their activation, these proteins must first 
be transported to the site of action, and this is facilitated by a peptide recognition signal 
for the cellular transport system. The recognition signal is an N-terminal leader sequence 
(signal peptide) that consists of approx. 15–30 amino acids placed on the N-terminus of 
the mature protein (. Fig. 5.1). According to the signal hypothesis of Günter Blobel and 
David Sabatini (Blobel and Sabatini 1971), the signal peptide is recognized by a signal 
recognition particle, guiding the nascent  polypeptide chain through the membrane of 
the endoplasmic reticulum. As soon as the signal peptide has passed the membrane, it 
is specifically cleaved from the nascent  polypeptide by a signal peptidase. Proteins with 
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a signal peptide are called preproteins or, in those cases where they also contain propep-
tides, preproproteins. Unlike signal peptides, propeptides are proteolytically removed to 
allow for protein activation (. Fig. 5.1).
The presence of a signal peptide gives an important clue as to the site of action of 
proteins. This knowledge in turn can help clarify function and, thus, help in determin-
ing whether that protein is a suitable target molecule. For this reason, methods for 
predicting the presence of signal peptides in the primary structure have been devel-
oped. An example is the program SignalP from the Center for Biological Sequence 
Analysis (CBS) at the Technical University of Denmark [signalp] (Petersen et al. 2011). 
The recognition of signal peptides by the signal recognition particle is not due to a 
conserved amino acid sequence but depends on physicochemical properties. A signal 
peptide usually consists of three parts. The first region (the n-region) contains 1–5 
usually positively charged amino acids, the second region (the h-region) is made up of 
5–15 hydrophobic amino acids, and the third region (the c-region) has 3–7 polar but 
mostly uncharged amino acids. A classical sequence alignment method is therefore 
unsuitable for the prediction of signal peptides. The SignalP program in its current 
fourth version is instead based on the use of neural networks. Using machine learning 
methods, the characteristics of a training data set with known sequences are learned 
and can be used for the prediction of unknown data. The trained neural networks are 
thus able to judge the properties of amino acids in unknown sequences, thereby allow-
ing the recognition of signal sequences. SignalP uses two different neural networks 
since signal peptides and transmembrane helices (7 Sect. 5.5.3) can hardly be differ-
entiated. One neural network is therefore trained with signal peptide sequences, while 
Cys 25
M1
M1 M2 M3 ExtensionPre Pro
M2
M3
Q-x(3)-[GE]-x-C-[YW]-x(2)-[STAGC]-[STAGCV]
[LIVMGSTAN]-x-H-[GSACE]-[LIVM]-x-[LIVMAT](2)-G-x-[GSADNH]
[FYCH]-[WI]-[LIVT]-x-[KRQAG]-N-[ST]-W-x(3)-[FYW]-G-x(2)-G-
[LFYW]-[LIVMFYG]-x-[LIVMF]
His 159
Asn 175
S
S S
S S S S
  . Fig. 5.1 Schematic illustration of a preproprotein exemplified by cysteine proteases of the papain 
family. The amino acids of the catalytic triad (Cys25, His159, and Asp175) are each located within the 
characteristic sequence motifs of cysteine proteases (M1–M3). Only a few cysteine proteases have an 
additional C-terminal extension for which a function is still not known
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the other is trained with sequences of transmembrane helices. Using this approach, 
the false positive rate of predicted signal peptides could be minimized.
Before the analysis is started it is important to choose the right organism group 
because the gram-negative bacteria, gram-positive bacteria, or eukaryotes. . Figure 5.2 
shows the graphical output of the SignalP program for the outer membrane protein C 
(precursor) from Salmonella typhimurium (OMPC-SALTY, P0A263). The C-score 
stands for cleavage site score, which was trained on the recognition of the cleavage site 
between signal peptide and the protein sequence, and predicts the cleavage site of SPase 
I. The maximum C-score occurs at the position of the first amino acid of the mature 
protein, so one position behind the cleavage site. The S-score, the signal peptide score, 
is trained on the differentiation of signal peptides and other sequences and has a high 
value if the corresponding amino acid is part of the signal peptide. Therefore, amino 
acids of the mature protein have a low S-score. The Y-score (combined cleavage site 
score) is a geometrical mean of the C-score absolute values and the gradient of the 
S-score and shows where the C-score is high and the S-score has its inflection point. 
Analysis of the three scores shows the likely cleavage site between amino acids 21 and 
22. In addition, two more values are calculated. The S-mean is the average of the 
S-scores of all amino acids of the signal peptide. Consequently, if there is a signal pep-
tide, this value should be high. The D-score is the arithmetic mean of the S-mean value 
and the maximum value of the Y-score. It will also be high if a signal peptide has been 
predicted.
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  . Fig. 5.2 Graphical output of SignalP server [signalp] at CBS
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5.3  Transmembrane Proteins
Biological membranes contain integral proteins that have various functions in the cell, 
such as acting as cell–surface receptors. Integration into the membrane lipid bilayer is 
accomplished by hydrophobic interactions between the protein and the nonpolar chain 
structures of the lipids. The polar head groups of the lipids build hydrogen bonds and ionic 
bonds with the protein. Integral membrane proteins are therefore always amphiphilic mol-
ecules that have both hydrophilic and lipophilic regions. These proteins are orientated 
asymmetrically in the membrane, i.e., some membrane proteins are only exposed on one 
side of the membrane, whereas others completely penetrate the membrane and are exposed 
on both the extracellular and intracellular sides. The latter are called transmembrane pro-
teins. The hydrophobic transmembrane domains are usually formed by α-helices.
The prediction of transmembrane proteins is of great importance for classification 
and defining function, as described previously for signal peptides. The program 
TMHMM [tmhmm] of the CBS server in Denmark can predict transmembrane 
domains. TMHMM is based on a hidden Markov model (HMM) that has been trained 
to detect hydrophobic transmembrane helices. Furthermore, the program also predicts 
the orientation of the individual domains in the membrane (intracellular or extracellu-
lar) and, accordingly, of the whole protein.
The graphical output of such a prediction with TMHMM is shown in . Fig. 5.3 for 
the transmembrane domains of the G protein-coupled receptor (GPCR) 
5- hydroxytryptamine-1B receptor of the mole rat Spalax leucodon ehrenbergi (5H1B- 
SPAEH). Such GPCRs are integral membrane proteins with typically seven transmem-
brane domains. In the graph, the probability of a transmembrane helix and its 
intracellular or extracellular localization is plotted along the amino acid sequence. 
Additionally, in the upper part of the figure, a schematic representation of the topology is 
inserted. The graphical representation of the probabilities also allows the recognition of 
transmembrane helices of relatively low likelihood.
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  . Fig. 5.3 Graphical output of TMHMM server [tmhmm] at CBS
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5.4  Analyses of Protein Structures
As stated earlier, the prediction of a protein 3D structure from an amino acid sequence 
is currently not feasible and will not be feasible for the foreseeable future. Therefore, 
experimental methods must be employed to determine protein structures. The two pri-
mary approaches are X-ray crystallography and high-resolution nuclear magnetic reso-
nance (NMR) spectroscopy. A third approach using the electron microscope is useful 
for large proteins. Overall, despite much technological progress, these methods are still 
very time-consuming and costly, and the successful resolution of a crystal structure is 
not guaranteed for every protein.
5.4.1  Protein Modeling
A useful and fast method for structure prediction is homology modeling of proteins based 
on sequence homology. The approach is based on the fact that related proteins within a 
protein family that have a high degree of amino acid sequence similarity also have similar 
protein folds (e.g., cysteine proteases of the cathepsin family) (see also . Figs. 5.5 and 5.6). 
Proteins for which the 3D structure is already known serve as reference proteins or tem-
plates. First, the amino acid sequence of the protein to be modeled is compared with the 
sequence of the reference protein(s) using pairwise or multiple- sequence alignments (in 
case of several reference proteins). For sequences with identities of more than 70%, the 
modeled structures can be predicted very accurately. However, for sequences with identities 
of less than 30%, difficulties with the modeling can arise. The sequence identities of struc-
turally conserved regions (SCRs) are frequently above those of less conserved loops, and 
both influence the degree of identity of the complete sequence. Interestingly, areas of little 
conservation are often found at the protein surface and have a comparatively small effect on 
SCRs, which are found inside the protein where most of the active centers are situated.
To identify SCRs  in reference proteins, a structural alignment of the amino acid 
sequences based on the secondary structure is performed. The sequence to be modeled is 
then arranged on the oriented templates, and the spatial coordinates of the SCRs  are then 
transferred to the model sequence. The coordinates of the loops are usually taken from 
similar regions of other protein structures. The spatial orientation of the side chains of 
individual amino acids in the SCRs is maintained as in the templates. For all noncon-
served side chains, the statistically most likely position is taken. The process of homology 
modeling is completed both by calculations that lead to energy minimization of the model 
and checking of the structural relevance of the resulting protein model. The SWISS-
MODEL Server [swiss-model] of the Swiss Institute of Bioinformatics in Lausanne can be 
used for the automatic calculation of homology models (Biasini et al. 2014). In the case of 
proteins with a high sequence similarity, the calculated models are often of high quality.
5.4.2  Determination of Protein Structures 
by High-Throughput Methods
The number of experimentally determined protein structures stored in the world’s only 
archive for structures of biological macromolecules, the Protein Data Bank (PDB), has 
grown enormously in recent decades [pdb] (Westbrook et al. 2003). In 1972, PDB con-
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tained just one structure, in 1992 the number was approximately 1,000, and by April 
2003 it had grown to 20,622. In November 2016, the PDB contained 124,029 structures. 
This remarkable increase in information can be attributed mainly to the technology 
process including automatization and high-throughput approaches for solving a struc-
ture. The Protein Structure Initiative was one main contributor to this advancement. 
This initiative was an international scientific consortium of different national initiatives 
from Japan, North America, and Europe. The aim was nothing less than to structurally 
solve all of the proteins encoded in the genomes of the most important organisms 
(archaebacteria, eubacteria, and eukaryotes).
To solve the structures, X-ray structural analyses and NMR spectroscopy were used in 
a high-throughput format. To decrease the number of protein structures to be experimen-
tally solved, only representatives of the different protein families were examined. The 
underlying idea was that proteins could be divided into protein families and that sequence 
similarity usually leads to structural similarity. The conclusion is that the number of differ-
ent structural folds of proteins found in nature must be limited. One estimate is that between 
10,000 and 30,000 protein families exist, and these contain approximately 1000–5000 differ-
ent protein folds. Of these, approximately 1400 folds are currently known. However, it must 
be considered that similar protein structures do not inevitably have similar functions and 
that different protein structures may also perform similar functions. For example, the cys-
teine proteases are divided into three structurally different groups based on protein folding 
patterns: the papainlike proteases, the Picorna virus proteases, and the caspases.
To accomplish the ambitious goal of the Protein Structure Initiative, the strategy was 
as follows:
 1. All known protein sequences were grouped into protein families using bioinfor-
matics methods.
 2. Representatives of each protein family were produced in sufficient quantity by 
molecular biological methods.
 3. The protein structures of these representatives were experimentally determined 
using protein crystallography or NMR spectroscopy.
 4. All other protein structures of the respective protein families were generated by 
homology modeling.
Using this procedure a huge amount of new protein fold patterns were identified, thereby 
making an important contribution to the functional elucidation of all known proteomes. 
In the meantime, the benefit for modern pharmaceutical drug research was questioned, 
since most protein structures were solved without function annotation. However, the 
results will be invaluable in the future. The current initiative called the Structural 
Genomics Consortium is therefore more focused on the structural solution of diseases-
relevant proteins. It should be possible to utilize these structures for structure- based ratio-
nal drug design and significantly support drug development (Burley and Bonanno 2002).
5.5  Structure-Based Rational Drug Design
From the sequencing of whole genomes and the generation of the corresponding biological 
information, a modern approach to pharmacological research has been established. To initi-
ate the development of a new drug, a drug target (de facto, a protein) that plays a key role in 
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the disease must first be identified (see also 7 Chap. 7). After the target’s function has been 
experimentally confirmed (drug target validation), small- molecule chemicals are identified 
that influence the protein’s function in such a way as to alleviate or cure the corresponding 
disease. The specific inhibition of an enzyme by a chemical inhibitor would be an example.
The overlapping technologies of computer-assisted approaches like bioinformatics, 
chemoinformatics, and molecular design have become essential components of modern 
drug discovery efforts. These strategies are indispensable for the identification and vali-
dation of drug targets as well as for the screening and design of new small molecules. 
Also of special importance is the three-dimensional structure of the drug target to allow 
for structure-based rational drug design. For example, virtual screening, which tests the 
protein target’s interaction with chemical entities in large compound libraries, is an 
established approach that is incorporated into most discovery strategies. Unlike experi-
ments conducted in the laboratory, virtual screening is automated, being conducted at a 
computer, and many chemical substances can be tested for their activity spectrum rela-
tively quickly. The most important approaches are pharmacophore-based screening 
(Wolber et al. 2008) and docking (Kitchen et al. 2004).
The word docking is the modern pictorial paraphrase of the lock-and-key concept 
postulated in 1894 by Emil Fischer (Fischer 1894). The specificity of the receptor–ligand 
complex is brought about by the geometric and physicochemical complementarity of 
both. Induced fit is another kind of this hypothesis, where the geometry of the binding 
site is adapted upon ligand binding. The best known programs in use are DOCK, devel-
oped by Irvin Kuntz at the University of California, San Francisco [dock] (Ewing and 
Kuntz 1996), GOLD from the Cambridge Crystallographic Data Centre [gold] (Jones 
et al. 1997), FlexX of BioSolveIT GmbH in Sankt Augustin [flexx] (Rarey et al. 1996), and 
Autodock developed at the Scripps Research Institute [autodock] (Morris et al. 2009).
5.5.1  A Docking Example Using DOCK
With DOCK all possible orientations of a ligand and its receptor can be generated. For 
example, the protein structure of an enzyme with a clearly defined active center can 
constitute a typical receptor. The structure of the ligand can originate from a database of 
chemical molecules such as the Available Chemicals Directory.
In the example shown, the cathepsin L-like cysteine protease of the infectious third- 
stage larva of the filarial worm Brugia pahangi serves as receptor. This enzyme is impor-
tant for the molting and development of this parasite. The protein structure was 
generated by homology modeling.
 1. The first step is the characterization of the active center (site characterization, 
. Fig. 5.4). To do this, the molecular surface of the active center is generated first 
(subprogram MS) and converted to a negative image (subprogram SPHGEN). 
Overlapping spheres are then fitted into the active center (. Fig. 5.5). The center of 
the spheres will eventually be replaced by the atoms of the ligand.
 2. In the second step, a calculation of physical, chemical, and topological parameters 
is carried out at each nodal point of a space grid (grid calculation) in order to 
compute a score, which can be either a contact score based on the ligand fit or a 
force field score.
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a b
   . Fig. 5.5 Spherical model of cathepsin L-like cysteine protease of filarial Brugia pahangi. The 
underlying protein structure was generated by homology modeling. a The most important amino 
acids in the active site cleft, which is located between the two main domains of the protein, are 
indicated in color. The active site cysteine (top) and histidine (bottom) of the catalytic triad are 
highlighted in yellow. The active site asparagine is hidden in the structure. Important amino acids of 
the S′ subunit are drawn in cyan, and those of the S subunit are in green and pink. b Graphical 
representation of characterization of catalytic cleft by DOCK program (subprogram SPHGEN).  
The centers of the overlapping spheres, where later the atoms of the ligands will lie, are  
represented in red
Receptor Coordinates
Site Characterization
MS              molecular “dot” surface
SPHGEN   negative image of site
Ligand Coordinates
DOCK
Matching
Orientation
Scoring
Grid Calculation
CHEMGRID    for force-field scoring
DISTMAP        for contact scoring
  . Fig. 5.4 Schematic representation of mode of operation of program DOCK [dock]
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 3. After these calculations, the actual docking can take place. This can be done in two 
modes, the single DOCK mode or the search DOCK mode. In the single mode, 
DOCK generates all possible orientations of a single ligand in the active center 
(. Fig. 5.6). In the search mode, large databases of chemical molecules are 
searched. To do this, the best orientation of every ligand is first generated and then 
saved as a relative score in comparison to all other ligands. The connections with 
the highest-ranking scores are examined for size, fit, and interaction with the active 
center. The best compounds can then be experimentally tested for activity in 
appropriate assays.
For the example of the cysteine protease of Brugia pahangi (Lecaille et al. 2002), a chemi-
cal database of known cysteine protease inhibitors was searched with DOCK, and hydra-
zide compounds known to inhibit the cysteine proteases of the parasites Trypanosoma 
cruzi, Trypanosoma brucei, Leishmania major, and Plasmodium falciparum had very 
high scores. The binding of the identified hydrazides was then more thoroughly exam-
ined in the single DOCK mode to identify the most promising inhibitors (. Fig. 5.6). 
Subsequent experiments with the best predicted inhibitors prevented the development of 
the infectious third-stage larva to the fourth-stage larva (Selzer 2003).
a b
  . Fig. 5.6 Model of catalytic cleft of cathepsin L-like cysteine protease of Brugia pahangi, into which 
a chemical compound was modeled using DOCK. a The protein is displayed in its secondary structure 
(ribbon model). In single DOCK mode, all possible orientations of a chemical compound (hydrazide) 
were generated. All overlapping orientations of this single compound are represented in the figure: 
carbon, green; oxygen, red; nitrogen, blue. b Based on the analysis of the docking experiment 
described in panel a, the most likely orientation of the hydrazide in the catalytic cleft of the cysteine 
protease is shown. Protein and chemical compounds are represented as spheres. Coloration is similar 
to those in panel a and . Fig. 5.5
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5.5.2  Docking Example Using GOLD
GOLD is another widespread docking software. The ligand conformations in the bind-
ing site are calculated using a genetic algorithm that is based on natural genetic evolu-
tion (. Fig. 5.7). The three-dimensional conformation of a molecule is described via its 
torsion angles, which are stored as a bitvector (the chromosome). Analogously to nature, 
this would represent the genotype of ligand conformation. Evolutionary processes are 
simulated by the mutation of single bits or exchange of single parts of the bitvector of 
two different chromosomes. Thus, the three-dimensional conformation is changed 
based on a random alteration of its chromosome. Subsequently, the three-dimensional 
conformation (the phenotype) will be created based on the chromosome and fitted into 
the binding site. Each binding pose will be assessed using its fitness based on a scoring 
function. Only poses with interactions favorable to the protein showing a high fitness 
will be selected for the next round of the genetic algorithm. These steps are repeated 
until a stable score is reached.
The protein–protein interaction between thioredoxin reductase (TrxR) and its sub-
strate thioredoxin (Trx) from Mycobacterium tuberculosis is a new target for the fight 
against tuberculosis. The docking software GOLD was successfully used for the identifica-
tion of the first inhibitors of this protein–protein interaction (Koch et al. 2013). Protein–
protein interactions are in general a particular challenge since they are mostly based on 
the surface of the proteins without any deep binding pocket involved. A detailed analysis 
of the available X-ray structure revealed an interesting point of targeting. An argine side 
initialisation random conformation
genotype → phenotype transfer into protein-ligand complex
scoring
result
high score: higher probability
random alteration
new ligand conformation
stable score
fitness calculation
convergence?
selection
new population
mutation, crossover
& migration
  . Fig. 5.7 Genetic algorithm used by docking software GOLD
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chain looks out of the globular thioredoxin like an anchor group (. Fig. 5.8, top section), 
together with a hydrophobic cleft and an additional hydrogen binding interaction nearby. 
GOLD was successfully applied to enrich molecules from a virtual library of 6.5 million 
compounds that presumably bind to this hydrophobic cleft showing both described 
hydrogen bonding interactions (. Fig.  5.8, bottom section). The 170 best ranked ones 
were evaluated in a biochemical assay, with 18 molecules showing an inhibition. Overall, 
this represents a hit rate of 10.5%. Although one could expect a higher hit rate by docking 
approaches at first sight, this is a remarkable result compared to the possible alternative. 
Only the X-ray structure was known at the beginning of the study. Thus, all 6.5 million 
compounds would have been tested to find the first inhibitors. The experimental effort 
would have been disproportionate in comparison to the 170 tested compounds.
5.5.3  Pharmacophore Modeling and Searches
Knowledge of the 3D structure of a receptor is essential for docking in a virtual screen. In 
the absence of either a 3D structure or homology model, virtual screening can nonethe-
less be attempted. As long as some ligands of the receptor are known, virtual screening 
based on a pharmacophore model can be applied. A pharmacophore model is an abstract 
concept that considers the interaction potential of a molecule with its target protein and 
describes the spatial arrangement of the ligand properties that are responsible for binding 
(Wolber et al. 2008). A superposition of several known inhibitors or active ligands of a 
protein based on their pharmacophoric properties can be used to construct a pharmaco-
phore model. Possible pharmacophore features are hydrogen bond acceptors and donors, 
hydrophobic and aromatic systems, and charges (. Fig. 5.9). The spatial arrangements of 
the individual properties are analyzed to retrieve a pharmacophore model or a 
Thioredoxin
Thioredoxin
Reductase
   . Fig. 5.8 Thioredoxin reductase (gray) and its substrate thioredoxin (green). The top cutout 
shows the target point for the docking-based virtual screening (yellow arrows: hydrogen bonding 
interaction). The bottom cutout shows the docking poses of four inhibitors sharing a common 
scaffold
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 pharmacophore hypothesis. By the analysis of virtual libraries based on this pharmaco-
phore model, molecules can be identified that show a similar spatial interaction pattern 
with a potential similar activity.
All possible 3D conformations of the virtual library must be created for the final 
screening process since the spatial arrangement of pharmacophore features are fitted in 
and compared to the pharmacophore model. The overlap is described by a score, and mol-
ecules with high agreement can be used as potential ligands for experimental evaluation. 
The reduced computational time in comparison to docking is the huge benefit of pharma-
cophore searches. For this reason they are often applied to reduce the size of virtual librar-
ies and filter for subsequent docking. Software for pharmacophore modeling and 
pharmacophore searches include, for example, MOE Pharmacophore Modeling [moe], 
Phase [phase] (Dixon et al. 2006), and Ligandscout [ligandscout] (Wolber et al. 2007).
When the 3D structure of a receptor is known, receptor-based pharmacophore 
modeling can also be used. In addition, protein–ligand complex structures can be used 
to create a pharmacophore model that contains information about the protein structure 
and the known ligand (Wolber et al. 2007).
5.5.4  Successes of Structure-Based Rational Drug Design
A frequently asked question is whether such virtual methods actually lead to drugs. The 
answer is clearly yes. There are more examples than can be listed here where virtual 
technologies have contributed considerably to the development of drugs. One should 
  . Fig. 5.9 Representation of a pharmacophore model. The pharmacophore features are shown as 
colored spheres. The shown properties are aromatic (yellow), hydrogen bond acceptor (red), and 
donor (green). A molecule fulfills this model when the pharmacophore features overlay with the 
pharmacophore model
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keep in mind, however, that the development of a drug is a demanding process that 
involves many different steps. Rational drug design is only a first step on the long road 
to a marketable drug.
Dorzolamid (trade name Trusopt, marketed by Merck since 1995), which is used for 
the treatment of glaucoma, is a carbonic anhydrase inhibitor that originated as the first 
drug from a program involving structure-based rational design. A second example, 
Captopril, is a drug that lowers blood pressure whose lead structure was based on a 
natural substance that inhibits angiotensin-converting enzyme (ACE). Enalapril, 
another effective ACE inhibitor, is a further development of Captopril. Further exam-
ples are the HIV protease inhibitors Saquinavir and Ritonavir (Norvir) from Roche and 
Abbott, respectively; the tyrosine kinase inhibitor Gleevec from Novartis, which is used 
in leukemia patients; and the neuraminidase inhibitors Tamiflu, from Roche, and 
Relenza, from GlaxoSmithKline, which would never have been developed without 
rational drug design (Klebe 2013).
There are a number of examples where the DOCK program has been used success-
fully. Particularly impressive have been studies with cysteine proteases. Using DOCK 
and homology models of the cysteine proteases of Leishmania major, small molecules 
were identified that block these drug target enzymes and stop the development of pro-
mastigote and amastigote Leishmania in cell culture without damage to host cells. In a 
mouse model of leishmaniasis, progression of the infection could be considerably 
delayed (Selzer et al. 1997, 1999). Similar results in animal models were achieved for 
cysteine proteases of Plasmodium falciparum (Shenai et al. 2002), Trypanosoma cruzi 
(Engel et al. 1998), and Schistosoma mansoni (Abdulla et al. 2007). For Trypanosoma 
cruzi, the success of cysteine protease inhibitors has set the stage for clinical trials against 
Chagas disease (Barr et al. 2005).
Rational design was also used for the development of proteasome inhibitors of para-
sites. The proteasome is a multicomponent complex of protease, which regulates, for 
example, important processes of the cell cycle. A detailed analysis of substrate specificity 
and the protein structure led to selective proteasome inhibitors of Plasmodium falci-
parum (Li et al. 2016). These inhibitors are able to inhibit the parasite’s growth in vivo 
without affecting the host cells. Another proteasome inhibitor is able to inhibit the pro-
teasome of kinetoplastids. All parasites were killed in in  vivo studies using a mouse 
model (Khare et al. 2016).
5.6 Exercises
 ? Exercise 5.1
Explore how many solved protein structures are currently present in the PDB 
database [pdb].
 ? Exercise 5.2
Find the entry CHER_SALTY/P07801 in the Swiss-Prot database [swiss-prot]. Does this 
database record contain information about the tertiary structure of the receptor?
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 ? Exercise 5.3
View the PDB database record of the receptor from 7 Exercise 5.2 (ID 1AF7) and 
display the molecular structure with one of the PDB visualization programs (NGL 
Viewer would be a good choice). What information, especially at the structural level 
(primary, secondary, tertiary structure), is recognizable?
 ? Exercise 5.4
Use NGL Viewer, which should be supported by all current browsers. What display 
options provide this viewer? Analyze the ligand interaction by selecting the ligand 
in the Ligand Viewer option.
 ? Exercise 5.5
Carry out some secondary structure predictions with the amino acid sequence of 
the Swiss-Prot database record CHER_SALTY. The necessary programs can be found 
at 7 http://www.expasy.org/proteomics/protein_structure. For example, use the 
JPred server predicted secondary structure and compare it to the experimentally 
determined secondary structure.
 ? Exercise 5.6
Does CHER_SALTY have a signal peptide? Give reasons for your assumption. Check 
the presence of a signal sequence using SignalP [signalp]. Note: Salmonella 
typhimurium is a gram-negative bacterium.
 ? Exercise 5.7
Retrieve the Swiss-Prot database record P41780 from the Swiss-Prot database [swissprot] 
and repeat 7 Exercise 5.6 with this sequence. How does the program SignalP work?
 ? Exercise 5.8
The prediction of transmembrane regions works in a very similar way to the 
determination of signal peptides. The appropriate program can be found at 7 http://
www.cbs.dtu.dk/services/. Determine the transmembrane regions of the 
G-protein- coupled receptor (GPCR) with the Swiss-Prot accession number (AN) 
Q99527. How many transmembrane regions are detected? Compare this result with a 
secondary structure prediction for this receptor. Note: In general transmembrane 
regions are helices.
 ? Exercise 5.9
Perform homology modeling with the Swiss-Prot sequence P29619. To do this, go to 
the Swiss model page of the Expasy server [swissmodel] and follow the hyperlink 
Start Modeling. Paste the sequence into input field and start building the model with 
Build Model. Save the text file returned by the server with the ending .pdb and open 
this file with the Swiss PDB viewer. The viewer is available free of charge at the Web 
site [spdbv]. Tutorials for using spdbv can be found at 7 http://www.expasy.org/
spdbv/text/main.htm. Another free visualization program is Chimera [chimera].
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6.1  The Identification of the Cellular Functions 
of Gene Products
The first human genome was published in 2001 by the Human Genome Project. At that 
time it was estimated that the number of human genes was in a range between 30,000 
and 35,000. It is known today that the human genome is quite young from a phyloge-
netic point of view and shows an enormous difference between the number of genes and 
the size of the genome. It contains 19,000–20,000 genes (Ezkurdia et al. 2014), with an 
overall size of 3.3 Gigabases (see also 7 Chaps. 4 and 7). Each human cell, except for 
sperm and eggs, has a complete set of genes. Obviously, however, a blood cell differs in 
its morphology and physiology from a liver cell. How, therefore, can these differences be 
explained if all cells have the same genetic material? The answer is simple. Not every 
gene is transcribed and expressed in every cell. It follows that only those proteins that 
are required are present in a cell at a given time during the cell’s lifetime. The proteome 
of a cell or tissue is therefore dependent on the cell type and its current state.
In principle, the gene base order (the genotype) must therefore be altered via mutation 
for a modification of the gene expression and the resulting changes of the phenotype. But it 
has been shown in recent decades that environmental factors can influence the phenotype 
by alteration of the gene expression without adapting the nucleotide sequence of genes. 
This adaptation of gene expression is called epigenetic (Allis and Jenuwein 2016) and plays 
a fundamental role in the activation and inactivation of genes. The characteristic of this 
epigenetic modification is influenced by environmental factors like nutrition and stress. 
Nuclear DNA does not appear in free form but in the form of chromatin, which represents 
the basic building block of chromosomes. The basic repeat element of chromatin is the 
nucleosome, where DNA is wrapped around eight histone proteins. Based on the compact 
wrapping and the aggregation of individual nucleosomes, a gene can be active or inactive. 
In an active state it is called euchromatin and in an inactive state heterochromatin. This 
activation state can be influenced by the modification of single histone side chains. As an 
example, the acetylation of lysine side chains allows for interactions with bromodomain-
containing proteins. The binding of these proteins increases the nucleosome accessibility 
and, therefore, the activity of transcription. In contrast, methylation leads to binding of 
chromodomain-containing proteins, which increases the nucleosome aggregation and 
decreases transcription (Allis and Jenuwein 2016). By now, a wide range of modifications 
and possible combinations are known, so that this is referred to as the histone code.
It also follows that knowledge of the genome and its genes is not sufficient to explain 
how a gene, a cell, or an organism works. To understand a complex biological system, one 
must study the regulation and expression of its genes, the function of expressed proteins, 
the quantitative occurrence of metabolites, and the effects of gene defects on an organism’s 
phenotype. Besides the knowledge about genes, the function of the gene product must also 
be known. The study of this complexity is frequently termed systems biology, which tries 
to understand complete biological organisms and the dynamics behind a biological system 
as a whole. Its aim is to obtain an integrated picture of all regulatory processes at all levels, 
from the genome to the proteome and the metabolome, and from a single protein’s behav-
ior to the organelle and the biomechanics of the complete organism. Modern methods for 
the functional analysis of genomes (functional genomics) are called transcriptomics, pro-
teomics, and metabolomics (. Fig.  6.1). These are usually high-throughput procedures 
that place heavy demands on data management and -analysis. These approaches are com-
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plemented by phenotypic analyses of model organisms and cells in vitro, also in a high-
throughput format. Phenome describes all phenotypes and its analysis is called phenomics.
6.1.1  Transcriptomics
Unfortunately, the functions of many proteins based on nucleotide sequences alone are 
unknown. However, information regarding gene regulation and gene expression can offer 
insights into the functions of gene products in cells, tissues, and organisms. For example, 
because a gene is expressed exclusively in muscle cells, it can be inferred that the gene 
product is presumably important for the physiology of this cell type. Many techniques 
exist to analyze gene regulation and expression, e.g., the northern blot, which is a method 
for the detection of mRNA in agarose gels utilizing nucleic acid hybridization, or reverse 
transcriptase polymerase chain reaction (RT-PCR), a technique for the amplification of 
specific nucleotide sequences derived from mRNA. These methods, however, permit only 
the simultaneous analysis of just a few genes and are unsuitable for the efficient analysis of 
large amounts of data. Therefore, it became necessary to develop high-throughput proce-
dures that permitted a more time-efficient analysis of whole transcriptomes.
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  . Fig. 6.1 Correlation between genotype and phenotype. From the genome via the transcriptome, 
proteome, and metabolome to the phenome. The example numbers in the genotype section are 
taken from Homo sapiens. The example in the phenotype section is taken from Drosophila melanogas-
ter (Graphics of DNA, RNA, and metabolite from Lehninger Biochemie, 3rd Edition 2001, printed with 
permission from Springer-Verlag, Heidelberg, Germany. D. melanogaster microscopy images printed 
with permission from F. Rudolf Turner of Indiana University)
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6.1.1.1  DNA Microarrays
An example of a high-throughput method is the DNA microarray, which is well suited 
for the determination of cellular gene expression. Because one can create a profile of 
every cell based on the genes expressed, this method is also referred to as expression 
profiling. The solid support material of a DNA microarray can comprise a glass slide on 
which several thousand nucleic acid spots are placed next to one another (. Fig. 6.2). 
Alternatively, other materials such as nylon membranes can be used as a support. Each 
DNA spot includes many copies of a unique single-stranded DNA, allowing for its 
unambiguous assignment to a specific gene (Holloway et al. 2002).
Many techniques are used for the production of DNA microarrays. In principle, one 
can distinguish between oligonucleotide arrays and cDNA arrays. For oligonucleotide 
arrays, short sequences of 20–50 nucleotides in length are synthesized directly on the 
support material (. Fig. 6.2). The procedure involves photolithography, which was orig-
inally developed for semiconductor production and is still used in the computer indus-
try. The glass slide is coated with linkers to allow for covalent bond formation with the 
nucleotides. The linkers are blocked with a photolabile protecting group to prevent the 
nucleotides from binding nonspecifically. By selectively applying a photo mask the pho-
tolabile protecting group is removed, thereby specifically activating selected array sec-
tors. Then the surface of the array is incubated with a nucleotide solution that contains 
only one specific nucleotide, e.g., dATP. At the positions that had been activated by the 
photo mask, the nucleotide can now bind covalently to the linker of the support mate-
rial. The nucleotides themselves are also blocked at the 5′ end with a photolabile protect-
ing group, and these must be activated again before the following reaction can occur. 
Thus, by multiple repetitions and by the application of various masks, an oligonucleotide 
array of choice can be produced. This technique can produce densely packed microar-
rays with over 250,000 oligonucleotide spots per square centimeter. In 1994, Affymetrix 
became the first company to introduce a commercially available DNA chip [affymetrix].
In contrast, for cDNA arrays, considerably longer cDNA probes are placed on the 
array support (. Fig. 6.2). First, the cDNAs are amplified to a length of several hundred 
nucleotides by means of PCR in the laboratory. These are then applied in tiny volumes 
as DNA spots onto the array support by means of a robot, after which they are immobi-
lized, e.g., by ultraviolet light. A number of suppliers of spotting robots use slightly dif-
ferent procedures. One method is microspotting, whereby PCR products are applied 
with a capillary directly onto the array support. Another procedure is microspraying, 
whereby the cDNA solution is sprayed, much like from an ink-jet printer but without 
the nozzle ever touching the array support. A density of greater than 2500 DNA spots 
per square centimeter can be obtained with cDNA arrays.
The cDNA array technology is popular in many research laboratories because it is 
economical. Also, there is flexibility in the choice of the starting material (organism, tis-
sues, or cells). Another microarray type is an oligonucleotide array, which is distinguished 
by an extreme density of high-quality spots. Because of the high density, for any given 
gene, several oligonucleotides can be placed on the array, permitting control of the results 
and increasing the precision of these arrays. The disadvantage of this technology is that 
the arrays are usually not produced in-house but must be purchased, often at consider-
able expense. Moreover, one is dependent on the arrays offered by the manufacturer 
which are not customizable.
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  . Fig. 6.2 DNA microarrays. a DNA microarray that consists of several thousand nucleic acid spots and 
arrayed in high density. b Schematic illustration of production of an oligonucleotide array using 
photolithography. c cDNA solutions are spotted during array production onto microarray plates by robots
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 z The Performance of an Expression Profiling Experiment with cDNA
Many expression profiling studies compare the gene expression pattern of two different 
cell populations, e.g., that of healthy cells (cell type A) with tumor cells (cell type B) 
(. Fig. 6.3). The first step is to isolate total RNA from both cell populations. The mRNA 
is transcribed into cDNA by the enzyme reverse transcriptase and simultaneously 
labeled by the incorporation of nucleotides that have been coupled to different fluores-
cent dyes. Usually, control cDNA (in this case from healthy cells) is labeled with Cy3 dye 
and sample cDNA (from the cancer cells) with Cy5 dye. Cy3 and Cy5 emit light in the 
green and red spectra, respectively. This method is referred to as direct labeling. In con-
trast, indirect labeling methods are used only if very small quantities of starting material 
are available. In this case, modified nucleotides are incorporated during cDNA synthesis 
that binds special dyes with a high affinity.
The labeled cDNA pools are mixed and denatured, and the single-stranded cDNAs 
are then incubated with the DNA microarray. DNA in the pools hybridizes to the com-
plementary single-stranded DNA molecules making up the array. Laser activation of 
the microarray in the emission frequencies of the dyes followed by quantitative scan-
ning of the emitted light measures the amount of bound cDNA. As a result, one gets two 
pictures, one in the green and one in the red wavelength range. If both are superim-
posed, a merged picture will result with colored spots (. Fig. 6.3).
If genes are differentially expressed, i.e., in one cell population there are larger quan-
tities of a specific mRNA, the spots will appear red or green. Spots will appear red if 
more Cy5-labeled cDNA is bound, i.e., an overexpression of those genes in the cancer 
cells compared to the controls. Conversely, spots will be fluorescent green if genes are 
less expressed in the cancer cells than in the controls. Spots appear yellow if red and 
green fluorescent cDNAs have hybridized to the spotted DNA in equal amounts. This 
means that the corresponding genes are expressed in the control and cancer cells at 
equal levels. Spots for which no complementary cDNAs are present in the pools appear 
black. Thus, it is obvious that the expression of a gene is a relative value between two 
samples; absolute quantities are not possible with cDNA arrays. This differs from oligo-
nucleotide arrays that allow for an absolute quantification.
 z Interpretation of an Expression Profiling Experiment
Although the idea behind microarrays is simple, their use and the analysis of the results 
are more complex. This is due to the numerous sources of error, including statistical 
errors, based on stochastic fluctuations that cannot be influenced and systematic errors 
that lead to measurement deviations. Such systematic errors can be due to incorrect 
calibration of the instrument or changing environmental conditions (e.g., fluctuations 
in the temperature or atmospheric humidity) during its operation.
Errors can be minimized by proper experimental design. Statistical errors can be 
minimized by the repetition of experiments. Samples should be freshly prepared each 
time to ensure that each experiment is independent. Systematic errors can be mini-
mized by a sophisticated experimental design and control experiments. One control 
experiment is dye swapping, in which cDNAs are labeled with a dye that is the opposite 
of that used in the original experiment (reciprocal labeling). Specifically, if in the origi-
nal experiment the cDNA from the cancer and control cells was labeled with Cy5 and 
Cy3, respectively, then in the dye swapping control experiment, the cDNA of the cancer 
cells should be labeled with Cy3 and that of the control cells with Cy5. Because the same 
cDNA preparation is used for both the original and dye swapping control experiments 
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  . Fig. 6.3 Comparison of gene expression levels in two different cell lines as part of an expression 
profiling experiment using cDNA microarrays (Iron chip, printed with permission from M. Mucken-
thaler, EMBL Heidelberg, Germany)
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and only the label differs, similar results should be obtained. Using the dye swapping 
control experiment, one can investigate whether an error occurred during labeling of 
the samples, and, if so, the extent of the error can be taken into account in the analysis 
of the results (Churchill 2002).
Interpretation of the data starts with an analysis of the figures made by the microar-
ray scanner. The intensities of each spot must be measured to convert them into numeric 
values. This is a complex and comparatively difficult step. The many thousands of spots 
must be unambiguously identified. To do this, the peripheries of the spots and the fluo-
rescence intensities in the two light channels must be measured and both then com-
pared with the background. Atypical spots that have irregular shapes or contain clumps 
of red and green color can be marked and ignored for further analysis. All of these 
processes are usually carried out by the software of the microarray scanner.
Considering the huge number of providers of microarrays and supplies and the dif-
ferent protocols and complicated experimental setup (split into numerous individual 
steps), it is not surprising that microarray data contain systematic errors. Examples are 
the uneven distribution of the hybridization solution on an array, which leads to the 
nonhomogeneous staining of some areas of the array, or the different half-lives of the 
dyes, which can lead to inaccuracies when measuring spot intensities. To compensate 
for such systematic errors, the expression profiling values must be normalized. 
Normalization is based on the hypothesis that most genes are not differentially expressed 
in the samples. Normalization not only adjusts the results but also ensures the compa-
rability of experiments carried out on different days or in different laboratories. There 
are numerous algorithms for normalization, and they all have advantages and disadvan-
tages. The choice of algorithm depends on the experience and preference of the 
researcher (Quackenbush 2001).
It has long been a subject of discussion whether microarray platforms from different 
suppliers can be compared at all. In spite of these concerns, several researchers have 
shown that comparison is actually possible with an adequate experimental setup. 
However, standardized protocols and adequate controls are essential (Ji and Davis 2006). 
To oversee quality control, two consortia have been formed with members from aca-
demic research groups, the microarray industry, and US agencies. The MicroArray 
Quality Control Project [maqc] establishes standard controls that are aimed at facilitating 
the comparison of microarray experiments. The External RNA Controls Consortium 
(ERCC) [ercc] has similar aims. The ERCC develops external RNA controls that are 
added to the experimentally isolated RNA before cDNA synthesis. In this way, the extent 
to which the results of a microarray experiment agree with defined minimal criteria can 
be verified.
The next step in data analysis is the identification of genes for which expression is 
significantly different between the two samples. For simplicity in early microarrays, it 
was assumed that all those genes for which expression in the samples varied by at least 
twofold were differentially expressed. Today more complex statistical procedures are 
used to identify those genes with significant differences in expression levels. These 
methods have the advantage of identifying genes with low yet significant differences in 
expression levels. After these statistical analyses, a final number of genes that is differen-
tially expressed is obtained. Importantly, the results should be validated by independent 
methods, such as northern blot analysis (Slonim 2002).
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The determination of the differential expression of individual genes is not the only 
interesting aspect of microarrays, however; also of interest is the recognition of patterns 
in gene expression profiles. The idea is that genes that belong to a pathway or react in 
concert to a given environmental stimulus are coregulated and, therefore, display a 
similar expression profile. Using cluster analysis all genes with similar expression pro-
files can be combined into groups or clusters. . Figure 6.4 shows such an analysis for 
164 bacterial genes that are divisible into 13 clusters. Cluster analyses provide valuable 
insights into the function of proteins. If genes for whose products no function is cur-
rently known clustered with well-characterized genes, then coregulated expression 
could indicate a similar function or a common pathway to those unknown gene prod-
ucts. The unknown proteins could then be specifically examined for these properties.
Each expression profiling experiment generates an enormous amount of data. One 
experiment can include dozens of microarrays, which in turn consist of several thou-
sand spots. Therefore, the resulting several hundred thousand or even millions of mea-
surements must be managed and analyzed using special databases in which the data can 
be saved and retrieved at any time. Example databases are the Gene Expression Omnibus 
of the National Center for Biotechnology Information (NCBI) [geo] and the 
ArrayExpress of the European Bioinformatics Institute (EBI) [arrayexpress]. In addition 
to results, one can also find unprocessed raw data as well as the protocols and conditions 
under which the experiments were performed. These data should comply with the min-
imum information about a microarray experiment [miame] protocol in which the 
minimum requirements for an explicit interpretation and reliable reproduction of the 
microarray experiments are defined (Brazma et al. 2001).
In summary, performing microarray experiments, inclusive of the bioinformatic 
component, is complex and places high demands on the experimenter. Luckily, a variety 
of software solutions exist that simplify the analysis of the data. A known commercial 
program for the analysis of microarray data is the GeneSpring GX collection of Agilent 
Technologies [agilent]. Frequently used software packages that were developed in the 
academic environment are Bioconductor [bioconductor], the TM4 suite [tm4], and 
GenePattern [genepattern].
Besides expression profiling there are a variety of other applications for microarrays 
(Gershon 2005) that have gained increasing importance, for example in tumor medi-
cine. The optimal treatment of a cancer patient is critically dependent on a diagnosis 
that is as precise as possible, which at present is based on a combination of clinical and 
histopathological data. In some cases, however, an exact diagnosis is difficult because 
tumors frequently have atypical properties. In such cases microarrays can help classify 
tumors according to their gene expression profiles. An example is acute leukemia. This 
cancer of leukocytes can be subdivided into acute lymphoblastic leukemia (ALL) and 
acute myeloid leukemia (AML) using clinical and morphological data for diagnostics. 
The distinction of these subtypes is essential because each is treated with different che-
motherapeutics. An initial study (Golub et al. 1999) examined whether reliable results 
could be obtained by molecular diagnostics with the help of DNA microarrays com-
pared to classical methods. The gene expression profiles from patients with a known 
diagnosis were analyzed and then compared with those from patients with an unknown 
diagnosis. The result demonstrated that the microarray diagnostic tool was reliable. In 
addition, a patient with a diagnosed atypical acute leukemia was also examined. Here 
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  . Fig. 6.4 Clustering of genes with similar expression profiles. Expression of 562 bacterial genes was 
measured in 10 different experiments. The expression profiles were then compared, and genes with 
similar expression patterns were grouped into clusters. In this figure, 13 clusters (black bars) with 
overall 164 genes are shown. For instance, cluster 13 contains 18 genes, which are highly expressed in 
the first 3 experiments (red), but then subsequently expression decreases (green). The red bar 
represents the threshold selected to define a cluster
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the microarray diagnostic tool showed that this patient’s gene expression profile was 
completely different from those of other patients. Its profile pointed more to a cancer of 
muscle tissue than to an acute leukemia. Because cytogenetic examinations also dis-
agreed with an acute leukemia diagnosis and favored a muscle tumor, the final diagnosis 
and chemotherapy were changed accordingly. Thus, the classification of tumors based 
on DNA microarrays provides validated support to the standard diagnostic techniques 
(Golub et al. 1999).
Another important field for the application of microarray technology is toxicology. 
Toxicological analyses are designed to identify the damaging consequences of chemical 
substances on cells. For example, a potential new antibiotic might not only kill the infec-
tious bacterium but also damage the cells or whole organs of the patient. Therefore, any 
new potential drug is studied for its toxicological properties by comparing them with 
existing toxins. These comparisons include gene expression profiling in DNA microar-
rays. If overlaps in the expression profiles between the known toxins and new com-
pound occur, then the new substance will be classified as being potentially toxic. The 
analysis of toxicological characteristics using DNA microarrays is also known as toxi-
cogenomics.
6.1.1.2  Serial Analysis of Gene Expression
Like DNA microarray technology, serial analysis of gene expression [sage] is a high-
throughput technology for measuring gene expression. SAGE facilitates the compari-
son of gene expression in different cells or tissues and, therefore, the identification of 
differentially expressed genes. SAGE also requires the isolation of total RNA from cells 
or tissues and the conversion of mRNA into cDNA using the virally sourced enzyme 
reverse transcriptase. The cDNA is not cloned, however, but instead is treated with 
certain restriction enzymes that cut the DNA at specific sites. This results in the gen-
eration of short DNA fragments from each individual cDNA pool with a length between 
10 and 11 nucleotides, a tag. Despite being so short, a tag is usually sufficient to unam-
biguously identify a specific mRNA. The tags are connected into long serial molecules 
and subsequently cloned into plasmids for sequencing. In a SAGE experiment, the 
frequency with which a tag appears in a sample is used as a measure of the magnitude 
of expression of the corresponding mRNA. For example, if the gene tag is found 5 times 
in a sample from healthy cells but 20 times in a sample from cancer cells, then one 
assumes that this gene is approximately fourfold overexpressed in the cancer cells. 
SAGE results can be saved in the Gene Expression Omnibus [geo] database at the 
NCBI. There, the information about each tag can be found, including its DNA sequence, 
frequency in tissues or cells, and the specific transcript from which the tag was derived 
[sage, sagemap].
The great advantage of SAGE over DNA microarrays is that all mRNA transcripts of 
a cell can be analyzed, including unknown transcripts (e.g., new splice variants). In the 
case of DNA microarrays, only mRNA transcripts are analyzed with existing cDNA 
spots on the microarray. Another advantage of SAGE is its steady reproducibility 
between experiments. One disadvantage of SAGE is the enormous amount of time 
needed to conduct high-throughput experiments. DNA microarrays, in contrast, show 
a high flexibility, and in the age of genome sequencing they allow for analyzing genes of 
the whole genome in a few experiments. SuperSAGE represents an improvement in 
6.1 · The Identification of the Cellular Functions of Gene Products
102
6
these methods that seems to compensate for the drawbacks by using different restric-
tion enzymes that produce bigger tags (Matsumura et al. 2006). Millions of tags can now 
be analyzed in combination with next-generation sequencing.
6.1.2  Proteomics
The quantification of mRNA by DNA microarrays or SAGE provides important infor-
mation about potential cellular functions of gene products. Measuring mRNA alone, 
however, is not sufficient to completely and precisely describe complex biological sys-
tems. Ultimately, cellular activities like metabolic processes are mediated by proteins of 
the proteome and not by genes of the genome or mRNA of the transcriptome. Analogous 
to the DNA microarray technology, therefore, high-throughput procedures have been 
developed for the parallel functional analysis of proteins, i.e., proteomics. Proteomics is 
classified into two categories: classical or quantitative proteomics and functional pro-
teomics. Classical proteomics deals with the identification and quantification of pro-
teins in cell lysates, whereas the aim of functional proteomics is the determination of 
protein function.
The Human Proteome Project [hpp] is an international consortium of several 
research groups that is comparable to the Human Genome Project. The aim is the sys-
tematic analysis and characterization of the human proteome for a better understanding 
of human biology on the cellular level. This should lead to improved medicinal applica-
tions (i.e., improved therapy and diagnosis of diseases). An important part of the project 
deals with a chromosome-based proteome analysis to analyze and understand the func-
tion of every single gene. A cooperation of different research groups in the fields of 
genomics, transcriptomics, proteomics, and metabolomics is needed to achieve this 
(. Fig. 6.5).
6.1.2.1  Classical Proteomics
Classical proteomics is similar to expression profiling, which is why it is also termed 
protein profiling. Both technologies permit the molecular fingerprinting of a cell based 
on the genes expressed at the mRNA or protein level. By comparing two or several such 
fingerprints, differentially expressed genes and proteins can be identified. Both tech-
nologies have advantages and disadvantages. Protein profiling detects the proteins that 
ultimately perform cellular functions. Also, the quantitative modifications in a protein’s 
composition based on either a new synthesis or breakdown (protein turnover) can be 
measured. Other advantages of protein profiling are the ability to verify posttransla-
tional modifications (e.g., phosphorylation and glycosylation) and to determine the 
protein composition of cellular compartments (e.g., of a mitochondrion or nucleus). 
One disadvantage, however, is that not all proteins are soluble, particularly transmem-
brane proteins, and therefore cannot be detected. A second limitation is the limit of 
detection such that weakly expressed proteins can be missed. In contrast, complete 
genomes can be analyzed in a few DNA microarray experiments, yet the assumption in 
expression profiling that the quantity of mRNA stochastically reflects that of the protein 
is often unwarranted. Moreover, the quantity of mRNA cannot provide information 
about protein turnover. Therefore, where possible, both expression and protein profiling 
should be performed as complementary techniques.
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A common procedure for protein profiling combines two-dimensional gel electro-
phoresis (2D gel electrophoresis) with mass spectroscopy. In 2D gel electrophoresis, 
cell proteins are first separated through a separating matrix (e.g., a polyacrylamide gel) 
according to their individual charges generated by an electrical field. Separation is, 
therefore, possible owing to two inherent properties of proteins, charge and mass. The 
charge of a protein depends on its amino acid composition, e.g., cytochrome c contains 
many basic amino acids and is, therefore, positively charged at neutral pH.  The net 
charge a protein carries depends on the pH of its surroundings, and the pH at which 
both the positive and negative charges of a protein are equal (i.e., a net charge of zero) 
is called the isoelectric point (pI). Accordingly, a protein will not migrate in the elec-
trical field when its pI equals the pH of its surroundings. Because each protein has a 
characteristic pI value, one can separate a protein mixture in a pH gradient using an 
electrical field. This method, called isoelectric focusing, is used in 2D gel electrophoresis 
as the first dimension for the separation of proteins. In the second dimension, proteins 
are separated only according to their molecular mass. Peptides with a low molecular 
mass move faster than larger proteins through the pores of the polyacrylamide gel. In 
this way, up to 10,000 different proteins can be separated in high-resolution 2D gels. 
After separation, proteins are made visible using different staining procedures (e.g., sil-
ver staining or staining with fluorescent dyes) (. Fig. 6.6). The gels are then digitized 
and evaluated with bioinformatic methods. Programs such as Melanie [melanie] at the 
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copy, AB: antibody, KB: knowledge base (Taken from 7 http://www.c-hpp.org/)
6.1 · The Identification of the Cellular Functions of Gene Products
104
6
Expasy proteomics server allow for the automatic detection and precise quantifica-
tion of protein spots. Furthermore, Melanie allows the comparison of several 2D gels. 
Colocalized protein spots on different gels are identified and their quantitative differ-
ences measured based on spot intensity. Melanie also contains algorithms for normal-
ization and statistical analyses with which the significance of the results can be judged 
to identify differentially expressed proteins.
The bioinformatic evaluation of 2D gels yields a list of expressed proteins for 
which only the isoelectric points and molecular masses are known. While the identity 
of some of these proteins can be determined using this information, for most proteins 
a partial determination of amino acid sequence is required. This sequence is com-
pared with a protein database, and if the protein already exists, the identity can be 
confirmed.
Various techniques are used for the determination of amino acid sequence. A reli-
able method is sequencing by Edman degradation, for which, however, relatively large 
amounts of protein are required. An advance in protein analytics is mass spectroscopy–
based analysis of peptides via matrix-assisted laser desorption/ionization–time of flight 
(MALDI–TOF). MALDI–TOF is sensitive enough to require only picomolar amounts 
of protein. Stained protein spots are excised from the polyacrylamide gel and incubated 
with a protease (e.g., trypsin), which hydrolyzes each protein into a specific peptide 
pattern. The peptides are extracted from the gel and analyzed after MALDI in a TOF 
spectrometer. For each peptide a specific peptide mass spectrum is generated (. Fig. 6.7). 
At the same time, all proteins in a database are digested into peptides in silico based on 
the same cleavage specificity of trypsin, and the theoretical mass spectra of these frag-
ments are calculated. The experimentally determined MALDI–TOF mass spectra are 
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  . Fig. 6.6 Two-dimensional 
polyacrylamide gel electrophore-
sis (2D-PAGE). A protein lysate of 
a bacterium was separated along 
a pH gradient (pH 3–10) in the 
first dimension and by molecular 
mass in the second dimension. 
The resolved proteins were then 
visualized by silver staining
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  . Fig. 6.7 Identification of proteins by cross-referencing data from mass spectroscopy experiments 
and mass spectra that were theoretically computed
then compared with the theoretical spectra, and those mass spectra that are identical are 
selected. Because a MALDI–TOF mass spectrum can result from more than one pro-
tein, definitive  identification of the protein requires the spectra of several peptides. 
Thus, if several of the mass spectra determined by MALDI and those determined theo-
retically agree, then the experimentally analyzed protein is the same protein as that 
identified in the database.
An alternative protein ionization technique is electrospray ionization (ESI). ESI is 
sensitive and particularly suited to the analysis of high-molecular-mass compounds like 
proteins. The advantage of ESI over MALDI is that one can couple ESI to a liquid 
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 chromatographic (LC) system. The latter can fractionate protein solutions and, at least 
with samples of moderate complexity (i.e., with a limited number of different proteins), 
replace the laborious 2D gel electrophoresis. By the direct coupling of an LC system to 
the mass spectrometer (LC/MS), protein identification is accelerated. The disadvantages 
of ESI are its strong sensitivity to alkali contamination and the somewhat more prob-
lematic assignment of distinct masses.
Other developments have also occurred in the field of mass spectroscopy (Griffin 
et al. 2001). In tandem mass spectroscopy (MS/MS), two mass spectrum analyzers are 
run consecutively, which greatly improves the sensitivity and selectivity of the system. 
For example, protein samples are ionized by ESI. Then, in the first spectrometer, ions of 
a given mass are selected and excited for further fragmentation, and detailed analysis is 
performed in the second spectrometer. Because of the combination of analyzers, there-
fore, an initial chromatographic separation may be unnecessary. In practice, however, 
these systems are frequently coupled as part of an LC-MS/MS system or even of a 2D 
LC-MS/MS system, which further increases sensitivity and selectivity.
6.1.2.2  Functional Proteomics
The aim of functional proteomics is to elucidate the function of proteins, e.g., identify 
protein–protein interactions. Many cellular processes are governed by such interac-
tions, and their identification is an important topic for the understanding of protein 
function overall. Examples are the allosteric inhibition of enzymes, the regulation of 
signal transduction cascades by protein kinases, and the assembly of structural protein 
complexes to form the cytoskeleton. Numerous methods allow the analysis of such 
interactions, such as affinity chromatography and the yeast two-hybrid system. Their 
applications, however, are usually confined to studying the interactions of a limited 
number of proteins. In the meantime, these methods have advanced to the point where 
they can be used to dissect protein–protein interactions in complete proteomes 
(. Fig. 6.8). In this context, the term interactome of an organism applies, and this type 
of research is also called interactomics.
To detect the interaction of two fusion proteins, the yeast two-hybrid system is com-
monly used (. Fig. 6.9). Protein X, for which an interacting protein is sought, is coupled 
to the DNA-binding domain of a transcription factor. Protein X is then mixed with the 
expression products translated from a cDNA library (arbitrary protein Y) that have been 
fused to the cognate transcription factor’s activating domain. Neither X nor Y alone is 
capable of forming a complete and functional transcription factor. Only when proteins 
X and Y interact are both domains brought together, and a functional transcription fac-
tor results that can activate the transcription of reporter genes. Their expression can be 
measured by activity tests and is thus indicative of an interaction between proteins X and 
Y. Using yeast two-hybrid, the whole proteome of baker’s yeast (Saccharomyces cerevi-
siae) was analyzed for protein–protein interactions, leading to 4540 interactions of 3278 
different proteins (Ito et al. 2001). An analysis of a large proportion of the human pro-
teome was also tested for protein–protein interactions. Approximately 2800 protein–
protein interactions for 1549 proteins were identified (Rual et al. 2005).
Tandem affinity purification (TAP) is another technology that is suitable for the 
analysis of multiprotein complexes. This technique is based on the combination of 
affinity chromatography and mass spectroscopy. The target gene is modified so that the 
gene product is labeled with a short peptide sequence or tag that facilitates the isolation 
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c
b
a
  . Fig. 6.8 Effects of pharmaceuticals on molecular networks. a Molecular network composed of 
proteins and lipids in healthy patients. Most connections are labeled in green, indicating a negative 
correlation between analytes. b Molecular network in diseased groups. The majority of correlations are 
labeled in red representing a change from a healthy to a diseased condition. c Molecular network in 
drug-treated patients. Many of the green links seen in healthy patients have been restored. However, 
in a second pathway, new network links appear (blue box). This is due to the off-target effects of the 
drug treatment (Printed with permission from BG Medicine Inc. USA)
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  . Fig. 6.9 Identification of protein–protein interactions using yeast two-hybrid system. Transcrip-
tion of a reporter gene can only be activated when a fusion protein composed of the DNA binding 
domain of a transcription factor (BD) and a random protein X (pX) interact with a second fusion 
protein containing the cognate transcription factor’s activating domain (AD) and a random 
 protein Y (pY)
of the labeled protein from the protein lysate. The procedure is gentle and simultane-
ously copurifies those interacting cellular proteins that were bound to the labeled pro-
tein. The isolated multiprotein complex is then separated by gel electrophoresis, and 
the individual components are analyzed by mass spectroscopy. In this way, 232 differ-
ent multiprotein complexes could be identified in the yeast Saccharomyces cerevisiae. 
Some of the multiprotein complexes consist of over 40 individual components. 
Furthermore, a potential function could be assigned to some unknown proteins based 
on their interaction with proteins with well-characterized known cellular functions 
(Gavin et al. 2002).
As is the case for every high-throughput experiment, the large quantity of data gener-
ated by interactomics requires the development of special databases. Example interactome 
databases are the IntAct Molecular Interaction Database [intact] and STRING [string]. To 
ensure that all relevant data of an experiment are included in the databases, the minimal 
information required for reporting a molecular interaction experiment (MIMIx) protocol 
regulates the minimal requirements for the storage of protein–protein interaction data 
(Orchard et al. 2007).
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6.1.2.3  Protein Arrays
An alternative method for the analysis of proteomes is based on protein array technol-
ogy (Eisenstein 2006). Protein arrays are built similarly to DNA microarrays. Spots are 
applied at high density to a coated glass plate or membrane. These spots consist of 
reagents that have a high protein-binding affinity (e.g., antibodies). Protein arrays are 
also suitable for the generation of a protein profile, whereby three different variants of 
protein arrays are distinguished (MacBeath 2002):
 5 One variant is the sandwich assay (. Fig. 6.10a), whereby antibodies are directly 
coupled to the protein arrays. The arrays are then incubated with a protein lysate. If 
a protein is present in the lysate for which an antibody has been spotted onto the 
array, then the protein will bind to that antibody. The detection of this binding is 
carried out with a secondary antibody that is directed against the same protein but 
to a different epitope than the primary antibody. The secondary antibody is labeled 
(e.g., with an enzyme that catalyzes a visually detectable reaction) to allow for the 
detection and quantitation of the binding.
Antibody
a
b
c
Protein Dye Array plate
  . Fig. 6.10 Protein arrays. a In a sandwich assay, antibodies that are attached to array plates 
selectively bind to antigenic proteins after incubation with a protein lysate. Detection of the captured 
protein is performed with a secondary antibody that binds to a different antigenic site on the protein. 
b In an antigen capture assay, the antigenic proteins are labeled directly prior to incubation with the 
protein array, thereby dispensing with the need for a labeled secondary antibody for detection. c In 
direct or reverse-phase arrays, proteins are directly coupled to array plates and detected with labeled 
antibodies
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 5 The second variant is the antigen capture assay (. Fig. 6.10b). As above, the 
primary antibodies are directly bound to the matrix. It differs from the sandwich 
assay in that proteins in the lysate are already labeled (e.g., with fluorescent dyes). 
With this assay two cell lysates can be compared by labeling the proteins of the 
respective lysates with different dyes. Both lysates are mixed and incubated with 
the protein array. Depending on the amount of labeled bound protein, one or other 
lysate will contain more labeled protein. The basic concept of this procedure is 
analogous to that of an expression profiling experiment.
 5 In the third variant, the direct or reverse-phase assay, proteins and not antibodies 
are coupled to the protein arrays followed by the use of labeled antibodies. This 
way, proteins that interact with the antibodies are identified (. Fig. 6.10c).
Protein arrays can also identify protein–protein interactions, as described in the previous 
section. Unlike the yeast two-hybrid system and TAP, however, it is an in vitro method. 
Protein interactions are analyzed outside the cell and under in vitro conditions – condi-
tions that may lead to interactions that do not occur in vivo. On the other hand, protein 
arrays have the advantage that they can be produced in large quantities, allowing for 
multiple repetitions of experiments and modification of the conditions (pH, tempera-
ture, protein concentration, availability of ions, and cofactors). Moreover, with such 
arrays, thousands of proteins and even whole proteomes can be analyzed at the same 
time. For example, proteins from baker’s yeast Saccharomyces cerevisiae were sought that 
could interact with the calcium-binding protein calmodulin. The array contained 5800 of 
the possible 6200 yeast proteins (Zhu et al. 2001). Thirty-nine proteins were identified as 
potential interacting partners, of which just six had already been described as calmodu-
lin-binding proteins. The example highlights how protein arrays can define novel pro-
tein–protein interactions. Furthermore, protein arrays can also aid the detection of 
protein interactions with glycosides, lipids, nucleic acids, or other general ligands.
6.1.3  Metabolomics
Comparison of tumor cells with normal cells shows how striking it is that in the former, 
metabolic enzymes are frequently overexpressed. This should not be surprising, however, 
because cancer cells grow faster and thus have a greater need for metabolites. The notion 
is, therefore, that by quantifying cellular metabolites cells can be profiled in a similar way 
as with either microarray or proteomic techniques. The total metabolite pool of a cell is 
called the metabolome, and the research field dealing with metabolic profiling is termed 
metabolomics (. Fig. 6.1). Metabolomics is a relatively new research area, although in 
1970 Robinson and Pauling had already described experiments to identify and quantify 
the metabolites in human urine. The Human Metabolite Database [hmdb] contains all 
metabolites that can be found in the human body or at least should presumably occur. The 
latter is based on known metabolic pathways, but the final evidence is still pending. The 
database contains over 42,000 entries about metabolites that are linked with over 5600 
protein sequences (Wishart et al. 2013). These entries comprise peptides, lipids, amino 
acids, nucleotides, carbohydrates, organic acids, vitamins, minerals, food additives, phar-
maceutical agents, toxins, pollutants, and any other chemical substances with a molecular 
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mass less than 2000 Dalton (Da). This list illustrates why the definition of the metabolome 
is so difficult compared with the genome, transcriptome, or proteome since depends not 
only on the genome but also the substance uptake from the environment (e.g., via food or 
pollution). Thus, the database does contains both endogen and exogen metabolites.
Despite the fact that the metabolome is rather small compared to the genome, tran-
scriptome, or proteome, the technical demands required for metabolomics are particu-
larly high. The reason for this lies in the extreme diversity of the various physical and 
physicochemical properties of the metabolites to be measured. Some metabolites are 
relatively small and hydrophilic (e.g., vitamin C), while others have a much higher mass 
and are nonpolar (e.g., cholesterol esters) (. Fig. 6.11). At present, no single technology 
exists to identify and quantify all metabolites simultaneously. However, technological 
progress over the last few years has resulted in methods that can measure a small num-
ber of metabolites in parallel. Usually, the relative quantities of the metabolites in two 
different samples are compared to each other, similarly to the approach with DNA 
microarrays. In addition, more sensitive equipment and adequate standards also allow 
for the absolute quantification of metabolites in a single assay.
Two methods are primarily employed to measure metabolites: nuclear magnetic res-
onance (NMR) and mass spectroscopy. Sensitive NMR spectroscopy can generate physi-
cal, chemical, electronic, and, especially, structural data from molecules and metabolites. 
The method more frequently employed, however, is mass spectroscopy. Usually a chro-
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matographic step (e.g., gas chromatography (GC)) to separate metabolites is performed 
first. Then, with the help of highly specialized equipment, more than 4000 raw data peaks 
can be measured, corresponding to approximately 1800 metabolite peaks (Kell 2006). 
Metabolomic experiments generate huge amounts of data, which must be analyzed and 
converted to biologically useful knowledge.
Many researchers have expressed the opinion that metabolomics describes the func-
tions within a cell better than genomics, transcriptomics, or proteomics. They  justify 
their opinion by the cell processes, pointing out that genes encode transcripts; tran-
scripts in turn encode proteins, and these are eventually responsible for the production 
of metabolites. Therefore, metabolites are at the end of the information chain and, thus, 
closely connected to their function. A further argument is the amplification of informa-
tion. It has been experimentally determined that even small changes in the concentra-
tion of a few enzymes can lead to significant changes in the concentration of many 
metabolites (Raamsdonk et  al. 2001). The reasons for this are that the synthesis and 
turnover of metabolites in general are catalyzed by several enzymes, and one metabolite 
can be involved in many different reactions. In this connection one may also speak of 
metabolic networks (. Figs. 7.3 and 7.4).
The strength of metabolomics is that it confers the possibility to construct models of 
quantitative changes in the metabolome due to its networked structure. Indeed, many 
models have already been devised, particularly for well-studied  organisms such as 
baker’s yeast, Saccharomyces cerevisiae. For example, with the help of a metabolic model 
that represents 750 genes and 1149 reactions in baker’s yeast, 4154 growth phenotypes 
were predicted. A comparison with experimental results showed that the model had, in 
fact, correctly predicted 83% of the phenotypes (Duarte et al. 2004). The generation of 
such metabolic models overlaps to some extent with another area, namely systems biol-
ogy, which is described in more detail in 7 Sect. 6.2.
Electronic noses, which are already available as portable devices, are another appli-
cation of metabolite analysis (Koczulla et al. 2011). Nanocomposite sensors are built 
into electronic noses for the detection of small amounts of molecular gases, acids, bases, 
and many other molecules. Patterns for different compositions can be retrieved and 
analyzed by computational methods using combinations of different sensors. Cyranose 
320, for example, is an electronic nose from Sensigent [sensigent] that can be used for 
the analysis of humans breathing air. In a study with 30 patients, it was possible to dis-
tinguish between the breathing air of patients with non-small-cell lung cancer, chronic 
obstructive pulmonary disease (COPD), and healthy patients (Dragonieri et al. 2009). 
In another  study three different bacterial strains, including methicillin-resistant 
Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) strains, 
were detected and differentiated (Dutta and Dutta 2006).
6.1.4  Phenomics
The phenotype or physical appearance is the sum of all extrinsic visible features of an 
individual (. Fig. 6.12). It refers to both morphological and physiological properties. 
Consequently, the visible and measurable properties of an organism or cell that are 
based on interactions of the genotype with the environment constitute the phenotype 
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(Sect. 6.1.2). By this definition, therefore, metabolomics, being measurable, are also a 
representation of a phenotype that is based on interactions of the genotype with the 
environment. Many methods exist in the context of functional genomics that define 
protein function based on phenotypes. This research area is also called phenomics if it 
is carried out in a high-throughput format.
Initially, forward genetic screens were used in which genomes were randomly 
mutated, the resulting phenotypes recorded, and the genes responsible for the modified 
phenotype identified. Using this approach several thousand genes were identified and 
characterized. The arrival of sequenced whole genomes offered alternative approaches 
to performing genetic screens for those genes without an ascribed function. The strat-
egy that links a distinct gene with its function is called reverse genetics.
As subsequent analysis, knockout experiments are often carried out whereby genes are 
selectively mutated (“switched off”) so that no functional protein is encoded. The conse-
quence can be an altered phenotype whose properties can then be accurately documented. 
If a gene encodes an essential protein, the resulting phenotype may be lethal, i.e., the cell or 
organism dies. Such knockout experiments are usually performed mainly in cell lines or in 
a
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d
  . Fig. 6.12 Phenotypes in the roundworm Caenorhabditis elegans. a Most strains are solitary feeders 
and do not show a clumping phenotype (Clp−). b Some strains aggregate on the border, recognized 
as the clumping phenotype (Clp+). The phenotype is caused by a naturally occurring genetic 
polymorphism in a single gene. c Phenotype of a moving wild-type worm (wt). d Phenotype of a trp-4 
knockout worm with an abnormal body posture. The ion channel mutants have a greater frequency of 
body movement with more pronounced flexing (a, b Printed with permission from Marie-Anne Félix, 
Institut Jacques Monod, France. c, d Printed with permission from X. Z. Shawn Xu, University of 
Michigan Medical School, USA)
6.1 · The Identification of the Cellular Functions of Gene Products
114
6
model organisms such as the fruit fly Drosophila melanogaster [genedisruptionproject]. 
The disadvantage of this method is the complicated and time-consuming experimental 
approaches required, reflected by the fact that complete and comprehensive genome-wide 
knockout data are available for only a few organisms (e.g., baker’s yeast).
Analogous to knockouts are “knockin” experiments to elucidate the function of gene 
products. In this case, genes are transfected into cells or organisms and then observed to 
determine whether they cause phenotypic changes. The knockin strategy is frequently 
used as additional proof of a protein’s function. If the phenotypic change of a prior 
knockout can be reversed by a knockin experiment, then there is little doubt as to the 
protein’s function. For example, a bacterium in which a specific flagellar protein has 
been knocked out is rendered immotile. If the same bacterial clone has the gene restored 
in a knockin experiment and subsequently recovers motility, then this is solid evidence 
that the protein is essential for proper flagellum function.
Unfortunately, knockout and knockin strategies are laborious and not amenable to 
high throughput. The discovery and experimental application of RNA interference 
(RNAi) has resulted in a revolution for reverse genetic screening. RNAi is an evolution-
arily conserved mechanism that involves the repression of gene expression by double-
stranded RNA (dsRNA) (Vanhecke and Janitz 2005). After gaining access to the 
cytoplasm of the cell, dsRNA molecules are first cut into lengths of 21–25 nucleotides, 
termed small interfering RNAs (siRNAs), by the enzyme dicer (. Fig. 6.13). The single-
stranded siRNA is then loaded into the enzyme complex called the RNA-induced 
silencing complex (RISC). The activated enzyme complex, guided by the siRNA strand, 
binds specifically to the complementary mRNA, which is cut by the endonuclease activ-
ity of the RISC.  In this way, the expression of the target gene is specifically blocked, 
preventing translation of the cognate protein. Because transcription blockade by RNAi 
may not always be complete, the term gene knockdown applies.
An advantage of RNAi technology is its efficiency. Experiments are fast, simple, 
cost-efficient, and, importantly, amenable to high-throughput formats. Numerous pub-
lications have analyzed complete genomes using RNAi. For example, 86% of all genes of 
the nematode Caenorhabditis elegans were examined by means of RNAi (Kamath et al. 
2003). Approximately 10% of the targeted genes led to a change in phenotype, of which 
approximately one-third were already known. In another study, new modulators of p53 
that causes cell cycle arrest in human cells were searched for by RNAi. Of the 8000 genes 
analyzed, five new modulators were discovered (Berns et al. 2004).
Unfortunately, not all RNAi results are absolutely reliable. For instance, it is 
known that the efficiency of RNAi is massively dependent on the incorporated nucle-
otide sequence. In some cases, the target mRNA is either only partly degraded or not 
at all, leading to a false negative result. The experimenter will see no change in the 
phenotype and infer that the gene product has no important function. Importantly, 
such data should be checked by an independent method, such as RT-PCR, to deter-
mine whether the target RNA has in fact been degraded. Conversely, RNAi can also 
generate false positive results. In this case, the siRNAs produced by the nuclease dicer 
can hybridize with more than one target mRNA, which in turn leads to the degrada-
tion of several mRNAs. Therefore, changes in phenotypes cannot be assigned unam-
biguously and, in the worst case, might lead to incorrect functional predictions of 
gene products.
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The PhenomicDB is a very interesting and integrated database in which phenotypes 
from different organisms that were generated by various methods (e.g., knockout, 
knockin, knockdown) are integrated into one database and linked to genotypic data. 
Furthermore, databases like the Human Genome Variation Database [hgvdb] store 
human genotype–phenotype relations (Brookes and Robinson 2015).
6.2  Systems Biology
The foregoing discussion on high-throughput procedures has established genomics, 
transcriptomics, proteomics, metabolomics, and phenomics as important technologies 
that facilitate the functional determination of gene products. Like all high-throughput 
experiments, however, these approaches produce false negative and false positive results. 
False negative results can lead to information being missed, whereas false positive 
results might lead the experimenter in the wrong direction. Therefore, to identify valid 
results, an idea was put forth regarding the integration of all available data from the 
aforementioned technologies and analyze them together (. Fig. 6.14). This integration 
of experimental data improves the reliability and the generation of more reliable hypoth-
eses. The research field that focuses on the integration of various high-throughput data 
is known as systems biology because it analyzes entire biological systems. Systems biol-
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  . Fig. 6.13 Specific degradation of mRNA by RNA interference (RNAi). A type III ribonuclease (dicer) binds 
to and cleaves double-stranded RNA (dsRNA) into 21–25 base pair duplexes, termed small interfering RNA 
(siRNA). The siRNA is incorporated into the multiprotein complex called RNA-induced silencing complex 
(RISC), which also contains an RNAse. RISC unwinds the siRNA, releases the sense strand, and facilitates 
hybridization of the antisense strand of the siRNA to the complementary strand of the cognate messenger 
RNA (mRNA). The binding activates the nuclease activity in the RISC, leading to cleavage of the target 
mRNA. The damaged mRNA is then degraded significantly, reducing the expression of the target gene
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ogy aims to produce as accurate a picture as possible of all the regulatory processes 
within a cell or organism by analyzing the interactions between the component parts of 
the biological system, e.g., metabolic pathways, organelles, cells, and tissues.
An example of a systems biology approach is the analysis of phagosomes, which are 
special organelles found in phagocytosing cells (e.g., macrophages). After phagocyto-
sis, particles such as bacteria are transported into phagosomes, where they are 
destroyed. In a study by Stuart et al. (2007), the phagosome of a cell line derived from 
the fruit fly Drosophila melanogaster was analyzed. Proteins of the phagosome were 
identified by classical proteomics methods. Construction of a protein–protein interac-
tion networks complemented the results, which were finally validated by RNAi exper-
iments. With the help of this systems biology approach a detailed model of the 
phagosome was built and new regulatory proteins and pathways associated with 
phagocytosis identified.
However, systems biology frequently goes beyond the mere description and inter-
pretation of experimental data. The ambitious aim is to develop computer models that 
simulate biological systems and predict consequences upon changing parameters (e.g., 
changing the concentration of a specific metabolite). One of the first mathematical 
models in biology was published in 1952 by Alan Hodgkin and Andrew Huxley, which 
explained the transmission of action potentials. Since then, the increasing availability of 
high-quality data (both quantitative and qualitative) and greater computer capacities 
have allowed for more realistic models to be developed. For example, a model has been 
generated to simulate glycolysis in baker’s yeast, Saccharomyces cerevisiae. Compared 
with experimental data, most metabolite concentrations were correctly predicted within 
a maximal deviation of two (Teusink et al. 2000).
Even more demanding are computer models that perform complete cell simulations 
(Ishii et al. 2004). A well-known model is the E-cell system that developed a “virtual 
bacterium” consisting of 127 essential genes from the genome of Mycoplasma genitalium 
(. Fig. 6.15). This bacterium has fewer than 500 genes and is therefore excellently suited 
Phenomics
Systems Biology
Data Integration Modeling
Metabolomics
Proteomics
Transcriptomics
Genomics
  . Fig. 6.14 Systems biology integrates data derived from different experimental technologies and 
generates computational models
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for the construction of a cell model. With the model, the transport of extracellular glu-
cose through the cell membrane was simulated, in addition to the metabolism of the 
sugar and the accompanying ATP production. The model also produced a surprise. 
When the concentration of extracellular glucose was set to zero, the model predicted a 
temporary increase in the intracellular ATP concentration before a final drop. This was 
contrary to the expectation that the ATP concentration would drop immediately upon 
depletion of the glucose. After much speculation, the conclusion was that the model’s 
prediction was correct. During glycolysis, two molecules of ATP are generated from 
each molecule of glucose. Following more detailed examination, it became apparent 
that in the first part of glycolysis, two molecules of ATP are spent before the production 
of four ATP molecules in the second part of the reaction. At the moment when the 
glucose concentration is lowered to zero, the consumption of ATP molecules stops 
before the generation of new ATP molecules, which are then consumed. Thus, the 
model recognized the short temporal shift and correctly predicted the temporary 
increase in ATP concentration.
translation proteins
degradation
mRNAtranscription
127 genes phospholipids
lipid biosynthesis
fatty acids glycerol
phospholipid
bilayer
tRNA
rRNA
glycolysis
glucose
ATP
ATP
ATP
lactate
  . Fig. 6.15 Overview of metabolism in E-cell model. The model cell has pathways for glycolysis and 
phospholipid biosynthesis, transcription, and translation
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In 2012, a computational model of the human pathogen Mycoplasma genitalium was 
presented that simulates the whole cell including all molecular components and their 
interactions (Karr et al. 2012). The model aimed at describing a complete cell cycle of a 
single cell and predicting observable cellular behavior. It was based on a complete 
genome with 525 genes and a detailed analysis of over 900 data sources, including pri-
mary sources, books, and a database. Overall, data sets of 192 wild-type and 3011 
knockout cells were calculated on a cluster with 128 nodes. The calculations were finally 
validated by experimental data that were not part of the model development. Deep 
insights into previously unseen and unobservable cell processes were made possible by 
the use of this model, like in vivo rates of protein–DNA interactions.
The emergence of systems biology has been accompanied by the development of a 
dedicated exchange format for the representation of biological models, the Systems 
Biology Markup Language (SBML). SBML is an XML-based computer-readable format in 
which biological networks are exactly described. The central idea of SBML was the cre-
ation of a standardized format that permits the simple exchange of data between many 
different software applications. Therefore, each calculated model can be tested in different 
software environments without additional effort. At the same time, specialized databases 
have been established in which computer models can be stored and are accessible to all 
interested scientists. One example database is the BioModels Database at EBI [biomodels].
6.3 Exercises
 ? Exercise 6.1
In the GEO Datasets database, find the entry GDS1399. GDS1399 is a microarray 
experiment that examines the effect of distinct gene mutations on global gene 
expression in Escherichia coli. The DAM mutant lacks the enzyme DNA adenine 
methyltransferase (DAM). This enzyme transfers methyl groups to sites with a 
characteristic short sequence in the E. coli genome and thereby exerts a significant 
influence on the regulation of gene expression. An E. coli strain without any genetic 
alteration is referred to as the wild type.
 1. How many replicates of the wild type and DAM mutants were used in the 
experiment?
 2. Determine the number of genes whose expression in the DAM mutant is 
increased or decreased. Use the option compare 2 sets of samples and analyze a 
twofold or more expression compared to the wild-type strain.
 3. For how many genes is the expression in the DAM mutant significantly different 
from that in the wild type? Use the two-tailed t-test (A vs. B) similar to 7 Exercise 
6.1-2 with a 0.050 level of significance.
 ? Exercise 6.2
Visit the web site of the Princeton University MicroArray database (PUMAdb, 
7 https://puma.princeton.edu/index.shtml). This database stores primary data, 
normalized data, and pictures of microarray experiments. You will find under Help a 
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number of descriptions and tutorials. Especially the section about data 
normalization provides a good overview on necessary data analysis. A World Session 
must be activated before access to the public data will be granted. Using Standard 
Search to search for a publication of van Brummeln et al. (2009) based on the 
organism Plasmodium falciparum. Deal with the available data.
 ? Exercise 6.3
Go to the web page of the BROAD Institute and test the software GenePattern 
(7 http://software.broadinstitute.org/cancer/software/genepattern/). A tutorial is 
provided that should allow a first analysis together with a look at the results within 
10 min. Test the program using these data sets.
 ? Exercise 6.4
Go to the Expasy home page and look for the software Swiss2DPage [swiss2dpage]. 
Use the function Search by description, ID or gene to search for the entry HSP60 (Heat 
Shock Protein 60). Select CH60-HUMAN.
 1. Open the 2D–PAGE of the entry “HEPG2_HUMAN.” The spots corresponding to 
HSP60 are marked in red. How many spots are found for HSP60? How can it be 
explained that several spots exist for one protein?
 2. Next, click on the picture of the 2D electrophoresis from liver (LIVER_HUMAN). 
How many spots correspond to HSP60 in this case? Why are fewer spots found 
now?
 3. Look at the protein lists for HEPG2_HUMAN and HEPG2SP_HUMAN (secreted 
proteins). Use the search protein list. Can HSP60 be found on this gel? Give 
reasons for the result.
 4. What methods were used to identify the proteins in both protein lists from task 
3?
 5. Search in the protein list of HEPG2_HUMAN from task c for the unknown protein 
that represents Spot 106. Click on its SWISS accession number P31929. Look for 
the section cross-references and follow the link UniProtKB/Swiss-Prot. What partial 
amino acid sequence of the protein was identified by microsequencing? 
Unfortunately, the entry was marked in UniProt as obsolete. You can find the 
sequence using the button history.
 6. Follow the link graphical interface on the start page for an overview about all 
gels together with identified proteins. Select 2D–Page of nucleolar proteins 
from Human HeLa Cells. Click on the highlighted spot with the lowest 
molecular weight and a pI value of approx. 5.7. Which protein is it? What is the 
molecular weight of the protein? Follow also the link at the entry External 
Data extracted from UniProtKB/Swiss-Prot. What synonyms are there for this 
protein?
 ? Exercise 6.5
Go to the protein–protein interaction database STRING (7 http://string-db.org/). 
Enter Thioredoxin reductase in the search field Protein Name and 
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Mycobacterium tuberculosis in the search field Organism. Select TrxB2 in 
the results list, and click continue. The network of feasible TrxB2 interactions will be 
shown as a search result. You can analyze the possible interactions by selecting TrxC 
and then re-center network on this node under the option action. Which other 
proteins show a direct molecular interaction with the highest confidence? Deal with 
View Settings and Data Settings and analyze particular interactions in detail.
 ? Exercise 6.6
Go to the home page of the program PeptideMass (7 http://www.expasy.org/tools/
peptide-mass.html). Run an in silico digest of the human protein kinase src 
(accession number P12931) with the enzyme trypsin. How many peptides with a 
mass of >1000 Da are generated by this digest? What is the peptide mass of the 
largest peptide?
 ? Exercise 6.7
Go to the Human Metabolome Database (7 http://www.hmdb.ca/). Find out, which 
food small molecule is responsible for the occurrence of 1-methylxanthine in the 
human body. To which Origin is 1-methylxanthine counted? Analyze the whole 
metabolic process 1-methylxanthine arises from. What molecule is the precursor?
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7.1  The Era of Genome Sequencing
The extraordinary achievements of genome-based biology in recent years can be 
explained for the most part by the technological progress in DNA sequencing as well as 
developments in hardware and software that have made it possible to store and annotate 
huge amounts of data. The total number of all freely accessible nucleotides in GenBank 
[genbank], the DNA sequence database at the NCBI, is 218 billion bases within 196 
million DNA sequences (Release 215.00, August 2016). The number of all protein 
sequences in the world’s largest nonredundant protein database UniprotKB [uniprotkb] 
at the EBI totals 65 million (September 2016).
The first completely sequenced genomes, from the microbial organisms Haemophilus 
influenzae (Fleischmann et al. 1995) and Mycoplasma genitalium (Fraser et al. 1995), 
were published in 1995. Today, 165,178 microbial genomes are being sequenced or are 
already sequenced (163,302 from bacteria and 1876 from archaebacteria) [gold] (August 
2016). Among these are the complete genomes of both virulent and nonvirulent strains 
of the same bacterium, which facilitates the identification of virulence factors. It is 
assumed that within the next few years, all important pathogenic microorganisms of 
humans, animals, and plants will have been sequenced. This flood of data will lead to 
new possibilities in the production of antimicrobial agents, vaccines, and diagnostic 
tests, all of which should aid the ongoing fight against infectious diseases (Selzer et al. 
2000).
Meanwhile, the complete genomes of 283 eukaryotic organisms are known. These 
include Saccharomyces cerevisiae (baker’s yeast), Caenorhabditis elegans (nematode), 
Drosophila melanogaster (fruit fly), Arabidopsis thaliana (mouse-ear cress), Takifugu 
rubripes (tiger puffer), Homo sapiens (man), and Mus musculus (mouse). Furthermore, 
as of September 2016, 13,000 eukaryotic genome sequencing projects are under way. 
These data will eventually contribute to the decoding of the secrets of biology and 
thereby help combat serious diseases of humans and animals.
7.2  Drug Research on the Target Protein
Systematic research into active substances as novel drugs dates back to the second half 
of the nineteenth century. A prime example is acetylsalicylic acid, which was synthe-
sized in 1897 by two chemists, Felix Hoffmann and Arthur Eichengrün of the company 
Bayer. It is now world famous under the trade name aspirin. It is still a disputed question 
as to which of the two chemists was the actual inventor of the synthesis of acetylsalicylic 
acid. Regardless, this substance has lost neither its economic nor scientific importance. 
Since then, the identification of active compounds, including those with bioactivity 
against infectious diseases, has been dominated by direct testing (screening) in biologi-
cal systems, mostly laboratory animals. Many antibiotics in use today were discovered 
in the first half of the twentieth century. However, since around the 1960s the number 
of new drugs has steadily declined. There are a number of reasons for this, including the 
constant decline in the success rate of nontargeted screening, the increased costs for 
research and development, and higher required safety standards. Furthermore, in the 
area of infectious diseases, the situation has been worsened by the emergence and 
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increased spread of drug resistance. However, at about the same time, a new era of 
molecular research began in 1953 with the deciphering of the three-dimensional struc-
ture of the DNA double helix by James D. Watson and Francis H.C. Crick.
By sequencing whole genomes and the ensuing biological information, the 
approach to drug discovery has changed. Thus, in the target-based approach 
(. Fig. 7.1), in which a target protein is used to search for new active compounds, the 
first step is to identify those proteins that are essential to the survival of the pathogenic 
organism. The second step is to find active chemical substances that influence the iso-
lated target protein in the desired way. Only after such optimized chemical substances 
with the desired activity spectrum have been found using these in vitro methods will 
further testing be performed in a biological system (see also 7 Chap. 5). For example, 
to develop a new antibiotic, an ideal prerequisite would be that the target protein is 
essential to the survival of the pathogenic bacteria under study and that the host 
Rational
drug design
Highly specific
drug
Target Organism
Scientist
  . Fig. 7.1 The analogy of a Christian icon to a target-based approach to drug development. The icon 
shows Saint George as a dragonslayer. The dragon symbolizes the target organism that can only be 
killed by a precise blow to the heart (target protein). All other targets are irrelevant. Based on this 
realization, Saint George (the scientist) uses his horse (scientific tools) to guide his lance (a highly 
selective drug) to the target. The original icon is in Preveli Monastery, Crete (Greece)
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organism does not also possess the same or similar protein that may also be targeted, 
potentially resulting in toxicity. In this scenario, comparative whole genomic analysis 
would be well suited to identify pathogen-specific targets. Indeed, this approach was 
taken by Huynen et  al. (1998) in their work on the genomes of three bacteria, 
Escherichia coli, Haemophilus influenza, and Helicobacter pylori. Orthologous proteins 
were identified either in all three or in two of the three organisms, in addition to spe-
cies-specific proteins. For H. pylori, the major causative agent of gastric and duodenal 
ulcers, the authors predicted that 123 proteins were involved in interacting between 
the pathogen and host, i.e., the proteins represented potential targets for the develop-
ment of an antibiotic. In pharmacological research, conserved targets usually lead to 
the development of broad-spectrum antibiotics, whereas with species-specific targets, 
narrow-spectrum antibiotics are generated.
Because of the increasing number of completely sequenced bacterial genomes, it is 
clearer which genes are generally conserved among bacteria and which are specific for 
certain bacterial species. However, it is not always easy to settle on the threshold of 
sequence similarity that blocks the pursuit of a target-based drug discovery approach 
due to potential toxicity arising from an unwanted interaction with the human pro-
tein counterpart. For example, bacterial dihydrofolate reductase has a sequence iden-
tity of 28% at the amino acid level to the corresponding human protein, yet the 
antibacterial drug, trimethoprim, is a very selective inhibitor of only the bacterial 
ortholog.
7.3  Comparative Genome Analyses Provide Information  
About the Biology of Organisms
Comparative genome analyses are frequently referred to as comparative genomics, 
whereby two or more genomes are compared to one another (Beckstette et al. 2004). The 
goal is to find similarities and differences between these genomes that yield information 
about the biology of the respective organisms. Another important aim of comparative 
genomics is the description of genome structure and the identification of coding and 
noncoding regions (Wei et al. 2002).
7.3.1  Genome Structure
Analysis of the structure of one or more genomes includes statistical measurements 
such as size and nucleotide composition, frequency of codon usage, and identifica-
tion of conserved regions between two or more genomes. The percentage and fre-
quency of guanine and cytosine (GC) content or adenine and thymidine (AT) content 
differ between groups of organisms and seem to have changed considerably in the 
course of evolution from microorganisms to multicellular organisms. Likewise, the 
codon usage for encoding identical amino acids is not the same in every organism 
(7 Chaps. 1 and 3).
Many comparative studies of the genomes of humans and mice have shown that 
their organization, to a large extent, is similar. This indicates that, since the last com-
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mon ancestor, the structural organization has been conserved. To describe such simi-
larities between evolutionarily related chromosomal segments among species, various 
terms have been defined or broadened in their definition. If two or more genes lie on 
the same chromosome, then one speaks of syntenic genes, or synteny. This definition 
only applies, however, within a species. Between species, the definition was expanded 
such that when syntenic genes of orthologous proteins on a single chromosome are 
conserved across species, the term conserved synteny applies. The order of the genes on 
the chromosomes is not considered (. Fig. 7.2). If, in addition, the order of the genes 
on the chromosomes is also conserved, then the regions are called conserved segments 
or conserved linkages.
With the growing number of completed eukaryotic genome sequences it has 
become apparent that conserved segments are present in all mammals. Although 
syntenic regions are observed between species such as humans and the puffer fish, 
  . Fig. 7.2 Homology map of X chromosome of rat, mouse, and humans as taken from NCBI. Shown 
is a part of the detailed map for the X chromosome. The syntenic genes in this chromosome area are 
indicated by gray lines (Printed courtesy of the NCBI)
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which separated approximately 450 million years ago, no larger blocks of conserved 
genome organization have been described thus far for such distantly related organ-
isms (Frazer et al. 2003).
7.3.2  Coding Regions
The comparative analysis of coding regions between different genomes includes not just 
the identification of protein-encoding regions but also the direct comparison of the 
types and numbers of orthologous and paralogous proteins. The identification of genes 
in prokaryotes is comparatively simple because there are relatively few noncoding 
regions. Normally 85% of a bacterial genome encodes proteins or RNAs, with the 
smaller portion encoding regulatory units or noncoding regions. In contrast, the pre-
diction of genes in eukaryotes is far more difficult because noncoding regions have 
increased in number over the course of evolution. Eukaryotic genomes possess a large 
number of intergenomic regions as well as a multitude of noncoding repeats. 
Furthermore, eukaryotic genes contain introns and exons, and different proteins fre-
quently arise as a consequence of alternative splicing (7 Chaps. 1 and 4). For instance, 
the genome of the prokaryote Escherichia coli has approximately 4300 genes at a genome 
size of 4600 kilobases (kb) with, on average, one gene for every kilobase in length. In 
contrast, the genome of the eukaryotic unicellular yeast Saccharomyces cerevisiae has 
approximately 6300 genes at a genome size of 12,000 kb, and the genome of the multi-
cellular worm Caenorhabditis elegans contains approximately 19,000 genes at a genome 
size of 97,000  kb. Phylogenetically speaking, the human genome is very young and 
shows an enormous difference between the number of genes and its genome size: 19,000 
to 20,000 genes at a total size of approx. 3.3 gigabases (Ezkurdia et al. 2014). There is no 
obvious connection between the size of the genome and the complexity of the organism, 
as demonstrated by the similar number of genes in the genome of C. elegans and humans. 
The relatively low number of protein-coding genes in the human genome can be under-
stood considering posttranslational modifications like alternative splicing that allow for 
one gene coding for several proteins (7 Chap. 4).
7.3.3  Noncoding Regions
The comparative analysis of noncoding regions, which in humans and other mammals can 
account for more than 97% of the genome, is still one of the greatest challenges of bioinfor-
matics. Still, this area of genome analysis has received much attention in the last few years in 
the hope of identifying genomic regulatory units. For instance, it has already been shown 
bioinformatically that conserved noncoding regions have an accumulation of transcription 
factor binding sites. Furthermore, the probability of identifying such regulatory areas in 
noncoding regions increases when more than two genomes of closely related organisms are 
compared. It has already been shown that half of the noncoding regions identified in a 
comparison of the human and mouse genomes are also conserved in the genome of the dog.
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7.4  Comparative Metabolic Analyses
For gene prediction, special emphasis has been placed on those genes that encode 
proteins involved in metabolism. Using gene prediction, it is possible to identify 
whether an organism possesses metabolic pathways, such as those in glycolysis or the 
citrate cycle, or whether alternative pathways are employed to generate energy. A 
comparison of two or more genomes at the level of their metabolic pathways can also 
be used to identify metabolic targets. This is particularly effective with prokaryotes 
because many genomes have already been sequenced. A number of software tech-
nologies are used to compare metabolomes: Encyclopedia of Escherichia coli Genes 
and Metabolism (EcoCyc) [ecocyc], Kyoto Encyclopedia of Genes and Genomes 
(KEGG) [kegg] (. Fig.  7.3), and the Reactome database [reactome] are among the 
best known.
The methods include manual and semiautomatic analyses. So far, however, there is 
no fully automatic analysis software that can calculate all the metabolic pathways. 
Furthermore, such databases are not always complete. Whereas initially the databases 
dealt mostly with metabolic pathways, over time regulatory mechanisms such as mem-
brane transport, gene regulation, and signal transduction have also been incorporated 
(. Fig. 7.4).
In sequenced genomes, genes or proteins can be divided into orthologous 
groups. Accordingly, proteins that are either present or absent can be systematically 
identified and the resultant functional metabolic pathways constructed. If some 
required proteins are missing, either the corresponding metabolism is nonfunc-
tional or other (including thus far unknown) proteins are involved. During the 
analysis of the genome of Helicobacter pylori it was noticed that neither glycolysis 
nor pentose phosphate metabolism was operational due to the absence of the requi-
site enzymes. Because both metabolic pathways generate protons and, therefore, 
lower pH, their operation would lead to an additional burden on an organism that 
already lives in the acidic environment of the stomach. In contrast, the genes coding 
for proteins that metabolize organic acids, such as those involved in anabolic gluco-
neogenesis, are present. Thus, H. pylori’s energy production seems to be fueled by 
amino acid degradation, and the substrates necessary are probably directly derived 
from the gastrointestinal tract.
To find specific metabolic pathways in KEGG, the genome must be compared with 
a reference genome. If the gene exists, it is highlighted in color. A sequence of colored 
rectangles therefore reflects the specific metabolic pathway in the studied organism 
(. Fig.  7.5). To be successful with this strategy, however, all alternatives must be 
known. It is often the case that a metabolic pathway does not show all the genes or 
proteins and is, therefore, considered incomplete. The reasons for this include that not 
all genes were predicted or some were predicted incorrectly or that current knowledge 
regarding the specific metabolic pathway is limited. It is also possible that one protein 
performs several functions and, thus, has a larger metabolic spectrum than originally 
suspected. Finally, alternative metabolic pathways that lead to the same biological 
result cannot be excluded.
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GLYCOLYSIS / GLUCONEOGENESIS
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  . Fig. 7.5 Metabolic map of glycolytic/gluconeogenic metabolism. The enzymes of this metabolic 
pathway known so far in humans are highlighted in color (Printed courtesy of KEGG)
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7.4.1  Kyoto Encyclopedia of Genes and Genomes
KEGG is a product of the Japanese GenomeNet and is widely used for the analysis of 
metabolic pathways. Two of the three main databases, PATHWAY and LIGAND, deal 
with metabolic processes in cells and organisms. The third database, GENE, contains 
gene and protein information from sequencing projects and is comparable to other pri-
mary databases (Kanehisa et  al. 2016). These databases are completed by BRITE, an 
ontology database for the description of biological relationships within pathways. 
Furthermore, KEGG offers information on experimental data from gene expression and 
yeast two-hybrid experiments (EXPRESSION). Another database, SSDB, contains 
information on groups of orthologous proteins.
The most interesting databases are undoubtedly PATHWAY and LIGAND. PATHWAY 
contains graphical representations of metabolic pathways from a number of organisms, 
mostly prokaryotes, but also eukaryotes. The representations of the metabolic pathways are 
similar to those in the Biochemical Pathways Chart from Boehringer Mannheim [biochem-
pathway]. The individual maps can be selected from a list or chart sorted according to the 
main metabolic pathways (. Fig. 7.3). The known enzymes in reference pathways can be 
highlighted in color. This facilitates comparison of metabolic pathways between organisms. 
. Figure 7.5 shows as an example of glycolysis/gluconeogenesis metabolism in humans. The 
enzymes drawn in green (small boxes) have already been described or are present in the 
human genome. The individual metabolic charts on the KEGG server are connected to the 
LIGAND database, a chemical database that contains the corresponding substances, 
enzymes, and reactions in the respective metabolic pathway. The small rectangular boxes 
with an enzyme number (enzyme classification, NC-IUBMB 1992) [enzyme] are for cross-
referencing. The EC number consists of four blocks of numbers, each separated by a period. 
The first number describes one of the six functional groups (oxidoreductases, transferases, 
hydrolases, lyases, isomerases, and ligases), the two blocks following refer to further sub-
classes within the main class. The last block is a consecutive number of each of the enzymes 
in the particular subclass. Further cross-references are indicated by the circular symbols next 
to the substance names (e.g., β-D-glucose) as well as the rounded borders of other metabolic 
pathways. The latter do not lead to the LIGAND database, however, but to a detailed descrip-
tion of the respective metabolic paths. In the case of glycolysis/gluconeogenesis metabolism, 
for example, this leads to the citrate cycle or pentose phosphate metabolism.
By clicking on the circle at Glycerate-1,3P2 a new window opens with an entry from 
LIGAND (. Fig. 7.6). In addition to a unique substance number, the substance name and 
the empirical and constitutional formulas of the substance are given. What follows are 
cross-references to entries of reactions in which 1,3-bisphospho-D-glycerate is involved, 
to the metabolic pathways in which it operates, and to enzymes that are associated with 
the conversion of 1,3-bisphospho-D-glycerate. The CAS number in the field DBLINKS is 
a unique number given to every chemical substance by the Chemical Abstract Service 
[cas] upon first publication. Moreover, this field lists hyperlinks to other databases. The 
section Structure contains a graphical representation of the chemical structure and a 
number of buttons, which allow one to download the structure in various formats.
In addition to database queries via a graphical representation of metabolic pathways, 
LIGAND facilitates text searches for reactants or enzymes and searches for the sub-
structures of more complex chemical structures.
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7.5  Groups of Orthologous Proteins
Upon completion of a genome sequencing project, attention is turned to the analysis 
and classification of the predicted genes and the possible function of their gene prod-
ucts. The simplest approach is to compare unknown gene sequences with known genes 
and assign a function based on similarity. Some of the tools were already described 
earlier in this book. Because the comparison of whole genomes or proteomes with con-
ventional methods is very laborious, however, commercial software packages have been 
developed that allow a comparison of large sequence data sets and the identification of 
common sequences, MUMmer, for instance (Delcher et al. 1999) [mummer].
In those cases where larger phylogenetic distances exist between organisms, direct 
sequence comparison is difficult owing to low sequence similarities. Another approach to 
phylogenetic classification of proteins, therefore, is by comparing orthologous and paralo-
gous genes. Orthologous genes develop through the formation of species out of a common 
ancestor; paralogous genes develop through gene duplication. It is common sense that the 
function of orthologous genes is more conserved than that of paralogous genes because 
the evolutionary pressure is reduced on paralogous genes after gene duplication. This con-
cept is called ortholog conjecture. Although this concept has been critically discussed 
recently (Studer and Robinson-Rechavi 2009; Nehrt et al. 2011), it is still considered valid 
and forms the backbone of most functional annotation methods (Huerta-Cepas et  al. 
2016). Therefore, the exact determination of orthology between proteins is of paramount 
importance. Unfortunately, the prediction of such relations is very difficult, analytically as 
well as informatically. The reasons for this are many and include nested duplications, 
genomic rearrangements, and horizontal gene transfers, which disguise the real relations.
Therefore, several complex systems for the classification of orthologous proteins 
have been developed. A well-known system was the COP database (Clusters of 
Orthologous Groups) at the NCBI [cog] (Wheeler et al. 2007). In addition to a text-
based search, it was possible to compare sequences against the database and to predict 
the function of gene products. The quality was very high, owing to its manual curation. 
However, the database was a static system, meaning the number and kind of species 
used to build the clusters were predetermined and could not be influenced by the user. 
The COG database was discontinued in 2013.
A current database of orthologous protein groups is the eggNOG database [eggnog]. 
The database contains clusters of orthologous groups on several taxonomic levels 
together with functional annotations. In addition, the database entries are spiked with 
gene ontoloy (GO) entries, KEGG metabolic pathways, and information on SMART/
Pfam domains. Currently the database contains 2031 eukaryotic and prokaryotic organ-
isms (version v4.5, 2015). Moreover, 1655 prokaryotes have already been precompared 
to the database. For the cluster-building process, data from several primary databases 
are used, and – after a quality assurance step – all sequences are pairwise compared to 
each other using Smith–Waterman alignments. Interesting matches are stored and 
grouped into clusters with respect to taxonomic circumstances. The idea behind this last 
step is that the resolution of orthologous groups is critically dependent upon the taxo-
nomic level under consideration. For instance, it can be reasonable to cluster a set of 
mammalian sequences together with some sequences of distantly related vertebrates. If 
we study the same set of mammalian sequences, however, on the taxonomic level of 
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primates, it can be reasonable to build two clusters. The eggNOG clustering is based 
upon the clustering used in the discontinued, manually curated COG database [cog], 
which lists the three kingdoms Eukaryotes, Bacteria, and Archaea: the COGs section 
contains all three kingdoms with a focus on Prokaryotes, KOGs contains the Eukaryotes, 
and arKOGs contains the Archaea. The clustering is thus done independently for each 
of the predefined taxonomic levels. Subsequently, inconsistencies that arise from incom-
plete proteomes or from assumptions of the heuristic algorithms are eliminated in an 
additional quality assurance step. In a last step, an automated, heuristic method is used 
to select the best matching annotation from different annotation databases. Such anno-
tations are human readable, and it is thus very difficult to use them in a statistical analy-
sis. Therefore, the COG database introduced a single letter classification, which is also 
used in the eggNOG database. Every orthologous group is assigned to a classification 
using a support vector machine.
The eggNOG database offers two query systems: a guided text search and a sequence 
query. For the guided text search, a search term – a protein or gene name – is entered. If 
  . Fig. 7.7 Result of a database query of eggNOG database. The taxonomic profile is shown for the 
resulting orthologous group (Printed courtesy of EMBL)
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there are entries for different organisms, the system prompts for the organism. Next, a 
list of target organisms can be selected. This can either be distinct organisms or all mem-
bers of a clade. Based on the target organism list, eggNOG selects the taxonomic level. 
The results include hyperlinks to different visual representations, for example, there 
might be a display of a phylogenetic tree of the sequences (. Fig. 7.7) that uses color 
markups for the source and target organisms, as well as for speciation and gene duplica-
tion. Moreover, it is possible to display a sequence alignment or a taxonomic or func-
tional profile. The analysis comprises all members of the orthologous group; species that 
are not part of the query are hidden, however. In addition, it is possible to display a 
detailed view of the pairwise orthologs.
In the sequence query, it is not possible to select a target organism list. First one of 
the three possible kingdoms must be selected. The result list shows the resulting orthol-
ogous groups in all taxonomic levels. Each of the entries has the same visualization 
hyperlinks as described for the guided text search.
A similar system, the Microbial Genome Database (MBGD), facilitates the 
dynamic calculation of clusters according to user-defined parameters [mbgd] 
(Uchiyama et al. 2015) (. Fig. 7.8). This approach takes into account that the classifi-
cation of proteins into orthologous clusters can depend on the choice of organisms 
  . Fig. 7.8 Result of a cluster analysis of the MBGD [mbgd]. The organisms E. coli (Ecs), H. pylori (Hpj), 
and S. cerevisiae (Sce) were selected for calculating the underlying cluster table (Printed courtesy of 
MBGD)
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and that a static set of clusters may unintentionally influence the results. The MBGD 
therefore provides a classification scheme rather than the static result of a classifica-
tion. The cluster calculation depends on the user’s parameter entries, either via orthol-
ogy or homology criteria, and is based on precomputed similarity tables of all the 
proteins in the database. Besides text-based queries, MBGD offers a tool to evaluate 
and annotate one’s own sequences.
7.6 Exercises
 ? Exercise 7.1
How many genome sequencing projects are ongoing and how many have been 
completed?
 ? Exercise 7.2
Go to the KEGG home page (7 http://www.kegg.jp/) and display the metabolic map 
of glycolysis/gluconeogenesis metabolism.
 ? Exercise 7.3
What enzymes catalyze the conversion of L-lactate to pyruvate? Does this conversion 
take place in humans? Does Saccharomyces cerevisiae make use of this metabolic step?
 ? Exercise 7.4
How do the enzyme hyperlinks differ between the reference pathway and a species-
specific map (e.g., Homo sapiens)?
 ? Exercise 7.5
Display the chart of glycolysis/gluconeogenesis metabolism and compare the species-
specific map of humans with that of Helicobacter pylori 26,695. What are the significant 
differences between the two maps? How can these differences be explained?
 ? Exercise 7.6
Go to the NCBI BLAST home page and perform a BLAST search with the sequence 
Q9ZK41 against the Microbial Genome Database for the genomes of the following 
organisms or groups of organisms:
 5 Staphylococcus aureus RF122 (taxid: 273,036)
 5 Streptococcus pneumoniae D39 (taxid: 373,153)
 5 Proteobacteria epsilon subdivision (taxid: 29,547)
 5 How many reasonable hits are obtained for each organism?
 ? Exercise 7.7
Go to the eggNOG database (7 http://eggnogdb.embl.de/) and search for the 
orthologous group (OG) of the cyclind-dependent kinase CDK1 from Homo sapiens. 
Use the clade Apicomplexa for the target organisms. What taxonomic level is 
automatically chosen by eggNOG?
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 ? Exercise 7.8
Repeat 7 Exercise 7.7 but select the Marsupials as the target organisms. What 
taxonomic level is chosen by eggNOG? How many sequences contain a PFAM kinase 
domain, and what is the frequency of occurrence for this domain? Are the respective 
marsupial sequences orthologs or paralogs? Are there paralogs within the selected 
taxonomic level?
 ? Exercise 7.9
Go to the MBGD (7 http://mbgd.genome.ad.jp/) and calculate a cluster table for the 
following organisms: Staphylococcus aureus RF122, Escherichia coli 536, and 
Saccharomyces cerevisiae S288C.
 ? Exercise 7.10
From 7 Exercise 7.9, how many clusters contain genes of all the selected organisms? 
Display these. To which functional category does the first cluster belong?
 ? Exercise 7.11
Go back to the start page of the MBGD (7 http://mbgd.genome.ad.jp/). In the 
overview of organisms, only those previously selected will be marked in red. Do a 
keyword search for the keyword fructokinase. How many entries are found?
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Solutions to Exercises
Chapter 1
 v Solution 1.1
DNA and RNA differ in the composi-
tion of their nucleotides. While in DNA 
deoxyribose is found as sugar residue, 
in RNA this is replaced by ribose. 
Furthermore, in RNA, the base uracil 
replaces thymine. DNA is present 
as a complementary double strand, 
whereas RNA is single-stranded.
 v Solution 1.2
In DNA, the base pairings A-T and C-G 
are seen. A purine ring is paired with a 
corresponding pyrimidine. Two hydro-
gen bonds are formed in the base pair-
ing of A-T, whereas three such bonds 
are formed in the pairing of C-G.
 v Solution 1.3
Genome describes all genomic DNA, 
transcriptome all mature mRNA, and 
proteome all proteins in an organism.
 v Solution 1.4
The amino acid sequence of proteins 
is determined by the genetic code. 
There are 20 naturally occurring 
amino acids, but only 4 bases in the 
DNA to encode them. Consequently, 
amino acids must be encoded by 
combinations of bases. A base dou-
blet of 4 bases allows for the encod-
ing of 42 or 16 amino acids and is, 
therefore, insufficient to code for 20 
amino acids. However, a base triplet 
allows for 43 or 64 combinations. 
Consequently, several triplets encode 
the same amino acid, and the genetic 
code is, therefore, referred to as being 
degenerate.
 v Solution 1.5
The name CRICK represents the 
amino acids cysteine, arginine, isoleu-
cine, cysteine, and lysine. Cysteine is 
encoded by the base triplets UGU or 
UGC; arginine by CGU, CGC, CGA, or 
CGG; isoleucine by AUU, AUC, or AUA; 
and lysine by AAA or AAG. Thus, one 
possible genetic code encoding an 
amino acid sequence for which the 
one-letter sequence would be CRICK 
is UGU CGU AUU UGU AAA
 v Solution 1.6
The central dogma of molecular biol-
ogy was coined by Francis Crick and 
describes the relation between DNA, 
RNA, and proteins. The information of 
DNA is transcribed into (messenger) 
RNA in the process of transcription, 
which is subsequently converted into 
proteins in the process of translation. 
This flow of information always pro-
ceeds in this direction in nature, with the 
exception of some RNA viruses that rep-
licate RNA and transcribe RNA into DNA.
 v Solution 1.7
Splicing refers to the removal of 
introns from premature messenger 
RNA. The process of alternative splic-
ing refers to varying possibilities 
for cutting and joining introns and 
exons. In this way one gene can code 
for several proteins. This is one expla-
nation of why there is a smaller num-
ber of genes in the human genome 
relative to the number of proteins.
 v Solution 1.8
A Venn diagram (Fig. 1.7) can be used 
to display the properties of amino 
acids. The amino acids threonine 
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and cysteine are indicated as hydro-
phobic, polar, and small. Isoleucine, 
leucine, and valine are hydrophobic 
and aliphatic.
 v Solution 1.9
By definition the primary structure of 
proteins is read from the N-terminus 
to the C-terminus.
 v Solution 1.10
Three structural building blocks are 
found in the secondary structure 
of proteins: the helix, the β-strand 
(building up a β-sheet), and nonrepet-
itive turns. In addition, loops are often 
mentioned, which consist of turns and 
connect helices or β-strands.
Chapter 2
 v Solution 2.1
Go to the start page at NCBI (7 http://
www.ncbi.nlm.nih.gov/). Select the 
term Protein in the pulldown menu 
search in the top left. Then enter the 
search terms in the desired combina-
tion into the text entry field next to 
the pull-down menu on the right. To 
start the database search, click on the 
button Search on the right, next to 
the text entry field. Depending on the 
combinations of search terms, different 
results will be obtained. For example, 
using hydrolysis AND arabinofu-
ranoside AND bacillus AND subtilis, six 
database records (as of March 2018) 
will appear. Because a plain text search 
was performed, not all six entries are 
coming from the organism Bacillus 
subtilis, the latter two entries are from 
Bacillus halodurans and from Paenibac-
cilus polymyxa. If you want to restrict 
the search to a specific organism, you 
need to limit the search term Bacil-
lus subtilis to the organism database 
field. In this case the query is Bacil-
lus subtilis[ORGN] AND hydrolysis 
AND arabinofuranoside. The result 
is then only the first four database 
entries.
 v Solution 2.2
To find the nucleotide sequence of 
the corresponding gene for IABF2_
BACSU open the second entry on 
the result page. IABF2_BACSU stands 
for Intracellular exo-alpha-L-arabi-
nofuranosidase 2. If you scroll down 
the entry you will find the section 
FEATURES and within that section the 
keyword gene. There you can find two 
gene aliases ASD and XSA.
Now enter the gene name 
XSA into the text entry field on 
the NCBI start page. Check that 
the term Nucleotide is selected 
in the pull-down menu. In addi-
tion, combine this word with the 
term Bacillus subtilis and restrict 
this search term to the organism 
field. It should look as follows: XSA 
AND Bacillus subtilis [ORGN]. AND 
operators can be skipped – several 
terms are connected automati-
cally with AND as long as no other 
operator is used.
Several database entries on the 
bacterium will be found, includ-
ing the complete genome of B. 
subtilis. Clicking the corresponding 
hyperlink will display the complete 
genome of the bacterium. The infor-
mation for the corresponding gene 
is again found in the features sec-
tion. It’s best to use the text search 
function of your browser to look 
for the gene name XSA. Above the 
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gene name, next to the keywords 
for the subsection (gene and CDS), 
are found the number of the first 
and last bases of the nucleotide 
sequence. If the keyword comple-
ment is indicated next to the num-
bers of the first and last bases, then 
the gene is localized on the comple-
mentary DNA strand.
 v Solution 2.3
Entrez is the database query system 
at NCBI. Therefore, go to the start 
page at 7 http://www.ncbi.nlm.nih.
gov/Entrez. Querying the system is 
done as in 7 Exercise 2.1. Enter the 
accession number P94552 into the 
text entry field and then click Search. 
Be sure that Protein is selected in the 
Search pull-down menu. Alterna-
tively, on the NCBI start page follow 
the hyperlink Proteins in the light 
blue panel on the left-hand side and 
then the hyperlink Protein Database 
to the Entrez system. Enter the acces-
sion number P94552 into the text 
field and click Search. Both alterna-
tives produce the database entry for 
the protein IABF2_BACSU.
 v Solution 2.4
Go to the start page of the EBI 
(7 http://www.ebi.ac.uk), enter the 
AN P94552 into the text entry field 
Find a gene, protein or chemical, and 
press the button with the magnifying 
glass. Among other entries, the data-
base record of the protein IABF2_
BACSU will be found. At first sight, 
the entry appears different from 
the corresponding entry at NCBI. As 
mentioned earlier in 7 Chap. 2, the 
standard view at the EBI server for 
the Uniprot database, from which this 
record arises, is graphical. The original 
database record can be seen upon 
following the hyperlink Format:Text, 
which is located in the blue bar 
directly above the database record. 
There one can also find hyperlinks to 
representations of the information in 
other formats.
 v Solution 2.5
In the graphically formatted view, 
the database record is divided into 
16 sections. In the first section, the 
protein name, the corresponding 
gene name, the organism name, and 
the entry’s status are listed. The status 
concerns the origin of the entry; it 
can either be reviewed, meaning the 
entry originates from UniProtKB/Swis-
sProt, or unreviewed, which means 
the entry originates from UniProtKB/
TrEMBL. The second section has to 
do with function and gives relevant 
references. It is followed by sections 
about taxonomy, expression, inter-
actions, and structure, followed by 
information on protein families and 
protein structure.
The section Cross-references (left-
hand side) lists hyperlinks to other 
databases that contain entries for 
this protein. A mouse click on one of 
these hyperlinks queries the relevant 
database and displays the database 
record. The Publications section lists 
relevant publications, and the section 
Entry information has information 
on the entry history, for example, 
the date of the last modification. The 
last two sections contain hyperlinks 
to useful documents and database 
entries for this entry.
Quite a bit of this information is 
available in the raw-text entry too, 
but not all of it, or at least not explic-
itly. This information is generated or 
retrieved from other databases on an 
ad hoc basis in the graphical view.
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 v Solution 2.6
Go to the graphical view of the 
database record from Exercise 2.5 
and follow one of the hyperlinks of 
reference 1. Depending on which one 
you clicked, the hyperlink provides a 
bibliography and a summary of the 
corresponding publication. For some 
references, a hyperlink to the com-
plete paper is available in addition, 
for example, reference 2.
 v Solution 2.7
Two genes, arf1 and arf2, of an 
unknown species that are homolo-
gous to the α-L-arabinofuranosidase 
1 or 2 of Bacillus subtilis are sought. 
To solve the problem, a short litera-
ture search will be performed. Return 
to the start page of NCBI and query 
PubMed by choosing PubMed in the 
pull-down menu on the left beside 
the text field. Enter the search terms 
into the text field. Using a combina-
tion of the terms bacillus subtilis 
AND arabinofuranosidase several 
publications are found. The solution 
to the question is hidden in the pub-
lication of Kim et al. (1998) (see refer-
ences section of 7 Chap. 2). Arf1 and 
arf2 are from Cytophaga xylanolytica 
and are homologous to proteins in 
Bacteroides ovatus and Clostridium 
stercorarium. You can further restrict 
the query, for example, with bacillus 
subtilis AND arabinofuranosidase 
AND arfI. With this query, only the 
Kim et al. publication is found.
 v Solution 2.8
One can search for a publication by 
an author in different ways. The sim-
plest way is to type the last name of 
the author into the text entry field 
on the NCBI start page and then 
click Go. Because a full text search 
is performed, all publications that 
contain the author’s name in the 
text will be displayed. To restrict the 
search to authors only, upon typing 
the name, specify the database field 
to be searched. To do this, enter the 
identifier of the appropriate data-
base field in square brackets (with-
out any blanks) immediately after 
the search term. For this example, 
the search string is Blobel[au], and 
only those publications that con-
tain the name Blobel in the author 
list are found. However, there are 
many authors with the last name 
Blobel besides Günther Blobel. To 
retrieve only Günther Blobel’s pub-
lications, Blobel G can be entered 
as a search term. Using this syntax, 
Entrez automatically recognizes the 
search for an author’s name and 
restricts the search accordingly. For 
several author names, their first 
two initials must be written without 
spaces after their surnames (e.g., 
Edison TA for Thomas Alva Edison). 
To restrict the search to the author 
field, [au] can be added again. In the 
tutorial for the PubMed database 
(7 http://www.nlm.nih.gov/bsd/
disted/pubmedtutorial/cover.html), 
additional useful information about 
how to restrict search results can be 
found.
 v Solution 2.9
Go to the Prosite Web page (7 http://
prosite.expasy.org/) and enter the 
sequence (Raw or FASTA format) into 
the text entry field in the section 
Quick Scan mode of ScanProsite, by 
cutting and pasting. Alternatively, 
the Swissprot AN P94552 or the 
Swissprot-ID ABF2_BACSU can be 
entered. Click on the Scan button to 
start the search.
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Unless the box Exclude motifs 
with a high probability of occurrence 
is checked, 30 hits will be found with 
the following four motifs: N-myris-
toylation site, CK2 phosphorylation 
site, N-glycosylation site, and PKC 
phosphorylation site (as of July 
2016). All four motifs carry the warn-
ing pattern with a high probability 
of occurrence, which means that 
they frequently occur in sequences 
and might lead to an incorrect 
functional annotation. Next to each 
motif is placed a hyperlink to the 
corresponding entry in the Prosite 
database.
 v Solution 2.10
Go to the start page of the PRINTS 
server (7 http://bioinf.man.ac.uk/
dbbrowser/PRINTS/index.php) and 
follow the hyperlink FPScan in the 
section PRINTS search. On the follow-
ing page in the text entry field, enter 
the sequence of the entry ABF2_
BACSU (raw format) by cutting and 
pasting. After clicking Send Query, 
the results page should not show 
any significant hits for the chosen 
sequence. Repeat the same search 
with the sequence ADA1B_HUMAN 
in the UniprotKB/SwissProt database. 
To do this, load the relevant database 
record from UniprotKB/SwissProt and 
enter the sequence in raw format 
by cutting and pasting. The results 
page should show the three highest 
scoring fingerprints in the first sec-
tion. The following two sections list 
the ten best fingerprints. Each of the 
three highest scoring fingerprints has 
three links, one each to the PRINTS 
database, to a graphical representa-
tion of the motif’s distribution along 
the sequence and to a 3D represen-
tation of the motif in the protein 
structure. The example sequence is a 
human adrenergic G-protein-coupled 
receptor, which is confirmed by the 
three fingerprints.
 v Solution 2.11
Go to the start page of the Blocks 
Web server (7 http://blocks.fhcrc.
org/), and follow the hyperlink Blocks 
Searcher. P35368 is the AN of the 
sequence A1AB_HUMAN from Exer-
cise 2.10. In case the corresponding 
browser window has been closed, 
download the sequence again from 
Swissprot and enter the sequence by 
cutting and pasting into the corre-
sponding text entry field of the Blocks 
Searcher. Also, enter your e-mail 
address into the appropriate field to 
receive the search results by e-mail. 
Then submit the query by clicking on 
Perform Search. After a few minutes, 
an e-mail in HTML format will arrive. 
If the e-mail program cannot display 
HTML, it can be saved and opened 
from within a browser.
The actual result of the search is 
found below a short description of 
the organization of the results page. 
The first section contains a summary 
of the search followed by a list of the 
possible hits. For ADA1B_HUMAN, 
nine possible hits should be listed. 
The first hit (alpha-1B adrenergic 
receptor signature) with an E Value 
of 3.2e-123 can be regarded as sta-
tistically significant, and all seven 
corresponding motifs are found. 
The E Value is a measure of the 
chance of finding a hit of the same 
quality within a random amino acid 
sequence. The value should be as 
small as possible in accordance with 
its mathematical definition (see also 
7 Chap. 3). The next four hits show 
decreasing statistical significances. 
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Also, not all motifs of the corre-
sponding class are found in most 
sequences; this suggests, therefore, 
that these receptors are part of a 
superfamily. The remaining hits are 
not statistically significant and can 
be disregarded. The lower part of the 
results page contains detailed infor-
mation on each of the possible hits.
 v Solution 2.12
Go to the start page of the Pfam Web 
server (7 http://pfam.xfam.org/), 
click on SEQUENCE SEARCH, and enter 
the sequence in FATSA format by cut-
ting and pasting to the search text 
field. Start the search by clicking GO.
After a few seconds the results 
of the query are shown. The most 
probable hit will be the Pfam protein 
family 7tm_1. This designation stands 
for the rhodopsin family of G-protein-
coupled receptors with seven trans-
membrane helices.
If you want to access the precal-
culated result, enter the AN or ID in 
the text field in the Jump section. 
Both result pages (calculated and 
precalculated) contain hyperlinks to 
annotations of the protein family.
 v Solution 2.13
Go to the start page of the Interpro 
Web server (7 https://www.ebi.ac.uk/
interpro/search/sequence-search), 
and enter the sequence (FASTA for-
mat) into the text field by cutting and 
pasting. Start the search by clicking 
on Search.
The results page displays each hit 
from the different member databases 
of Interpro in graphical format. The 
result is identical to the results of 
the previous exercises, i.e., querying 
Interpro can frequently replace the 
searches of the individual databases.
 v Solution 2.14
Go to the start page of the RCSB PDB 
database (7 http://www.rcsb.org), 
and type in the search term Bovine 
Rhodopsin into the text field at the 
top of the page; then click Go. The 
search will return 32 hits in PDB (as 
of July 2016). However, because a 
full text search was performed, not 
all hits represent the 3D structure of 
bovine rhodopsin. The structure with 
the highest crystallographic resolu-
tion of 2.2 Å has the PDB ID 1 U19. 
Clicking on the title or the picture of 
the structure will display the data-
base record. The Structure Summary 
lists the relevant reference, some 
information about the experimental 
method, the crystallographic unit 
cell, biological function, and cocrys-
tallized ligands. Also, a ribbon rep-
resentation of the biological unit is 
shown. In the menu beneath, several 
hyperlinks to different representa-
tion methods are given. The button 
Download Files allows for download-
ing the structure file in different 
file formats. Detailed information 
regarding the preceding individual 
points can be found on the tabs 
View, Annotations, Sequence Details, 
Structure Similarity, Experiment, and 
Literature. Thus, the crystallization 
temperature of 283 K is found in the 
section Experiment, and the graph 
in the section, Sequence Details, 
details a cysteine bridge (yellow line 
between two cysteine symbols).
 v Solution 2.15
Go to the start page of Entrez 
(7 http://www.ncbi.nlm.nih.gov/
entrez/), and in the Search menu 
select the database PubChem BioAs-
say. Then type HERG channel activity 
into the text field on the right and 
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click Search. For the development of a 
potential drug, knowledge of its hERG 
activity is paramount. Therefore, it is 
not surprising that quite a few hERG 
assays are used, currently 6047 (as of 
July 2016). Position 10 lists an assay 
that corresponds exactly to our query: 
HERG Channel Activity, Assay ID (AID) 
376. It reports that 1960 compounds 
were tested so far using this assay, 252 
of which were active.
 v Solution 2.16
Go to the start page of PubChem 
(7 http://pubchem.ncbi.nlm.nih.
gov) and select the tab Compound, 
or go to Entrez (7 http://www.ncbi.
nlm.nih.gov/entrez/) and select the 
database PubChem Compound in 
the drop-down menu at the top. 
Enter the search term fenbendazole 
in the text field and click on Search. 
Ten compound entries are found (as 
of March 2018). The first entry is on 
fenbendazole, while the remaining 
entries are about derivatives of fen-
bendazole. If you click on Bioactivity 
Analysis on the right, you can see in 
the overview that fenbendazole and 
its derivatives were tested in 1608 
bioassays and that fenbendazole was 
found active in 93 cases.
Repeat the search with the search 
term Albendazole. Its chemical struc-
ture is rather similar to that of fen-
bendazole; the difference lies in the 
substitution pattern of the thioether. 
Albendazole and its derivatives have 
been tested in 1525 bioassays and 
were active in 117 cases.
Information on the usage of the 
compounds can be found in the sec-
tion Pharmacology and Biochemistry 
of both database entries. Both com-
pounds are nematocidal drugs that are 
used in the veterinary environment.
 v Solution 2.17
Go to the start page of PhenomicDB 
(7 http://www.phenomicDB.de), and 
enter the search term coproporphyria 
into the text field at the top of the 
page. In the menu Select Organisms, 
choose the term All or restrict your 
search to humans with the term 
Human. Using the Shift and Alt keys 
in Windows, one can select several 
terms in this and the other selection 
menu, Select data fields to show. For 
the other parameters leave the stan-
dard settings untouched and click 
Search. Six genotypes (three humans, 
two mouse, and one rat) and seven 
phenotypes should result. The first 
phenotype bears the name Copropor-
phyria and is causally associated with 
a defect in the gene CPOX. Click the 
button Orthologies on the left next to 
the corresponding genotype. For D. 
melanogaster, ten genotype entries 
in FlyBase are shown, of which some 
entries in the field Phenotypic class 
contain the entry lethal. Therefore, a 
similar genotype-phenotype relation-
ship also exists in the fruit fly.
Chapter 3
 v Solution 3.1
Open the Needle application and 
enter the two sequences. Enter a Gap 
open penalty and a Gap extend penalty 
of 1.0 and the desired matrix at more 
options. Start the analysis by click-
ing submit. The results will be shown 
directly after calculation. The scores 
for the best alignment of the two 
sequences will be 31.0, 29.0, and 48.0 
with the BLOSUM62, PAM250, and 
PAM30 matrices, respectively. The cal-
culated alignments are quite different, 
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however. For example, with PAM30 
the introduction of several gaps is 
suggested. This shows that the choice 
of a similarity matrix is important for 
the assessment of an alignment.
 v Solution 3.2
Go to the NCBI page [ncbi] and select 
the protein database with the term 
Protein in the pull-down menu in the 
top left besides the search field. Then 
enter the search string 5-hydroxy-
tryptamine 2A receptor into the text 
field next to the pull-down menu on 
the right. Click Search next to the text 
field on the right. To limit the search 
further, you can combine the search 
string homo sapiens with AND. Sev-
eral entries for the human serotonin 
receptor are found. Check the box to 
the left of the Swiss-Prot database 
record (Swiss-Prot AN P28223; ID 
5HT2A_HUMAN). Then select the 
data format FASTA by clicking FASTA 
and save it via the pull-down menu 
Send To. Alternatively, examine the 
sequence in the browser and copy 
and paste it for Exercise 3.3.
 v Solution 3.3
Go to the NCBI-BLAST page [ncbi-
blast]. You have to use the blastp 
software since the query sequence 
is that of a protein and the search 
should be executed in the non-
redundant protein database of 
NCBI. Click on Protein Blast [blastp]. 
Then copy and paste the sequence 
from Exercise 3.2 into the search 
text field. Rather than the sequence 
text, only the AN (P28223) or the 
NCBI identifier (gi|543727) may be 
used. However, this is a distinctive 
feature of the NCBI-BLAST server 
and not available for all servers on 
the Web. Explanations about this 
text field and other fields or menu 
items can be found by following 
the respective hyperlink next to 
the entry field (e.g., Search). Start 
the search by clicking on BLAST. All 
additional settings can be used for 
a refinement of the BLAST search, 
but this needs some practice. Upon 
sending the query, a confirmation 
page is displayed that includes a 
multidigit request ID. This ID allows 
the later retrieval of the result. 
Often the BLAST analysis takes a 
little time, e.g., owing to a large 
number of concurrent queries of 
the server, but a self-updating sta-
tus page will display until the analy-
sis is finished.
More than 250 hits are returned 
from the database (as of December 
2016), whereas only 100 are displayed 
using standard settings. The graphical 
overview provides a summary of the 
position and length of the hits with 
respect to the query sequence. The 
quality of the hits (alignment score) is 
color-coded.
 v Solution 3.4
The blastn program is found on the 
NCBI-BLAST Web site [blast] using the 
hyperlink Nucleotide BLAST or in the 
blastx program using the hyperlink 
blastx. You can also switch between 
both programs on each search site 
using their named tabs. Execute both 
programs with the same nucleotide 
sequence (AB037513). Either the 
sequence can be downloaded from 
the server, as detailed in Exercise 
3.2, or its accession number can be 
entered into the search text field 
Enter Query Sequence (Exercise 3.3). 
Select Database Others (nr etc.) 
and Reference genomic sequences 
for blastn and Nonredundant pro-
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tein sequences for blastx. Limit the 
analysis to the organism Drosophila 
melanogaster by entering Drosophila 
melanogaster under Organism.
The blastn search stops with 
the information that no significant 
similarity can be found. With tblastx, 
however, more than 100 database 
records are found, and some of these 
show a high significance. The discrep-
ancy between the results is due to 
differences in how blastn and blastx 
execute searches and the codon 
usage between the two species. 
While blastn performs a simple com-
parison at the nucleotide level, blastx 
works at the protein level by first 
translating the query sequence into 
all six reading frames and then com-
paring these six theoretical proteins 
against a protein database. Because 
the genetic code is degenerate, an 
amino acid can be encoded by differ-
ent codon triplets. The codon usage 
between Drosophila melanogaster 
and Homo sapiens is so different that 
no good agreement was found at the 
nucleotide level.
 v Solution 3.5
Go to the Global Align program at 
NCBI. Enter the two ANs into the cor-
responding text fields in the sections 
Enter Query Sequence and Enter 
Subject Sequence. Before starting the 
analysis, select the appropriate pro-
gram. Click Align.
The result shows that in the two 
sequences, two regions with an iden-
tity of over 40% are present. In the 
human serotonin receptor, the two 
regions lie close together, whereas 
they are separated by more than 200 
amino acids in the sequence of Dro-
sophila melanogaster. The graphical 
overview displays very well the spa-
tial arrangement of these sequence 
regions. However, this overview 
should not be considered definitive 
because it contains little information 
regarding the alignment quality.
 v Solution 3.6
Enter the protein sequences in FASTA 
format in the text field STEP1 – Enter 
your input sequences or open a text 
file with all sequences in FASTA for-
mat. Click Submit. The result page 
shows four different tabs. The stan-
dard view Alignments shows the final 
multiple-sequence alignment. On 
Show Colors the single amino acids 
are colored, which supports an easy 
analysis. The Phylogenetic Tree tab 
shows a tree representation, whereas 
the distances between the sequence 
represent the sequence similarity.
The multiple alignment of the 
three proteins shows a low number 
of matches, whereas two sequences 
show identical amino acids in wide 
areas and even more when conserved 
amino acids are considered. Identical 
amino acids in all three sequences 
occur quite rarely. In the Phylogenetic 
Tree view this can be clearly seen since 
all sequences have similar  distances.
The alignment can be stored 
as a simple text file with the exten-
sion. clustal so that the alignment 
can be viewed with other software. 
Click on Download Alignment File 
above Alignment. Other visualization 
tools include, for example, SeaView 
[seaview] and BioEDIT [bioedit], 
which is unfortunately not updated 
but still creates good results. Use the 
Open File dialogue to open a saved 
file, change to file format All Files (“.”) 
if your file is not shown. The correct 
format is usually recognized when 
the file is opened.
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You will find other useful tools on 
the expasy home page. An in-depth 
study of this page is therefore recom-
mended.
 v Solution 3.7
The multiple alignment makes it obvi-
ous that the sequences are very simi-
lar. The amino acids are either identical 
or conservatively exchanged over wide 
regions. The sequence NP_640355.1 
has an insertion of approx. 10 amino 
acids. Because of the high identity, one 
can assume that they are homologous 
sequences. Indeed, the sequences are 
proteases of the cathepsin family from 
different species:
Q28944.1 Cathepsin L precursor 
Sus scrofa (pig)
P25975.3 Cathepsin L precursor 
Bos taurus (cattle)
NP_081182.2 Cathepsin 3 precur-
sor Mus musculus (mouse)
NP_640355.1 Cathepsin Q Rattus 
norvegicus (rat)
NP_001903.1 Cathepsin L prepro-
protein Homo sapiens (human)
AAH12612.1 similar to Cathepsin 
L Homo sapiens (human)
The phylogenetic tree indicates 
the relationship between the six 
sequences. A close relationship 
between the two human sequences, 
as well as between the sequences 
from cattle and pig, is calculated. 
According to this analysis, therefore, 
the sequences from mouse and rat 
are more distantly related.
 v Solution 3.8
Enter AC012088 into the search field 
of the NCBI server. Copy-paste the 
FASTA sequence of the eukaryotic 
cosmid into the input field of the 
Genscan server [genscan]. If the 
sequence has been saved in FASTA 
format to the hard disk, the file 
can be sent to the Genscan server 
by File upload. Before starting the 
analysis, the organism from which 
the sequence is derived must be 
selected in the pull-down menu 
Organism. Because AC012088 is a 
human sequence, Vertebrate must 
be chosen. Click Run GENSCAN after-
wards. Optionally, a name for the 
sequence can be given; however, it 
will only be used for identification 
in the report. Depending on the set-
tings (pull-down menu Print options), 
either just the proteins predicted to 
be present in the query sequence 
or the predicted proteins together 
with the corresponding nucleotide 
sequences will be displayed. It is also 
possible to display a graphic identi-
fying the position of the predicted 
coding nucleotide sequences along 
the query sequence. For cosmid 
AC012088, two proteins are pre-
dicted, one of which is encoded by a 
single exon gene, meaning that the 
gene consists of a single exon with-
out introns.
Chapter 4
 v Solution 4.1
Go to the dbEST home page at 
7 https://www.ncbi.nlm.nih.gov/
dbEST/index.html and follow the 
hyperlink Number of ESTs in the 
lower part of the page. The dbEST 
contains more than 74 million ESTs; 
13.5 million come from humans and 
mice. Therefore, about 20% of all 
EST sequences come from these two 
organisms (dbEST release 130101).
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 v Solution 4.2
Go to the home page of dbEST and 
enter Magnifera indica in the search 
field for Search EST. The search results 
in 1714 hits. A search for Mangifera 
indica [ORGANISM] results in 1690 
hits (dbEST release 130101). The dif-
ference between the two queries 
lies in the database fields that are 
searched. In the first case, all data-
base fields are searched for the term 
Mangifera indica. For instance, if a 
database entry says gene A is similar 
to gene B of Mangifera indica, this 
database entry would be reported 
even if gene A came from a totally 
different organism. In the second 
query, only the database field Organ-
ism is searched. Only database entries 
that come from Mangifera indica are 
reported in this case.
 v Solution 4.3
Click on the small triangle at the 
top or bottom of the page beside 
the keyword Send to and select the 
option File in the drop-down menu. 
Then select the option FASTA in the 
Format field and click on Create File. 
Save the file on your computer’s hard 
disk. The file can be viewed using any 
editor installed on your computer, 
e.g., Notepad in Windows.
If you do not want to save the 
FASTA sequence but just display it, 
you can click on the keyword Sum-
mary at the top or bottom of the 
page and then select the option 
FASTA or FASTA (Text) in the drop-
down menu. You are then presented 
with a preselected number of 
sequences. In the standard setup, it is 
20 sequences.
 v Solution 4.4
Go to the home page of the CAP3 
sequence assembly program of the 
PRABI-Doua Institute (7 http://doua.
prabi.fr/software/cap3). Copy the 
first 75 EST sequences of Magnifera 
indica into the search field and start 
the program by clicking on the Sub-
mit button. Inspect the results in the 
files Contigs, Single Sequences, and 
Assembly Details, and save the results 
on your computer’s hard disk. In 
total, the sequence assembly of the 
75 Magnifera indica EST sequences 
leads to 4 contigs (Sept. 2016). Each 
of the contigs is built by two ESTs. In 
addition, many singletons are found. 
These have no similarities to other 
ESTs and therefore are not assembled 
into contigs.
 v Solution 4.5
Analyze the four contigs individu-
ally by copying them into the search 
field at the NCBI BLASTx page. Select 
the database nonredundant protein 
sequences (nr) and start the BLAST 
search by clicking on the BLAST but-
ton. Some of the contigs are very 
similar to already known genes or 
proteins, e.g., the WRKY transcrip-
tion factor 58 of Manihot esculenta, 
the cassava plant. Not all contigs 
lead to reliable hits. The less reliable 
hits belong to new, as yet unknown 
genes. So far, nothing is known about 
the function of these genes.
 v Solution 4.6
Go to the database search system 
Entrez of the NCBI. In the drop-down 
menu at the top of the page, select 
Nucleotide and enter the AN AI590371 
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into the text field to the right. To dis-
play the sequence in FASTA format, 
click on FASTA. Save the sequence 
on your computer’s hard disk by 
selecting the option File in the Send 
to drop-down menu. You can display 
the file using any text editor.
 v Solution 4.7
Go to the home page of the NCBI 
and run a blastn search in Basic 
BLAST. Cut and paste the EST FASTA 
sequence you saved earlier into the 
box Enter Query Sequence. Select the 
database Nucleotide collection (nr/
nt) and click on the BLAST button 
to start the search. Forty sequences 
result in clear hits in the nonredun-
dant nucleotide database, 12 of 
which come from Homo sapiens, 26 
from other primates (e.g., Pan troglo-
dytes, Gorilla gorilla, Macaca mulatta), 
and 2 from Sus scrofa, the domestic 
pig (Dec. 2016).
 v Solution 4.8
The NCB databases contain cross 
references to other databases. To go 
to the UniGene database, open the 
GenBank entry of the sequence by 
following the hyperlink NM_080870.3 
or the cross-reference link GenBank. 
In both cases the GenBank entry of 
the sequence is displayed. In the 
right column you will find a section, 
Related Information, that contains 
hyperlinks to the UniGene database 
and to the OMIM database. First, fol-
low the hyperlink for the UniGene 
database and open the UniGene 
cluster Diffuse panbronchiolitis 
critical region 1, HS.631993. Even 
before you open that cluster you 
can already see in the summary that 
41 sequences belong to this clus-
ter. Once you open the cluster, you 
can find the information that 35 of 
the sequences are EST sequences, 
while 6 of the sequences are mRNA 
sequences (Dec. 2016).
For information on the related-
ness to diseases you need to use 
another database. Go back to the 
GenBank entry and follow the hyper-
link to the OMIM database. If you fol-
low the first link of the resulting page, 
you will find information on the clon-
ing and expression of that very gene, 
on its gene structure, on its mapping, 
and on its nomenclature. For informa-
tion about related diseases follow the 
second link. In the section Description 
you will find the information that the 
gene product is involved in a rare 
chronic inflammation of the bronchi-
oles. This disease occurs almost exclu-
sively in East Asia. Only a few cases 
are reported outside this area, mainly 
in patients of East Asian descent.
 v Solution 4.9
Go back again to the Unigene entry 
(Exercise 4.8) and follow the hyperlink 
EST Profile in the section Gene Expres-
sion. The origin of the ESTs allows for 
the conclusion that the gene will be 
expressed in the stomach, the colon, 
the pancreas, and the adrenal gland. 
Moreover, the protein can be found 
in several tumors.
 v Solution 4.10
Go to the database query system 
Entrez of the NCBI. Select Protein in 
the drop-down menu at the top of 
the page and enter the AN P01108 
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into the text field at the right. Select 
the Display option FASTA and save the 
sequence in FASTA format on your 
computer’s hard disk by selecting the 
option File in the Send to drop-down 
menu. You can display the file using 
any text editor.
 v Solution 4.11
Go to the BLAST home page of the 
NCBI and run a tblastn search under 
Basic BLAST. Cut and paste the saved 
c-myc FASTA sequence into the box 
Enter Query Sequence. Alternatively, 
you can run the BLAST analysis by fol-
lowing the hyperlink Run BLAST in the 
section Analyze this sequence in the 
database entry in Exercise 4.10. If you 
take this approach, it is important 
to change to the tab tblastn on the 
BLAST page.
Select the database Expressed 
sequence tags (est) and enter mouse 
(taxid: 10090) into the field Organism. 
Start the analysis by clicking on the 
BLAST button. The graphical analysis 
Distribution of the top [number of hits] 
Blast Hits on the Query Sequence tells 
us that more than 100 murine ESTs 
are similar to the proto-oncogene 
c-myc. It is striking that the majority 
of EST sequences show a remarkable 
identity either to the 5′ or 3′ end of 
the sequence. The reason for this 
distribution lies in EST production. 
ESTs are generated by sequencing the 
ends of cDNA clones.
 v Solution 4.12
While the vast majority of excellent 
hits (alignment score > 200, red bars) 
show a 100% alignment with the 
murine c-myc, ESTs with alignment 
scores of 80–200 (magenta bars) are 
only identical to 60–80%. This might 
be due to the fact that these ESTs 
code for a second, very similar, pro-
tein. To prove this hypothesis, we can 
blast these hits against the UniProtKB 
database using the BLAST algorithm 
blastx. The best hit we get is a protein 
called B-myc that is highly similar 
to c-myc. This is the proof for our 
hypothesis and means we identified a 
similar gene by analyzing ESTs.
 v Solution 4.13
The NCBI has a very large bookshelf 
of online textbooks. You can find this 
bookshelf at the NCBI home page in 
the section Literature or in the sec-
tion Popular Resources. If you want to 
search all textbooks for a given term 
at the same time, select Books in the 
Entrez drop-down menu and enter the 
search text into the text box on the 
right. For this exercise enter the search 
term Genes and disease and follow the 
hyperlink to this book on the results 
page. If you want to limit the search, 
you can use quotes around the search 
term. Go to the section Nutritional 
and Metabolic Diseases in the table 
of contents and find the hyperlink 
to Phenylketonuria. The human phe-
nylalanine hydroxylase is located on 
chromosome 12. On the right-hand 
side, in the section Gene sequence, you 
will find a hyperlink to the Entrez Gene 
database, which will give you hyper-
links to other relevant databases. 
Entrez Gene is always an interesting 
starting point for database searches.
 v Solution 4.14
Go to the NCBI database dbSNP and 
search for the reference cluster rs334 
under Search by IDs. The SNP rs334 
is an SNP in the human genome. 
Information on the genetic variation 
can be found in the section GeneV-
iew. The colored table lists the kinds 
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and results of the mutation. For SNP 
rs334 an adenine is exchanged for 
a thymine in the gene hemoglobin 
subunit beta, which leads to an 
amino acid exchange from glutamate 
to valine. The hyperlink HBB will bring 
you to the database Entrez Gene. 
Here you can find information about 
the related disease. Patients with this 
mutation suffer from a disease called 
sickle-cell anemia, which is prevalent 
in areas where malaria is endemic.
Chapter 5
 v Solution 5.1
Go to the home page of the PDB 
database [pdb]. The total number of 
solved structures is indicated on the 
upper left edge of the page beside 
the logo. At the time of writing 
(November 2016), 124,029 structures 
were stored in the database.
 v Solution 5.2
Go to the Expasy page [expasy] and 
follow the hyperlink UniProtKB at 
Popular Resources, or use the URL 
directly: 7 http://www.uniprot.
org/. Enter the AN P07801 or the 
ID CHER_SALTY into the text entry 
field at the top of the page. Click the 
Search button. The database record 
of the Salmonella typhimurium pro-
tein chemotaxis protein methyltrans-
ferase will be shown. Information 
about the tertiary structure of this 
protein can be found by following 
the hyperlinks to the Structure sec-
tion of the PDB database. Change 
the Link Destination to RCSB PDB to 
go to the PDB. The PDB allows you 
to download the database entry for 
visualization in an external visualiza-
tion tool (e.g., Chimera [chimera] or 
Swiss-PDB Viewer [spdbv]; see also 
Excercise 5.9) or directly visualize the 
protein within the browser. For the 
latter, follow the link View in 3D in 
the Structure Summary tab. The struc-
tures stored in the PDB database 
not only represent a single protein 
but often display complexes such as 
bound ligands, dimers, and solvent 
environments. It is therefore often 
the case that several records exist in 
the PDB database for a single gene, 
e.g., CHER.
 v Solution 5.3
An alternative method to open a PDB 
entry is to enter the unique PDB ID 
1AF7 directly into the search field of 
the PDB start page. When you do this, 
you end up directly at the structure 
summary of PDB entry 1AF7. The 
structure summary presents an over-
view of the database record. In addi-
tion to the description of the stored 
structure and the original reference, 
information regarding the experi-
mental method used to determine 
the crystal structure is presented (e.g., 
X-ray diffraction). Furthermore, in the 
Annotations tab, the structure sum-
mary gives some references to other 
databases (e.g., CATH, SCOP, PFAM).
You can follow the link View in 
3D at Structure Summary to display 
the 3D structure or go directly to the 
Table 3D View. You can set up the 
viewer directly below the displayed 
protein structure. The structure will 
usually be displayed in a secondary 
structure view as a cartoon. Here 
you will recognize the protein back-
bone and the spatial arrangement of 
secondary structural elements. NGL 
Viewer can be set up using several 
options on the right.
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 v Solution 5.4
Various protein representation modes 
are provided by NGL Viewer that can 
be selected using the field Style: a 
schematic secondary structure repre-
sentation (cartoon), only the protein 
backbone (backbone) or complete 
side chains (licorice), and the protein 
surface (surface). Moreover, the color 
representation can be adapted using 
the field color.
The ligand SAH (S-Adenosyl-L-
homocysteine) has several hydrogen 
bonding interactions with the pro-
tein. After selecting the ligand in the 
field Ligand Viewer, these hydrogen 
bonds can be analyzed in more detail. 
The tab Structure Summary at 2D 
Diagram & Interactions can be used to 
view the interactions in a schematic 
2D diagram.
 v Solution 5.5
Go to the Swiss-Prot database of 
the Expasy server and search for the 
database record of the protein CHER_
SALTY, as described in Exercise 5.2. 
Open the start page of the Expasy 
server, and look for Jpred or another 
secondary structure prediction tool 
at Categories → Proteomics. Enter the 
saved sequence of CHER_SALTY into 
the input field of the selected server. 
The input can be performed by copy-
ing and pasting, as described in pre-
vious exercises. Once the fields have 
been completed, start the analysis. 
Some servers will return the results 
via e-mail, so be sure to enter a valid 
e-mail address.
The predicted secondary struc-
tures agree to a greater or lesser 
degree with the actual secondary 
structure depending on the predic-
tion program used. The actual sec-
ondary structure is available from the 
Swiss-Prot database record. Detailed 
secondary structure information can 
be found in the section Structures 
after selecting more details. The mode 
of operation of each server affects the 
quality of the prediction. A distinc-
tion is made between methods that 
align the query sequence with those 
of known secondary structures and 
then apply this information to the 
prediction and methods that perform 
an ab initio calculation. If an align-
ment can be done with the query 
sequence, then a significantly better 
prediction is to be expected.
 v Solution 5.6
The protein CHER_SALTY is a meth-
yltransferase that is not secreted. 
Consequently, it is not expected to 
contain a signal peptide. To verify 
this, go to the SignalP server [signalp] 
and enter the sequence into the 
input field either by copy-paste or by 
file upload. Then select Gram nega-
tive bacteria in the section Organism 
Group. The remaining options do not 
need to be changed. Click Submit. A 
status page will be shown where you 
can enter an e-mail address at which 
to receive notification. The analysis 
takes just a few seconds before the 
results appear and replace the status 
page. If the other settings were left 
unchanged, both the text output and 
graphical display of the analysis will 
be displayed. It is obvious that no sig-
nal peptide exists.
 v Solution 5.7
Enter the sequence ABPE_SALTY (AN 
P41780) into the input field of the Sig-
nalP server as described in Exercise 5.6. 
Because ABPE_SALTY is also a Salmo-
nella typhimurium protein, select Gram 
negative bacteria in the section Organ-
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ism Group and submit the job. SignalP 
predicts the presence of a signal 
peptide. The neural network predicts 
a signal peptide for the first 23 amino 
acids and that the cleavage site will be 
between amino acids 23 and 24.
 v Solution 5.8
Go to the entry page of the Center 
for Biological Sequence Analysis 
(7 http://www.cbs.dtu.dk/services/) 
and follow the hyperlink TMHMM at 
the bottom. Enter the saved amino 
acid sequence of the Swiss-Prot data-
base record Q99527 via copy-paste 
or by file upload into the input field 
of the TMHMM server. In addition, 
choose one of several output formats. 
For this exercise select the format 
Extensive, with graphics. Click Submit. 
After a brief status page the results of 
the analysis are displayed. With the 
selected settings the results page con-
tains both a text output and a graphi-
cal representation. The first few lines of 
the text output summarize the analy-
sis, and these are followed by lines 
referring to individual segments of the 
protein. Each segment is described 
numerically by the first and last amino 
acids. In addition, the localization of 
each segment is given. The keywords 
inside, outside, and transmembrane 
indicate that the corresponding seg-
ment lies within the cytosol, extracel-
lular matrix or as a transmembrane 
helix within the lipid bilayer, respec-
tively. These are also displayed in the 
graphical overview of the results.
The TMHMM server identifies seven 
transmembrane helices for the protein 
CML2-HUMAN. Seven transmembrane 
helices are typical for G protein-
coupled receptors. Depending on the 
program used for secondary structure 
prediction, the seven  transmembrane 
helices also coincide with the predicted 
secondary structure.
 v Solution 5.9
The Swiss-Prot sequence can be 
retrieved using UniProt [uniprot]. 
The sequence can be downloaded 
at Sequence. Enter the sequence into 
the provided file of the SWISS-MODEL 
server or upload it. Start building the 
homology model using Build Model. 
A summary page with an integrated 
visualizer will be shown after success-
ful model generation. Here, you can 
also download the final model for fur-
ther analysis and visualization using 
software like Chimera [chimera]. 
Chimera is freely available and can be 
downloaded for Microsoft Windows, 
Mac OS, and Linux. Several tutorials 
are available at 7 https://www.cgl.
ucsf.edu/chimera/docindex.html as 
a starting point and introduction on 
how to use chimera.
Chapter 6
 v Solution 6.1
Go directly to the GEO database 
(7 https://www.ncbi.nlm.nih.gov/
geo/), or select GEO data sets at the 
NCBI start page (7 https://www.ncbi.
nlm.nih.gov/) and enter GDS1399 
in the search field. In the latter case, 
select the data set GDS1399 with the 
title DNA adenine methyltransferase 
and mismatch repair mutants [Esch-
erichia coli].
 1.  Click on Experiment design and 
value distribution and then click 
on click for details. The newly 
opened window shows the num-
ber of wild-type and mutant repli-
cations (in each case 3).
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 2.  After selecting Compare 2 sets 
of samples, select Value means 
difference, 2+ fold, lower and 
higher, respectively, in the pull-
down menu Step 1. In Step2 the 
selection must be Group A for all 
wild-type and Group B for DAM 
mutants. The result is 3349 or 
3129 genes that are up- or down-
regulated, respectively, in the 
DAM mutant.
 3.  In Exercise 6.1-2, the mean values 
from the corresponding three 
replicates of the wild-type and 
DAM mutant are compared. 
The variation within the three 
replicates is not considered at 
this point. Therefore, this kind 
of calculation is statistically not 
supported. To obtain statistically 
significant results, a t-test is used 
by default for the analysis of 
microarray data. This well-known 
test asks the question whether 
the observed differences in the 
mean values of the wild-type 
and DAM mutant are due to the 
mutation or just chance. In such 
a case, there is no difference 
in the expression of the gene 
between the wild-type and DAM 
mutant.
In this data set there are 581 
genes that are significantly up- 
or downregulated in the DAM 
mutant as compared to the wild 
type with a significance level 
of 0.05. On the right side of the 
results page, all expression data 
in all replicates for each gene are 
displayed. Clicking on the expres-
sion profiles will show a detailed 
view. Check randomly some of 
the results.
 v Solution 6.2
The World session can be activated in 
the field researcher login on the start 
page. Click on activate a world session 
in the first section. Afterward you can 
find the  standard basic search in the 
field search. Select Publications and 
Plasmodium falciparum as organism. 
The result is the desired publication. 
The abstract is shown through Dis-
play Data, the available data by a sec-
ond click on Display Data. The picture 
of the microarray, for example, can be 
shown using Clickable Image. You can 
get information about a target gene 
of a colored spot by clicking on it.
 v Solution 6.3
The program GenePattern offers 
many functions for analysis and visu-
alization that allow a comprehensive 
analysis of microarray experiments. 
GenePattern offers many individual 
software modules and has a clear and 
easy-to-use interface.
 v Solution 6.4
 1.  On the left side, click on [descrip-
tion, ID or gene] and enter HSP60 
in the field Enter search keyword. 
Select CH60_HUMAN in the list of 
results and click on the 2D–PAGE 
figure of the entry HEPG2_HUMAN.
The 2D gel of the HepG2 cells 
shows five spots that represent 
HSP60. All these spots have the 
same molecular weight (approx. 
60 kDa) but differ in their pI val-
ues. The differences are probably 
due to posttranslational modifica-
tions, e.g., phosphorylation, which 
affect the pI value. The phosphate 
group changes the charge of 
the protein and, thus, also the pI 
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value. HSP60 can be phosphory-
lated at several sites simultane-
ously, which explains why there 
are several spots for HSP60.
 2.  The 2D gel of liver tissue reveals 
only three spots for HSP60, unlike 
HepG2 cells. Thus, there seems to 
be less posttranslational modifi-
cation of HSP60 in the liver com-
pared to HepG2 cells.
 3.  Click on Maps in the protein list. 
Select HEPG2_HUMAN and HEP-
G2SP_HUMAN, respectively, as a 
reference map (at Choose a map). 
Then choose Execute Query.
In the 2D gel of secreted pro-
teins from HepG2 cells, there are 
no spots for HSP60 (HEPG2SP_
HUMAN). This indicates that the 
protein is not secreted.
 4.  Three methods were used to 
identify the proteins.
{Gm} - Gel matching: Here, 
existing 2D gels are compared. 
If spots with the same molecular 
weight or pI value are found, and 
the proteins are already known, 
then it is assumed that these pro-
teins are in fact identical.
{Im} - Immunodetection: 
Immunodetection uses specific 
antibodies for unequivocal 
identification. A protein is unam-
biguously recognized if it is rec-
ognized by an antibody.
{Mi} - Microsequencing: Protein 
spots are excised from the gel, 
eluted from the gel slices, trypsin-
digested, and then sequenced.
 5.  Microsequencing identified the 
sequence LVKKQTYHI.
 6.  The protein is human S100-A4. 
This is an abbreviation for S100 
calcium-binding protein A4. The 
protein has a molecular weight 
of 14.4 kDa and two alternative 
names, CAPL and MTS1, that can 
be accessed by selecting the Uni-
ProtKB entry AN P26447.
 v Solution 6.5
Change in the tab Settings the mean-
ing of network edges to molecular 
action and minimum required inter-
action score to highest confidence. 
TrxC, trx-2, and MRA_3953 are the 
only interactions with two connec-
tions to trxB. In fact, TrxC and trx-2 
are the natural substrates of thiore-
doxin reductase from Mycobacterium 
tuberculosis. Clicking on the connec-
tion reveals that this information 
was taken from curated databases. 
MRA_3953 is similar to TrxC, which 
was retrieved by analyzing homolog 
proteins of other species.
 v Solution 6.6
Enter the accession number P12931 in 
the search field, select the enzyme 
Trypsin, and choose 1000 under Display 
the peptide with a mass bigger than. 
After clicking Perform, 21 peptides with 
a mass > 1.000 Da are shown. They are 
all the results of a tryptic digest of the 
human protein kinase src. The largest 
peptide has a mass of 5072 Da.
 v Solution 6.7
Enter 1-Methlyxanthine in the 
search field. 1-methylxanthine is the 
main metabolite of caffeine. It was 
assigned to the origin Drug Metabo-
lites and Endogenous, although 
caffeine is a food product. You can 
find a link to the KEGG database and 
to caffeine metabolism by follow-
ing the links at Biological Properties. 
There, you can see that caffeine is 
degraded to 1-methylxanthine via 
theophylline.
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Chapter 7
 v Solution 7.1
Go to the GOLD Genomes OnLine 
Database (7 https://gold.jgi.doe.
gov/). At the time of writing (Decem-
ber 2016), the first table lists 121,393 
genome sequencing projects; 9092 
genomes are completed and 66,684 
genomes are in permanent draft sta-
tus. The hyperlinks in the table fields 
lead to listings of the corresponding 
genome sequencing projects that 
contain further information regard-
ing the individual projects. Using the 
hyperlink Download Excel Data File 
the data can be downloaded to your 
computer’s hard disk for a quick and 
easy statistical analysis.
 v Solution 7.2
Go to the KEGG home page 
(7 http://www.kegg.jp/) and fol-
low the hyperlink PATHWAY to the 
PATHWAY database. TGglycolysis/
gluconeogenesis metabolism is a 
part of carbohydrate metabolism, so 
the corresponding metabolic chart 
is found in the section Carbohydrate 
Metabolism. Select the hyperlink 
Glycolysis/Gluconeogenesis to display 
the metabolic map. Alternatively, 
the map can be found by following 
the hyperlink KEGG Atlas and then 
selecting Metabolic Pathways. Then 
open the Glycolysis/Gluconeogenesis 
pathway by clicking the colored area 
of the corresponding pathway in the 
graphical map.
 v Solution 7.3
The entry Pyruvate is in the lower 
third of the metabolic map and 
L-Lactate is to the right of it. A double 
arrow connects the two entries. An 
enzyme (EC 1.1.1.27) is written on this 
arrow that catalyzes the conversion 
of L-lactate to pyruvate. By clicking 
on the EC number the correspond-
ing enzyme entry can be found. EC 
1.1.1.27 is an oxidoreductase (L-lac-
tate dehydrogenase).
To see whether this conversion 
takes place in humans, select the 
organism, in our case Homo sapiens 
(human), in the drop-down menu 
above the pathway map and click the 
Go button. In the reloaded pathway 
map, the actually used enzymes are 
marked in green, including enzyme 
EC 1.1.1.27. This conversion takes 
place in the human body.
For comparison with S. cerevisiae 
you can follow the same procedure. 
The organism list is quite long, so 
you can just enter the first letters of 
the organism name. Once the search 
term is unambiguous, the full name 
is automatically entered and you can 
click on the Go button. EC 1.1.1.27 is 
not marked green, i.e., S. cerevisiae 
does not have a gene coding for this 
protein and, therefore, does not use 
this metabolic pathway.
 v Solution 7.4
Follow the hyperlink to EC 1.1.1.27 in 
the metabolic map from Exercise 
7.3 (glycolysis/gluconeogenesis 
metabolism in humans). The entries 
for LDHA, LDHB, LDHC, LDHAL6A, 
and LDHAL6B from the GENES data-
base are shown. This means that in 
species-specific metabolic charts, the 
hyperlinks of these enzymes lead to 
individual records in the GENES data-
base. In the reference map, however, 
the enzyme hyperlinks lead to entries 
in the ORTHOLOGY database.
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 v Solution 7.5
Go to the KEGG home page (7 http://
www.kegg.jp/) and open the chart for 
human glycolysis/gluconeogenesis 
metabolism as described in Exercise 
7.3. In a second browser window, 
display the species-specific meta-
bolic pathway of Helicobacter pylori 
26,695. A direct comparison of the 
two pathways indicates that enzymes 
EC2.7.1.11 and EC2.7.1.40 are miss-
ing within H. pylori. Both proteins 
are kinases, i.e., they are phosphate 
group–transferring enzymes. Infor-
mation about the function of both 
can be found by retrieving the entries 
for the corresponding EC number in 
the ENZYME database. To do this, go 
back to the KEGG home page and 
enter the two EC numbers one by 
one in the text field at the top of the 
page. Press the Search button. The 
reaction can be found in the section 
Reaction (IUBMB). The hyperlink in 
this field leads to a graphical repre-
sentation of the structural formula of 
the reactants. Phosphofructokinase 
(EC 2.7.1.11) catalyzes the conversion 
of fructose-6-phosphate to fructose-
1.6-bisphosphate via an irreversible 
reaction. In a subsequent irreversible 
reaction, pyruvate kinase (EC 2.7.1.40) 
catalyzes the conversion of phos-
phoenolpyruvate to pyruvate – the 
last step of glycolysis. Comparison 
of both metabolic maps leads to the 
conclusion that H. pylori lacks two 
important enzymes of glycolysis. 
Consequently, H. pylori has an incom-
plete glycolysis pathway. This is not 
difficult to understand when one 
considers that the natural habitat of 
H. pylori is the acidic environment of 
the stomach of mammals. Therefore, 
if pyruvate were to be produced, a 
further acid burden would result. 
Consequently, the bacterium does 
not utilize this metabolic step.
 v Solution 7.6
Go to the BLAST home page of the 
NCBI (7 https://blast.ncbi.nlm.nih.
gov/Blast.cgi) and follow the hyper-
link Microbes beneath the text field 
BLAST Genomes. The resulting special 
BLAST page can be used to BLAST 
against microbial genomes. Because 
a BLASTP is desired, choose the tab 
blastp. Enter the accession number 
Q9ZK41 in the text field. Go to the 
organism selection and enter the 
names of the desired organisms in 
the text field. Additional text fields 
can be generated by clicking on the 
button PLUS (+). Start the analysis by 
clicking the BLAST button at the bot-
tom of the page.
Relevant database hits for the 
following organisms are found 
for Helicobacter pylorii. Obviously, 
the sequence with the accession 
number Q9ZK41 is the glucose/
galactose transporter of H. pylori 
that is encoded by the gene gluP. No 
homologous proteins were found in 
the genera Staphylococcus and Strep-
tococcus.
 v Solution 7.7
Go to the home page of the eggNOG 
database (7 http://eggnog.embl.de/) 
and click on the Search button. Enter 
the search term cyclin-dependent 
kinase 1 in the text field. As soon as 
the entry is unambiguous, it is auto-
matically completed and you need 
enter only a few letters and select 
the correct entry. In the next step, 
click on the yellow hyperlink 2 spe-
cies and select the organism Homo 
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sapiens. Enter Apicomplexans in 
the next text field. This entry is also 
checked and completed in real time. 
Start the query by clicking the Explore 
and Download Orthologous Groups 
button. Right below the orthologous 
group’s ID KOG0594 you can find the 
taxonomic level, which in this case is 
Eukaryotes.
 v Solution 7.8
Either go back to the home page 
and repeat the search as described 
in Exercise 7.7 or delete the target 
organisms on the results page of 
Exercise 7.7 by clicking on the small 
cross icon in the upper right in the 
field taxa. Then enter the search 
term Marsupials in the text field Add 
target taxa… Again, the search term 
is checked and completed in real 
time. Right below the orthologous 
group’s ID ENOG410URJI you can find 
the taxonomic level, which in this 
case is Mammals. To see which PFAM 
domains have been found, follow the 
hyperlink Functional Profile at the end 
of the description and select the tab 
Domains. The PFAM domain Pkinase 
was found in 32 sequences, which 
is a frequency of occurrence of 97% 
(December 2016).
Follow the hyperlink Phylogenetic 
Tree. The blue markup at the branch-
ing between the Tasmanian devil 
(Sarcophilus harrisii) and the Brazilian 
opossum (Monodelphis domestica) 
denotes orthologs. A red markup 
further up in the tree at a branching 
denotes a paralog sequence in the 
proteome of the gray mouse lemur 
(Microcebus murinus). This part of the 
phylogenetic tree is drawn in light 
gray because the organisms were not 
included in either the query or the 
target organisms.
 v Solution 7.9
Go to the home page of the MBGD 
(7 http://mbgd.genome.ad.jp/), click 
on the blue button marked Taxonomy 
Browser, and select the desired organ-
isms. To do so, you first must delete 
the preselection by clicking on the 
button Clear All at the top of the page; 
then you can select the organisms. 
If you click on the button Expand 
All and use your browser’s search 
functionality, it is easier to find the 
organisms. Staphylococcus aureus 
RF122 can be found under Firmicutes-
Bacilli-Bacillales-Staphylococcaceae-
Staphylococcus-Staphylococcus aureus, 
Escherichia coli 536 can be found 
under Proteobacteria-Gammaproteo-
bacteria-Enterobacteriales-Entereo-
bacteriaceae-Escherichia-Escherichia 
coli, and Saccharomyces cerevisiae 
S288C can be found under Eukaryota-
Ascomycota-Saccharomycetes-Saccha-
romycetales-Saccharomycetaceae-Sac-
charomyces-Saccharomyces cerevisiae. 
Click the button Choose checked taxa. 
On the next page, you can either click 
the button Create/View Cluster Table 
or alter the homology parameters 
beforehand by clicking the button 
Change Homology Parameters. The cal-
culation of the cluster can take a few 
minutes. While the calculation is being 
done, a self-refreshing HTML page is 
displayed. Once the calculation is fin-
ished, the cluster table is displayed.
 v Solution 7.10
The phylogenetic profiles of the 
selected organisms are shown on the 
page Occurrence Pattern of the cluster 
table of Exercise 7.9. The columns of 
the table (occurrence patterns) cor-
respond to the organisms, the rows 
correspond to the individual profiles. 
If one organism has proteins in a 
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cluster, a green block is drawn at the 
corresponding position in the table. 
Thus, the phylogenetic pattern we are 
looking for is a green bar that spans 
a full row because all organisms have 
proteins in the cluster. To this phy-
logenetic profile (December 2016) 
correspond 476 clusters. To display an 
individual cluster, click on the colored 
bar to the right of the profile. Which 
cluster is displayed depends on the 
area of the colored bar you clicked. 
The colors correspond to the func-
tional categories. To display the first 
cluster, click on the purple section of 
the bar. The purple color  coding shows 
that this cluster contains proteins that 
belong to the functional category 
amino acid biosynthesis. The legend 
of the color code can be found at the 
home page following the hyperlink 
Function Categories.
 v Solution 7.11
Go to the start page of the MBGD 
(7 http://mbgd.genome.ad.jp/). 
If the selected organisms are not 
highlighted in the Organism selection 
window, click Reload/Refresh. Then 
enter the search term fructokinase in 
the text entry field to the left of the 
organism overview and click the Go 
button. Three entries are found in the 
cluster table.
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Glossary
@ In 1972, the engineer Ray Tomlinson wrote 
the first e-mail program (Bolt Beranek and 
Newman, Inc.). He needed a character that would 
separate the first part of an e-mail address from 
the host’s designation or domain. In addition, 
the required character should not appear in any 
name. Tomlinson decided to use the @ character 
on the keyboard of his teletypewriter Model 33. 
The character had been known from writings 
and prints of the baroque period (seventeenth 
century) and represented the Latin ad. Today @ is 
read as at and is an essential component of every 
e-mail address
Accession Number A unique identification 
number for a database record in a sequence 
database. Accession numbers are static, i.e., they 
do not change even after database updates
Affinity chromatography A technique for the 
purification of proteins that makes use of the 
affinity of a protein for a distinct substrate or 
ligand (e.g., antibodies for antigens)
Algorithm Derived from al-Chwarizmi (Abu 
Dscha'far Muhammad ibn Musa al-Chwarizmi, 
Arab mathematician, A.D. 825). A logical 
sequence of steps for solving mathematical 
problems
Alignment Adjustment of two (pairwise align-
ment) or several (multiple alignment) sequences 
so that similar or identical amino acids or nucleo-
tides are arranged vertically to produce matches
Alpha (α) helix An ordered folding pattern of 
the secondary structure of proteins. The α-helix 
displays a pitch of 0.54 nm with 3.6 amino acid 
residues per turn
Alternative splicing Generation of different 
mRNA transcripts from one pre-RNA using differ-
ent splice sites
Amino acids The building blocks of proteins. 
Proteins are built from the 20 naturally occurring 
amino acids
Analogy A classification according to com-
mon features of the structure or the function 
considered to be essential (e.g., proteins that 
have similar folds or functional centers yet can-
not be grouped by a common ancestral protein; 
e.g., head and mouthparts of arthropods, such 
as insects, compared to those of vertebrates). 
See also Homology, Character, Relationship, 
Phylogeny
Annotation Information on possible relation-
ships and the derivation of possible biological 
functions
Antigen Compound that activates the immune 
system to generate antibodies. An antigen, for 
example, is a surface protein of a bacterium
Antibody A protein (also referred to as immu-
noglobulin) that binds to an antigen and con-
sequently allows cells of the immune system to 
neutralize the antigen
Applet A small computer program that is 
downloaded from a server and executed on one’s 
own computer. Applets are usually written in the 
programming language JAVA
Array See Microarray
Array express A database at the European 
Bioinformatics Institute where the results of 
microarray experiments can be stored and are 
accessible at any time
ASCII American Standard Code for Information 
Interchange. Code table for the encoding of 128 
accent-free characters (a–z, A–Z, 0–9, as well as 
special and control characters). ASCII files are 
often referred to as plain text or flat file
Assembly See Sequence assembly
Base Basic building block of DNA and RNA. A 
sequence of bases (nucleotide sequence) forms 
the blueprint for a gene product
Base pair Pairing between two bases on oppo-
site nucleotide strands of DNA or RNA. In DNA, 
adenine pairs with thymine, and in RNA, it pairs 
with uracil; cytosine always pairs with guanine
Beta (β) sheet Regular secondary structure 
element as building block of overall folding 
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pattern of proteins. β-sheets are built of differ-
ent, extended parts of the polypeptide chain, 
the β-strands. These strands can be orientated 
either in the same or opposite directions, leading 
to parallel or antiparallel β-sheets. Successive 
amino acid residues are on opposite sides of the 
plane of the β-sheet with a repetition unit of two 
residues and a distance of 0.7 nm
Binary file A file that includes nonreadable text, 
such as, for example, executable programs, vid-
eos, and sound files
Biochip See Oligonucleotide array
Bioinformatics (applied) Application of infor-
matic and mathematical concepts to large sets 
of biological data in order to accelerate and 
improve biological research. Applied bioinfor-
matics is important in the fields of molecular 
biology, biochemistry, chemistry, and medicine
Bioinformatics (theoretical) The development 
of computer-based databases, algorithms, and 
programs to accelerate and improve biological 
research. Theoretical bioinformatics is important 
in the field of computer science
Biomarker Characteristic biological markers that 
can be used for personalized medicine. These 
are, for example, metabolites or specific gene 
expressions.
BLAST Basic Local Alignment Search Tool. 
Heuristic algorithm to search for sequences in 
sequence databases
BLOSUM BLOcks SUbstitution Matrix, sub-
stitution matrix for the alignment of protein 
sequences. BLOSUM matrices were introduced 
by Henikoff and Henikoff in 1992 and are well 
suited to the alignment of remotely related 
protein sequences. BLOSUM matrices are char-
acterized by an affixed number that indicates 
the sequence identity of the sequences used to 
derive the matrix. Accordingly, the BLOSUM62 
matrix is based on the observed substitution pat-
terns of sequences that share 62% identity and is 
well suited for the alignment of sequence with a 
similar identity
Broad-spectrum antibiotic A substance that 
kills bacteria or stops bacteria from reproducing 
and for which the mode of action is based on a 
ubiquitous target
Browser Software to access the World Wide Web 
(e.g., Firefox, Internet Explorer, Opera, Chrome)
CAP3 Sequence assembly program based on 
the Smith–Waterman algorithm
CATH Structural protein database that hierarchi-
cally classifies protein domains into four groups: 
Class (C), Architecture (A), Topology (T), and 
Homologous Superfamily (H)
cDNA Complementary DNA; a DNA that is pro-
duced from mRNA as a template with the help 
of the viral enzyme reverse transcriptase. Like 
mRNA, cDNA does not have introns
cDNA array DNA microarray consisting of 
in vitro–amplified cDNA that is spotted onto a 
support material
cDNA library A cDNA library contains all cDNA 
transcripts of a cell, tissue, or whole organism. Unlike 
a genomic library, it contains only coding DNA
CDS See Coding sequence
Central dogma of molecular biology DNA is 
transcribed in the process of transcription to 
mRNA, which is then translated into proteins 
during translation (Francis Crick, 1957)
CERN Conceil Européen pour la Recherche 
Nucléaire, or Organisation Européenne pour la 
Recherche Nucléaire. European organization for 
nuclear research based in Geneva and with a 
research station in nearby Meyrin. The develop-
ment of the World Wide Web started at CERN to 
organize research data in such a way as to make 
it available to researchers in other countries
Character A property of a protein or species 
(e.g., motif, structure, function, morphology, 
physiological process) that distinguishes it from 
other proteins or species. Phylogenetic research 
always deals with either character pairs or char-
acter strings that can be resolved into character 
pairs. Such character pairs can be differentiated 
into relatively ancestral (plesiomorph) or rela-
tively derived (apomorph) character partners. 
See also Analogy, Homology, Relationship, and 
Phylogeny
Cheminformatics or Chemoinformatics  
Analogous to the term bioinformatics, chemin-
formatics includes all scientific disciplines that 
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apply concepts from mathematics and informatics 
to large data sets facilitating chemical research. 
It mainly deals with the processing of molecular 
structures and huge chemical databases in chemi-
cal and pharmaceutical research. In the wide sense, 
it also includes all computer- based methods of 
molecular design.
Chromatography A method for the separation 
of substance mixtures involving stationary and 
mobile phases. The term chromatography was 
coined by the Russian botanist Mikhail S. Tsvet 
(1872–1919), who used the method to isolate 
pigments from plant extracts
CIB Center for Information Biology. Japanese 
bioinformatics institute that manages the 
nucleotide database DDBJ
Clade A branch, monophylum, monophyletic 
group, or closed descent community. A system-
atic unit that includes a common ancestor and all 
descendants
Classical proteomics Classical proteomics deals 
with the identification and quantification of pro-
teins in cell lysates
Client Computer program that communicates 
with a server. Browsers are classical clients that 
communicate with Web servers
Clone A population of genetically identical 
organisms, cells, or bacteria that have a common 
origin. For example, a bacterial clone in a cDNA 
library consists of several thousand bacteria that 
all possess the same cloned DNA sequence on 
a plasmid. Another meaning for the term clone 
refers to a group of recombinant DNA molecules 
that are descended from an initial molecule 
(DNA clone)
Cloning A specific DNA sequence is inserted 
into plasmids that serve as vectors. The DNA 
sequence, as part of the plasmid, is then propa-
gated by transformation into bacteria
Cloning vector See Vector
Cluster A group that contains similar objects. 
Examples are expressed sequence tag sequences 
that are clustered owing to sequence similarities 
or genes that are assigned to a cluster owing to 
similar expression profiles
Clustering Process of grouping together objects 
into single clusters due to concurrences
Coding sequence Part of the DNA that is tran-
scribed into mRNA during transcription and then 
translated into protein
Codon Set of three nucleotides (base triplet) of 
DNA or RNA that code for one of the 20 natural 
amino acids
Codon usage Species-specific use of the differ-
ent possible codons that encode amino acids
Comparative genomics Simultaneous compari-
son of two or more genomes with the aim of 
identifying similarities and differences between 
those genomes
Compiling Assembly of a new complete data-
base from a number of individual databases
Computer model A mathematical model to 
simulate a biological system that allows the pre-
diction of certain properties (e.g., the concentra-
tion of metabolites at a given time) and, because 
of its complexity, can only be solved with the aid 
of a computer
Consensus sequence A single common DNA or 
protein sequence derived from a multiple align-
ment. Each position of the consensus sequence 
comprises that nucleotide or amino acid that 
occurs most often in the sequence alignment
Conserved sequence Part of a DNA or protein 
sequence that has remained constant during 
evolution
Contig Contiguous segment of a genome that 
was generated by joining overlapping sequences
CORBA Common Object Request Broker 
Architecture. Industry standard that allows the 
connection of different objects and programs 
regardless of the programming language, 
machine architecture, or locations of the com-
puters
Database Collection of data organized to allow 
easy access to its content
dbEST Publicly accessible database at NCBI that 
stores expressed sequence tags (ESTs)
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dbGSS Publicly accessible database at NCBI that 
stores Genome Survey Sequences (GSSs)
dbSNP Publicly accessible database at NCBI that 
stores short genetic variations such as single 
nucleotide polymorphisms (SNPs)
DDBJ DNA Data Bank of Japan. Together with 
the databases EMBL and GenBank, DDBJ forms 
the International Nucleotide Sequence Database
Deletion Mutation in a nucleotide sequence 
where single nucleotides or whole regions are 
missing compared to the original sequence
DNA Deoxyribonucleic acid. DNA carries genetic 
information. It consists of a pair of nucleotide 
strands that wind around a common axis to form 
a double helix. The pairing of the nucleotide 
strands occurs via hydrogen bonds between 
specific base pairs
DNA denaturation Conversion of double- 
stranded nucleotide sequences into single- 
stranded sequences. The hydrogen bonds 
between the single strands can be destroyed by 
strong heating, for example. The generation of 
single-stranded nucleotide sequences is a pre-
requisite to hybridization with complementary 
single-stranded sequences, e.g., in the assembly 
of a DNA microarray
DNA microarray Miniaturized technology based 
on the method of nucleic acid hybridization. 
With DNA microarrays, gene expression profiles 
of cells can be analyzed, for example. One dif-
ferentiates between oligonucleotide and cDNA 
microarrays
DNA sequence Sequence of base pairs in a 
DNA fragment, gene, chromosome, or complete 
genome
DNA sequencing Method to determine the 
nucleotide sequence of a DNA molecule. A com-
mon method is the dideoxy chain- termination 
method published by Frederick Sanger in 1977
Docking Computer-assisted fitting of a ligand 
into the binding pocket of a protein
Domain Delimited functional unit of a protein 
with its own discrete folding. The complete func-
tionality of a protein results from the combina-
tion of different domains
Dynamic methods Breakdown of a problem 
into subproblems and reuse of the solutions for 
subproblems. To solve a problem of size n, all 
subproblems of size 1, 2,…, n−1 are solved. The 
solutions are saved in a table from which the 
solution for n is derived. Dynamic methods are 
usually very exact; however, they can be very 
slow (e.g., the Smith–Waterman algorithm)
EBI European Bioinformatics Institute that is 
part of EMBL and is located in Hinxton near 
Cambridge, UK
E-cell project International research project 
with the aim of simulating biological phenom-
ena on the computer and developing tools, tech-
nologies, and programs for the computational 
simulation of a complete cell
Edman degradation Method to determine the 
sequence of polypeptides
EMBL European Molecular Biology Laboratory. 
It was founded in 1974 and is funded by 16 
European countries and Israel. Its headquarters 
are in Heidelberg, Germany. Other sites are in 
Hamburg (D), Grenoble (F), Hinxton (GB), and 
Monterotondo (I)
ENTREZ A general query system for all available 
databases at NCBI
Enzyme A protein that works as a catalyst, i.e., 
to reduce the activation energy of a reaction and 
thereby influence reaction rate. Catalysts do not 
change the direction of a reaction
Epitope Part of a protein bound by antibody
ESI Electrospray ionization; in mass spectrom-
etry, a method to generate ions. Because of the 
gentle ionization of the analyte molecule, the 
method is particularly suitable for the analysis of 
biomolecules
EST Expressed sequence tag. Partial sequence of 
a cDNA clone
Eukaryotes Organisms in which cells have a 
nucleus and other subcellular  compartments, 
such as mitochondria. All organisms are eukary-
otic with the exception of viruses, bacteria, 
cyanobacteria, and archaebacteria
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European Nucleotide Archive A data of 
nucleotide sequences, located at the European 
Bioinformatics Institute
Exon Coding region of a eukaryotic gene. Exons 
may be separated from one another by noncod-
ing introns
ExPASY Expert Protein Analysis System. A WWW 
server of the Swiss Institute of Bioinformatics to 
analyze protein sequences. The Expasy server 
hosts the Swissprot database, among others
Expression profiling Determination of gene 
expression pattern of a cell or tissue with the aid 
of DNA microarrays
FASTA Heuristic algorithm to search for 
sequences in databases
FASTA format Simple database format to store 
sequence data. The FASTA format consists of a 
single header line that starts with the character >.  
It is directly followed (without a space) by an 
identifier and, optionally (separated by a space), 
a short description. Subsequent lines contain the 
sequence information
Fingerprint A number of sequence motifs that 
were derived from multiple alignments and 
form a characteristic signature for members of a 
protein family
Flat file Contains data that do not have any 
structural relationship to one other. Most bio-
logical databases consist of flat files
Frameshift Deletion or insertion in a DNA 
sequence that leads to a shift in the reading 
frame of all subsequent codons. In nature, frame-
shifts can arise by accidental mutations. In DNA 
sequences, frameshifts are frequently observed 
owing to reading errors by sequencing machines
Functional genomics Parallel analysis of genes of 
a given organism to identify the function of gene 
products. Methods used to identify gene function 
are, for example, DNA microarrays, serial analysis 
of gene expression (SAGE), and proteomics
Functional proteomics The aim of functional 
proteomics is to identify the functions of 
proteins. An important aspect of functional pro-
teomics is the identification of protein–protein 
interactions
Fusion protein Product of a hybrid gene. Such 
hybrid genes are frequently produced experi-
mentally so that the resulting fusion proteins can 
be purified or detected
Gap Gap in a sequence alignment that arises 
from insertions or deletions
GCG Genetics Computer Group. A number of 
bioinformatics programs to analyze DNA and 
protein sequences. GCG was founded in 1982 as 
a service of the University of Wisconsin and is, 
therefore, also known under the name Wisconsin 
Package. GCG became a commercial software in 
1990 and is distributed worldwide by Accelrys 
Inc.
Gene A DNA segment that contains genetic 
information encoding protein. A gene comprises 
several units, including exons and introns and 
flanking regions that mainly serve in gene regu-
lation. Genes are also described as the functional 
units of a genome
GenBank A database located at NCBI in which 
nucleotide sequences are stored
GeneChip See Oligonucleotide array
Genetic code Key for the translation of genetic 
information into proteins. Three bases (base trip-
let) encode an amino acid. Different base triplets 
can code for the same amino acid (degenerate 
code). With a few exceptions, e.g., in mitochon-
dria or ciliates, the genetic code is universal for 
all living organisms
Gene expression Process in which the informa-
tion encoded by a gene is translated into func-
tional structures. Expressed genes are those that 
are transcribed into RNA and then translated into 
protein, or those that are only transcribed into 
RNA (without translation)
Gene family Group of related genes that result 
in similar protein products
Genome All the genetic information of an 
organism. The genome represents the sum of all 
genes, those parts of the DNA that influence the 
expression of the genetic information and those 
areas yet to be functionally characterized
Genomics Research field that deals with the 
analysis of the complete genome of an organism
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Genomic library A gene bank that consists of 
many clones with genomic DNA. Unlike a cDNA 
library, a genomic library also contains noncod-
ing DNA, such as gene introns, and DNA regions 
without genes
Genotype Entirety of all genetically determined 
characteristics of an individual
Genotyping Experimental determination of the 
genotype of an individual
GEO Gene Expression Omnibus. A database at 
NCBI that stores a variety of gene expression 
data and can be queried. This includes the results 
of DNA microarray and SAGE experiments
Global alignment Alignment over the entire 
length of two sequences
Glycosylation Posttranslational modification 
whereby sugar residues (under the release of 
water) are linked to proteins after translation 
is completed. Other organic molecules such as 
lipids can also become glycosylated
GSS Genome Survey Sequence. Like EST 
sequences, GSSs are generated by single- pass 
sequencing of the end regions of DNA clones. In 
contrast to ESTs, to generate GSSs, clones from 
genomic libraries are sequenced. Therefore, GSSs 
can also contain regions that lie outside of genes
Heuristic methods Procedures based on a 
sequence of approximations. Heuristic methods 
try to find optimal or at least nearly optimal solu-
tions in an exponentially large space of solutions 
by problem-specific information. Though fast, 
heuristic methods may not find all possible solu-
tions (e.g., BLAST algorithm)
HGVbase A database at the Karolinska Institute 
in Sweden that records information regarding 
variations in the human genome. HGVbase will 
be developed into a genotype/phenotype data-
base in the near future
Hidden Markov Model The hidden Markov 
model (HMM) is named after the Russian 
mathematician A. A. Markov (1856–1922). It is a 
stochastic process (conjecturing, dependent on 
randomness) in which parameters that obey the 
system equations are not directly observable 
but can only be observed by derived quantities. 
HMMs consist of states, possible transitions 
between these states, and the state transition 
probabilities. In a specific state a result can be 
generated by taking into consideration all prob-
abilities. The results, not the states, are visible to 
an external observer, i.e., the states are hidden. 
HMMs are used for the derivation of profiles from 
multiple protein alignments to identify new pro-
teins, for example
HomoloGene NCBI database of homologous 
proteins from different species
Homology A classification based on the phylo-
genetic origin of structures. Characters that were 
inherited either unchanged or changed from 
common ancestors (e.g., specific kinases of mice 
and humans, or extremities of mice and humans) 
are considered homologous. See also Analogy, 
Character, Relationship, and Phylogeny
Homology map Tabular overview of syntenic 
regions from the chromosomes of two species
Homology modeling Development of a three-
dimensional computer model (in silico) of a pro-
tein structure using as a template the structure 
of a similar protein that has been solved experi-
mentally by X-ray analysis
Hybridization Pairing of two complementary 
and single-stranded DNA molecules to generate 
a double-stranded molecule through the forma-
tion of hydrogen bonds between complemen-
tary bases. For instance, hybridization is used 
to isolate complementary sequences in cDNA 
libraries
Identity Number of identical sequence positions 
in an alignment
Immobilization Covalent attachment of nucleic 
acids to solid supports. DNA can be immobilized 
onto nylon membranes by UV irradiation, for 
example
In silico In silicon. Silicon is the material com-
puter chips consist of. It means an experiment 
simulated on a computer
In vitro Latin: with/in glass; outside a living 
organism. Denotes the location where an experi-
ment is performed or a compound tested, e.g., 
a drug
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In vivo Latin: with/in the living; within (the 
body of ) a living organism. Denotes the location 
where an experiment is performed or a com-
pound tested, e.g., a drug
Indexing Process describing the contents of 
databases with the help of descriptors, informa-
tive keywords, catchphrases, or text and, thus, 
allows for the efficient querying of documents 
within a database
Intergenetic region Noncoding subunit of a 
DNA sequence between genes
Insertion Incorporation of single nucleotides or 
whole nucleotide blocks into a DNA strand
Interactome Entirety of all interactions in a cell
Interactomics Bioinformatics discipline that 
deals with the study of interactomes, i.e., the 
interaction of all proteins and other molecules 
in a cell
InterPro Integrated protein motif database at 
the European Bioinformatics Institute that con-
sists of several individual databases
Intron Noncoding part of a gene in eukaryotes. 
See also Exon
Isoelectric focusing Electrophoresis technique 
that separates proteins based on their individual 
pI values
JAVA Object-oriented, hardware- independent 
programming language developed by Sun 
Microsystems, Inc. Java programs or applets can 
theoretically run on any computer that supports 
the Java runtime environment (JRE), indepen-
dently of the respective computer architecture 
(e.g., PC, MAC, UNIX)
J. Craig Venter Institute Institute for gene 
analysis. It was funded through a combination of 
different institutes: Center for the Advancement 
of Genomics (TCAG), Institute for Genomic 
Research (TIGR), Institute for Biological Energy 
Alternatives (IBEA), and J. Craig Venter Institute 
Joint Technology Center (JTC).
Knockdown Method for elucidating the func-
tion of genes or proteins. For example, block-
ing transcription of a target gene by means 
of RNAi may result in phenotypic changes 
that can be analyzed. Because translation may 
not need to be 100% blocked to achieve the 
desired effect, the term knockdown applies 
rather than knockout, where translation is 
blocked completely
Knockin Method for elucidating the function 
of genes or proteins. To this end, a transcribable 
gene is transfected into cells or organisms and 
the resulting phenotypic changes analyzed. 
Frequently a knockin is used to reverse the 
change in phenotype caused by a knockout. If 
successful, then there is little doubt as to the 
function of the corresponding gene
Knockout Method for elucidating the function 
of genes or proteins. With a knockout, the tran-
scription of individual genes is entirely blocked. 
From the analysis of any resulting phenotype 
conclusions can be drawn as to the function of 
the inhibited gene. Frequently, knockout experi-
ments are combined with knockin experiments
Local alignment Alignment of sequences that 
does not take into account the entire sequence 
length
Locus Position of a genetic marker or a gene on 
a chromosome
LocusLink Database at NCBI that contains 
curated sequence data and descriptive informa-
tion about genetic loci
Low-complexity region Region of DNA or pro-
tein that consists of one or few recurring bases or 
amino acids
MALDI–TOF Matrix-assisted laser desorption/
ionization–time of flight. Mass spectroscopic 
technique that is frequently used to identify 
proteins
Mass spectroscopy Spectroscopic technique 
that is used, for example, to determine the 
composition of peptides based on the masses of 
individual amino acids
Metabolite Intermediate of a biochemical meta-
bolic reaction
Metabolome Entirety of all metabolites of an 
organism
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Metabolomics Scientific discipline that deals 
with the analysis of metabolites, i.e., the meta-
bolic products of the cell
Metagenome Entirety of all genomic informa-
tion of microorganism community, e.g., of a 
biotope
Metagenomic Scientific discipline that deals 
with the analysis of metagenomes
Microarray See DNA microarray
Model organism Organism that is used for the 
analysis of biological questions relevant also in 
more complex organisms (e.g., D. melanogaster, 
C. elegans, M. musculus, D. rerio, A. thaliana, S. 
cerevisiae, E. coli). However, the functional units 
being studied must be quite similar in the two 
organisms
Model system See Model organism
Motif Conserved region within a group of 
related nucleotide or protein sequences
mRNA Messenger RNA. RNA molecules synthe-
sized during transcription and serve as templates 
for protein synthesis
Multiple alignment Alignment of at least three 
sequences. See also Alignment
Mutation Changes in genome due to spontane-
ous events or triggered by mutagens such as 
ultraviolet light or chemicals. Leads to perma-
nent loss or exchange of bases in DNA sequence
Narrow-spectrum antibiotic Antibiotic with a 
mode of action limited to a species-specific target 
protein found within a small group of bacteria
NCBI National Center for Biotechnology 
Information. The United States’ contribution 
to the International Database Collaboration, 
which includes EMBL and CIB. NCBI is part of the 
U.S. National Library of Medicine, itself a part of 
the U.S. National Institutes of Health (NIH)
Needleman and Wunsch algorithm Dynamic 
algorithm to compute a global alignment of two 
sequences
Nematode Roundworm or threadworm. 
Example: Caenorhabditis elegans
Neural network Computational decision- 
making process to address complex problems 
that is analogous to the operation of the brain. 
A major characteristic of neural networks is their 
ability to adapt so that newly entered informa-
tion can be recognized differentially
Next-generation sequencing Different 
approaches to the sequencing of whole 
genomes in a short time. It is based on DNA frag-
mentation that are extended with a known short 
DNA sequence and subsequently amplified. The 
amplified DNA strands are amplified
NMR Nuclear magnetic resonance. NMR is a 
spectroscopic technique to determine protein 
structures
Nonredundant database Complete database 
composed of individual databases so that each 
database record is present only once, even if 
more than one component database contains 
the corresponding entry
Normalization Correction of experimentally 
derived data to ensure accurate comparison 
between experiments. An example is the nor-
malization of data that is necessary in expression 
profiling experiments
Northern blot Method to detect mRNA. After 
electrophoretic separation in an agarose gel, the 
RNA is transferred onto a nylon or nitrocellulose 
membrane. On this membrane, individual mRNA 
transcripts can then be detected by hybridizing 
with labeled and complementary nucleic acids
Nucleic Acids Research Molecular biological jour-
nal of the Oxford University Press. The first issue 
in January of each year is the database issue. All 
relevant biological databases are listed in this 
issue. In July 2003, a software issue was pub-
lished for the first time that listed and described 
freely available biological software
Nucleotide Basic building block of DNA and 
RNA. Nucleotides consist of a base (C, A, T, G in 
DNA or C, A, U, G in RNA), a phosphate group, 
and a sugar residue (deoxyribose in DNA, ribose 
in RNA)
Oligonucleotide array DNA microarray that 
consists of several thousand single-stranded 
oligonucleotides. An oligonucleotide array is also 
called a GeneChip or BioChip
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Oligonucleotides Short DNA segments that 
consist only of a few nucleotides. These can act 
as starting points for PCR or they can be used in 
DNA microarrays as gene markers, for example
Open reading frame A region within a DNA 
sequence that starts with a translation start 
codon (ATG) and ends with a translation stop 
codon (e.g., TAA)
Orthologous proteins Homologous proteins 
that perform the same function in different 
organisms. Example: A serine protease in the 
digestive tract of humans and mice
PAGE Polyacrylamide gel electrophoresis. 
Analytical method to separate proteins based on 
their individual charges by applying an electric 
field across a polyacrylamide gel matrix
Palindrome A DNA sequence that is inverse- 
complementary identical, i.e., where identical 
bases are present on complementary positions 
of the sense and antisense strand. For example, 
the complementary DNA sequence to GAATTC 
is CTTAAG, and the inverse-complementary to 
that is again GAATTC. Such palindromes are fre-
quently recognized by restriction enzymes
PAM Matrix Point accepted mutation matrix. A 
substitution matrix for the alignment of protein 
sequences. The PAM matrix was developed in 
1978 by Margaret Dayhoff and is based on a sta-
tistic analysis of sequence differences. The PAM 
matrix describes the number of accepted muta-
tions between two sequences. A PAM205 matrix 
represents 80% accepted mutations, which 
means an identity of 20%
Paralogous proteins Homologous proteins in 
the same organism that have similar, but non-
identical, functions. Example: Two serine prote-
ases in the mouse. See Orthologous proteins
Pathway Metabolic route. Functional network 
between proteins
Pathway mapping Technique for the identifica-
tion of multiprotein complexes. These complex 
proteins belong to a common pathway
PCR See Polymerase chain reaction
PDB Database containing 3D structures of bio-
logical macromolecules, such as proteins
Personalized medicine Tailoring of patient 
treatment to genetic predisposition and the indi-
vidual metabolic profile
Pfam A protein motif database based on hidden 
Markov models
Phenotype Appearance of a trait in an organism 
that is based on both a genetic disposition and 
environmental influences. Examples of pheno-
types are the eye color of humans or the associa-
tion of certain diseases with families
Pharmacogenetics/genomics Specific field that 
associates genetic predisposition with the differ-
ing reactions individuals might have to drugs
Pharmaco-metabonomics Method that ana-
lyzes those factors, e.g., genetics and environ-
ment, that influence the effects of drugs
Pharmacophore The whole of steric and 
electronic properties that are necessary for an 
optimal interaction with a specific biological 
target structure. This leads to or blocks a biologi-
cal response
Pharmacophore model Spatial arrangement of 
features of one or several molecules essential for 
that interaction with the protein. This model is 
normally based on the steric overlap of molecu-
lar structures of known drugs or inhibitor mol-
ecules and deduction of a pharmacophore from 
the analysis of congruent molecular properties
Pharmacophore screening Search for molecules 
in a virtual database with similar spatial feature 
arrangements to a calculated pharmacophore 
model
PhenomicDB Multiorganism genotype–phe-
notype database. PhenomicDB integrates data 
from a number of different genotype–phenotype 
databases, thereby allowing cross- organism data 
comparisons
Phenome Sum of all phenotypes of a cell, tissue, 
organ, organism, or species
Phenomics Scientific discipline that aims to 
understand the function of proteins using phe-
notypes
Phosphorylation Enzymatic process that 
involves the transfer of a phosphate group to 
proteins by a protein kinase
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Phrap Widely used sequence assembly program
Phylogenetic analysis Analysis of phylogenetic 
relationship between different organisms and 
their ancestors. Such analyses can include mor-
phological, physiological, and genetic characters. 
See also Analogy, Homology, Relationship, 
Character, and Phylogeny
Phylogenetic tree Graphical representation 
of phylogenetic relationships between organ-
isms. Among others, phylogenetic trees can be 
derived from multiple-sequence alignments of 
DNA or protein
Phylogeny Phylogenetic evolution of living 
organisms and the origin of species over the 
course of the Earth’s history. See also Analogy, 
Homology, Relationship, and Character
pI value pH value at which the positive and 
negative charges of a protein are neutralized and 
the net charge is zero. The pI value is also called 
the isoelectric point
PIR Protein Information Resource. A database 
for protein sequences and their functions at the 
Georgetown University Medical Center
Plasmid Small ringlike DNA that can replicate 
independently of the chromosomal DNA of the 
cell. Plasmids are usually between 5,000 and 
40,000 base pairs in length. They contain the 
information for building proteins, e.g., antibiotic 
resistance genes. Bacteria can exchange plas-
mids. Because plasmids replicate quickly and are 
easily transferable between cells, they are used 
as vectors in genetic engineering to introduce 
and propagate genes in bacteria or yeast cells
Polymerase chain reaction PCR. Reaction in 
which defined DNA fragments are exponentially 
amplified in vitro with the help of DNA polymer-
ases. PCR was invented by Kary Mullis in 1983, 
who was awarded the Nobel Prize in Chemistry 
in 1993
Polymorphism Genetic variation in DNA 
sequence of individuals within a population
Posttranslational modification Enzymatic 
modification of a protein upon completion of 
translation. Examples are the phosphorylation 
and glycosylation of proteins
Primary database Database that includes bio-
logical sequence data (DNA or protein) as well as 
accompanying annotation data
Primary structure Linear sequence of amino 
acids in a protein
Profiles Position-specific assessment table to 
describe sequence information in a complete 
alignment. For each position in the sequence, 
profiles describe the appearance of certain 
amino acids, conserved positions, and deletions 
or insertions
Prokaryotes Organisms that do not have a 
defined nucleus or other cellular compartments 
such as mitochondria. Bacteria belong to the 
prokaryotes
Promoter A nucleotide sequence preceding 
a gene that determines where and when the 
gene is transcribed and to what extent. The 
enzyme RNA polymerase recognizes the pro-
moter and binds to it, thereby initiating gene 
transcription
Prosite Protein Database at the European 
Bioinformatics Institute. It contains information 
about protein families and domains, together 
with functional groups and characteristic signa-
tures of proteins
Protease Enzyme that processes or degrades 
other proteins or peptides. The term peptidase 
is also used
Protein array Miniaturized technique with many 
thousands of proteins coupled to a solid support, 
allowing for their simultaneous functional analy-
sis (e.g., for protein–protein interactions)
Protein families Most proteins can be grouped 
into a protein family based on sequence similari-
ties. Proteins or protein domains that are part of 
a protein family have similar functions and can 
be traced back to a common ancestral protein
Protein kinase Enzyme that transfers  phosphate 
groups onto proteins (phosphorylation). 
Phosphorylation frequently modulates the activ-
ity of target proteins
Protein lysate Protein mixture that arises after 
the lysis of cells
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Protein profiling Experimental technique that 
allows the understanding of a cell’s profile based 
on the expressed proteins
Protein turnover Time period between the syn-
thesis of a protein and its degradation
Proteins Proteins consist of one or several 
amino acid chains (polypeptides). Each amino 
acid is connected to the next by a peptide bond, 
and a protein’s sequence is determined by the 
nucleotide sequence of the corresponding gene. 
Proteins have various tasks in a cell (e.g., acting 
as enzymes, antibodies, hormones)
Proteome Entirety of all proteins of an organism
Proteomics Scientific field that deals with the 
proteome of an organism by structural and func-
tional analysis of proteins
Proteogenomics Scientific field that deals with 
the connection between the genome and the 
proteome
ProtEST Part of the NCBI database UniGene. 
ProtEST contains the EST sequences of a UniGene 
cluster that show a hit upon translation into a 
protein sequence
PSI-BLAST Position-specific iterated BLAST. A 
program to find new members of a protein fam-
ily within a protein database. PSI-BLAST also aids 
the identification of remotely related proteins
PubChem Database at NCBI that contains infor-
mation of small molecules and their biological 
activity
Point mutation Single base change in a DNA 
molecule
Quality score Measure that reflects the qual-
ity of each sequenced nucleotide of a DNA 
sequence as determined by DNA sequencers. 
Using the quality score, poor-quality DNA 
regions can be removed from the final sequence
Quaternary structure Association of several 
protein subunits to form a functional protein
Ramachandran plot Diagram showing torsion 
angles φ and ψ in a conformation map. Enables 
the analysis of sterically allowed and disallowed 
conformation
Reading frame Within a gene, groups of three 
nucleotides (codons) define an amino acid or 
a translation start or stop signal. Therefore, 
during protein translation, the reading frame 
corresponds to a sequence of consecutive 
“words” with three “letters” each. If even a single 
nucleotide (letter) is inserted or lost within 
the gene, then the reading frame subsequent 
to the mutation will misalign, resulting in the 
generation of a premature stop codon and a 
truncated, nonfunctional protein. On the other 
hand, the reading frame remains unchanged by 
the insertion or deletion of three nucleotides, 
resulting in either the gain or loss of one extra 
amino acid
Regular expression Formalized description of 
a set of strings. Regular expressions allow the 
definition of a number of possible characters for 
every position in the string. The Prosite database 
uses regular expressions for the description of 
the characteristic signatures of protein families
Relationship In a genealogical sense, an abbre-
viation represents a phylogenetic relationship. 
Unfortunately, the term is used very differently 
(e.g., also in terms of related forms = similarity). 
Two species or types or protein (A and B) are 
regarded as more closely related compared 
to a third party C if they are descendants of a 
common ancestor not shared by C. Therefore, 
any ancestor that A and B share with C must 
be older than the common ancestor of A and 
B. Consequently, the degree of a phylogenetic 
relationship between species or proteins 
depends on how close common ancestors are to 
the present state. See also Analogy, Homology, 
Character, and Phylogeny
Reporter gene Gene that encodes an easily 
detectable product. For instance, this can be an 
enzyme that converts a substrate resulting in a 
color (change) that can be measured
Restriction enzyme Bacterial enzyme that cuts 
DNA molecules at specific recognition sequences
Reverse transcriptase Enzyme that catalyzes 
the transcription of RNA into DNA
RNA Ribonucleic acid. Molecule chemically 
related to DNA that is central to protein synthe-
sis. DNA is transcribed into mRNA, which in turn 
is translated into proteins. Besides mRNA, a num-
ber of other RNA species exist (e.g., tRNA, rRNA)
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RNAi RNA interference. Naturally occurring 
mechanism in eukaryotic cells that blocks the 
expression of single genes. See also Knockdown
RT-PCR A version of PCR that amplifies specific 
sequence regions in RNA. The RNA is first tran-
scribed with the viral enzyme reverse transcrip-
tase into cDNA, and then specific sequences 
defined by primers are exponentially amplified 
by DNA polymerases
SAGE Serial analysis of gene expression. 
Experimental method to analyze gene expres-
sion in cells or tissues. SAGE, like DNA micro-
arrays, is adaptable to the high-throughput 
production of expression data
SBML Systems Biology Markup Language. An 
XML-based computer-readable format that pre-
cisely describes biological networks. Allows an 
easy data interchange between different programs
SCOP Structural Classification of Proteins. A 
database that categorizes proteins with a known 
structure according to structural criteria
Score matrix See Similarity matrix
SDS-PAGE Sodium dodecyl sulfate polyacryl-
amide gel electrophoresis. See also PAGE
Secondary database Database that contains 
information derived from primary database. 
Fingerprint and motif databases such as Prosite, 
Blocks, and Pfam are secondary databases
Secondary structure Ordered folding pattern 
of polypeptide scaffold without consideration of 
position of amino acid side chains. Example fold-
ing patterns are the α-helix, β-sheet, and loops
Sequence Nucleotide or amino acid sequence
Sequence assembly Generation of an alignment 
from overlapping short sequences of DNA fol-
lowed by the assembly of a consensus sequence
Sequence retrieval system SRS. Database man-
agement and query system to administer flat 
file databases. Among others, SRS is used on the 
European Bioinformatics Institute server to query 
biological databases
Sequencing Determination of nucleotide 
sequence in DNA or amino acid sequence in pro-
teins. See also DNA sequencing
Server Computer or computer program that 
transfers information over a network, e.g., the 
Internet, to a client
SIB Swiss Institute of Bioinformatics
SignalP Computer program to estimate the 
N-terminal signal peptides of proteins
Signal peptide Short N-terminal amino acid 
sequence (often between 15 and 30 amino 
acids) that serves as a signal for cellular transport 
machinery
Similarity Evaluation of similarity of amino acid 
sequences. This implies the definition of similar-
ity relationships between the 20 standard amino 
acids
Similarity matrix Mathematical phrasing of 
similarity relationships between amino acids on 
the basis of defined model and the analysis of 
related amino acid sequences
Significance Significant result that does 
not occur by chance. The result is, therefore, 
assumed to be reliable with a high probability. 
Significance is calculated by a number of statisti-
cal tests
Singleton EST sequences that show no overlap 
with other EST sequences and, therefore, cannot 
be grouped into contigs
siRNA Small interfering RNA. Small species 
of RNA (21–28 nucleotides in length) that are 
important in modulating transcription in eukary-
otic cells
Six-frame translation Translation of a DNA 
fragment into the six possible reading frames. 
This procedure is necessary when only 
 uncharacterized DNA fragments are available 
and no details on the direction of the frame exist. 
See also Reading frame
SMD Stanford Microarray Database. Database 
that allows the storage and retrieval of both 
raw data and normalized data from microarray 
experiments, and pictures of the corresponding 
arrays
Smith–Waterman algorithm Dynamic algorithm 
to determine the optimal local alignment of two 
sequences. The Smith–Waterman algorithm can 
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also be used to search databases. Though sensi-
tive, the procedure is slow
SNP Single nucleotide polymorphism. Genetic 
variation caused by a change in a single nucleo-
tide
Splice variants Proteins of different length origi-
nating from a process called alternative splicing
Spotting Placing DNA spots onto a cDNA array 
with the help of a robot
SRS See Sequence retrieval system
Stackpack Computer program developed to 
cluster EST sequences
Structural genomics Worldwide initiative to 
automate the experimental analysis of the three-
dimensional structures of as many proteins as 
possible
STS Sequence tagged sites. Short, unique DNA 
sequences that are used to tag genomes
Substitution matrix See Similarity matrix
Swissprot Curated high-quality protein 
sequence database of Swiss Institute of 
Bioinformatics See also Expasy
Synteny Synteny refers to two or more genes 
lying on the same chromosome of a species
Syntenic regions Chromosomal regions are 
syntenic if genes of orthologous proteins are 
in the corresponding chromosomal regions 
between two species, whereby the gene order is 
not considered
Systems biology Scientific discipline with the 
aim of understanding biological organisms 
in their entirety. It involves the creation of an 
integrated picture of all regulatory processes 
from the genome to proteome and metabolome 
and on up to organelles, and the behavior of the 
entire organism
TAP Tandem affinity purification. Method to 
identify multiprotein complexes.
Target Protein that plays a central role in disease 
and whose activation or inhibition has a direct 
influence on the course of that disease
Target protein See Target
Target-based approach Modern search for drug 
targets that is carried out in vitro with a defined 
target protein
Tertiary structure Spatial organization (includ-
ing conformation) of an entire protein molecule 
or other macromolecule consisting of a single 
chain
TMHMM Computer program to determine the 
transmembrane domains of proteins using hid-
den Markov models
Toxicogenomics Scientific field that analyzes 
the effects of toxic substances on cellular gene 
expression
Transformation Transfer of nucleic acids into 
living cells or bacteria (transfection). Also: 
Transformation of a normal cell into a tumor cell, 
for example by activation of oncogenes
Transcription Act of producing an RNA copy of 
DNA using the enzyme RNA polymerase
Transcription factor Protein that positively or 
negatively influences the transcription of genes, 
frequently by interacting with RNA polymerase
Transcriptome Entirety of mRNA transcripts of 
an organism
Transcriptomics Scientific discipline that per-
forms global analyses of gene expression with 
the help of high-throughput techniques such as 
DNA microarrays
Translation Synthesis of proteins at ribosomes 
using mRNA as the template
Transmembrane domain Part of a protein that 
passes through a cell membrane
Turn Irregular secondary structure element 
as building block of overall folding pattern of 
proteins. Turns consist of three to six amino acids 
and are responsible for the globularity of pro-
teins owing to the conformational space of the 
polypeptide backbone
Two-dimensional (2D) gel electrophoresis  
Electrophoretic technique to separate protein 
mixtures. Proteins are initially separated in the 
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first dimension according to their individual 
isoelectric points (pI value) and then in the 
second dimension according to their molecular 
weights
UniGene Database at NCBI that contains all 
nucleotide sequences of a gene and describes 
them nonredundantly
Uniprot Joint database of EBI, SIB, and 
Georgetown University that contains all the 
information of the Swissprot, TrEMBL, and PIR 
databases and serves as a central repository of 
protein information
UniSTS Nonredundant NCBI database contain-
ing STS markers from different sources
UTR Untranslated region. That part of RNA or 
cDNA that contains noncoding sequences. One 
distinguishes between 5′ UTR, which is upstream 
of the translation start codon and contains 
important regulatory regions such as the ribo-
some binding site, from the 3′ UTR, which starts 
with the translation stop codon and often con-
tains a terminal poly A-sequence
Vector Usually plasmid (DNA ring) or phage 
(virus that attacks bacteria) to transfer genes 
between organisms. Vectors can be propagated 
in cells or bacteria as they include regulatory 
DNA fragments that are necessary for replication
Virtual screening In silico–based searches for 
putative bioactive molecules in virtual data-
bases. Pharmacophor-based searches and dock-
ing are often applied computational methods
Wildcard Character used as placeholder that 
represents one or more arbitrary characters in 
file name of a command
X-ray crystallography Technique to determine 
the three-dimensional structure of proteins 
based on protein crystals
Yeast two-hybrid system In vivo method to iden-
tify protein–protein interactions in yeast cells
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Acute lymphatic leukemia (ALL) 63
Affymetrix 94
Alternative splicing 60
Alternative Splicing Annotation Project 61
Angiotensin-converting enzyme (ACE) 86
Antigen capture assay 110
Arabidopsis thaliana 68
B
Basic Local Alignment Search Tool (BLAST) 19, 20, 
42–44, 138
 – algorithm 46, 56, 57, 70
 – applications 45
Biochemical Pathways Chart 133
Bioinformatics 79, 80
 – evaluation, 2D gels 104
 – methods 103
 – protein and DNA sequences comparison 14, 36
Biological databases
 – genotype-phenotype 25, 26
 – molecular structure 27–29
 – primary 14–23
 – secondary 23, 25
Biological system 92
Biomarkers 65–67
BioModels Database 118
Biowolf cloud system 68
blastn program 48, 150
Blocks substitution matrix (BLOSUM) groups 39
Bl2seq algorithm 45
Brugia pahangi 80–82
Build Model 87, 157
C
Caenorhabditis elegans 52
CAP3 program 56
Captopril 86
Caspases 57, 79
CATH database 29
Cathepsin L-like cysteine protease 81
cDNA
 – array technology 94
 – library 55
 – probes 94
Center for Biological Sequence Analysis (CBS) 75, 77
Chemoinformatics 80
CHER_SALTY 86, 87, 155, 156
Cholesterol ester biosynthesis 111
Chromatographic separation 106
Chromosome-based part of the Human Proteome 
Project (C-HPP) 103
Classical proteomics 102, 103
Cleavage site score (C-score) 76
c-myc 70
Coding regions, comparative analysis 128
Comparative genomics
 – of coding regions 128
 – drug discovery 124–126
 – of noncoding regions 128
 – structure 126, 127
Complementary DNA (cDNA) clones 53
Contigs 56, 57, 69, 70, 152, 153
CYP2D6 enzyme 63
Cysteine proteases 75, 78–82, 86
D
Database searches, proteins/nucleotide sequence- 
based 42, 43, 45
Data management and analysis 92
dbEST 54, 59, 69, 152
dbGSS database 54
dbSNP database 62
Direct labeling 96
Direct/reverse-phase assay 110
Direct sequence comparison 135
DNA 2, 4, 11, 142, 144
DNA Database of Japan (DDBJ) 14, 15, 17
DNA microarrays 96, 99
DOCK program 80
Dorzolamid 86
D-score 76
Dye swapping control experiment 98
E
E-cell model 117
Edman degradation 104
EggNOG database 135, 136, 138, 161
Electrospray ionization (ESI) 105
EMBOSS application 48
Enalapril 86
ENA Online Retrieval 17, 19
Encyclopedia of Escherichia coli Genes and 
Metabolism (EcoCyc) 129
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Ensembl database 53
Entrez database 16, 17, 23, 30, 70, 71, 144, 145,  
148, 153–155
Escherichia coli 56
Eukaryotic genomes vs. prokaryotic genomes 52
Eukaryotic transcription 5
European Bioinformatics Institute (EBI) 17, 46
European Molecular Biology Laboratory (EMBL) 17
European Molecular Biology Open Software Suite 
(EMBOSS) 47
European Nucleotide Archive (ENA) 14
Expasy proteomics server 87, 103, 104
Expression profiling experiment 96, 98, 99
F
FASTA sequence 32, 46, 48, 49, 68–70, 149
FASTQ file 68
Forward genetic screens 113
Functional proteomics 106, 108
G
Gapped BLAST 46
GenBank database –20, 14, 16, 23, 52, 61, 124, 153
Gene defects 92
Gene duplication 137
Gene expression 92, 97, 99
Gene Expression Omnibus (GEO) database 101,  
118, 157
GenePattern 99, 119
Gene prediction 129
GeneSpring GX collection of Agilent 
Technologies 99
Genetic code 5, 11, 37
Genome 11
 – description 142
 – sequencing projects 14, 135, 138
 – structure 126, 128
Genome-based biology 124
GenomeNet 133
Genome sequencing 46, 124
 – projects 14, 135, 138
 – See also Human genome sequencing
Genome Survey Sequences (GSSs) 54
Genome-wide association study (GWAS) 66
 – GWAS Central 62
Genotype-phenotype databases 26, 33
Genscan analysis 47, 151
Gleevec 86
Global Align program 150
Global sequence alignment 39, 45
Glycolysis/gluconeogenesis metabolism 133,  
138, 160
GOLD docking software 83, 84
GOLD Genomes OnLine Database 160
G protein-coupled receptor (GPCR) 77, 87
GrailEXP program 61
Gram negative bacteria 156
H
Haemophilus influenzae 52
Helix cloud system 68
Hemograms 66
HFE gene mutation 66
Hidden Markov model (HMM) 77
High-throughput methods 78–79
HIV protease inhibitors 86
HomoloGene 26, 54
Homology map of X chromosome 127
Homology modeling 36, 80
HTS-Mapper Web site 68
Human Genome Project 92
Human genome sequencing
 – beginning of 52
 – biomarkers 65
 – ESTs
 – annotation, bovine intestine 57, 58
 – cDNAs 53–55
 – coding and noncoding 57, 58
 – contigs 56, 57, 69, 70
 – dbEST 54
 – vs. GSSs 54
 – protein families identification 59
 – quality trimming 56
 – UniGene database 54
 – unknown genes identification 56
 – NGS 67
 – personalized medicine 65
 – pharmacogenetics 63
 – proteogenomics 68
 – splice variants 60
 – STSs 52–53
Human Genome Variation Database 62
Human glycolysis/gluconeogenesis  
metabolism 161
Human immunodeficiency virus 1 (HIV-1) 61
Human Metabolite Database 110
Human Proteome Project 102
I
Identity matrix 37
Indirect labeling methods 96
IntAct Molecular Interaction Database 108
Integrated Molecular Analysis of Genomes and their 
Expression (IMAGE) consortium 54
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Integrated Resource of Protein Families, Domains 
and Sites (Interpro) 25
Interactome databases 108
Ion semiconductor sequencing 67
J
JPred server 87
K
Knockin strategy 114
Knockout and knockin strategies 114
Kyoto Encyclopedia of Genes and Genomes 
(KEGG) 161
 – bacterial secretion pathways 129
 – metabolic pathways 129
L
Leishmania major 86
LIGAND database 133
Ligand SAH (S-Adenosyl-L-homocysteine) 156
Ligation, by sequencing 67
Local sequence alignment 39, 46, 48
Loops 74
M
Macromolecules
 – nucleic acids 2
 – proteins 2
Mass spectroscopy 105, 111
Mass spectroscopy–based analysis  
of peptides 104
Matrix-assisted laser desorption/ionization–time of 
flight (MALDI–TOF) 104
Mercaptopurine 63
Messenger RNA (mRNA) 53, 55–58, 60, 61, 66, 67, 
69, 142, 153
Metabolic profiling 65
Metabolomics 65, 92, 93, 110–112
Metabonomics 65
MicroArray Quality Control Project 98
Microarray technology 101
Microbial Genome Database (MBGD) 137,  
139, 162
Molecular biology 6, 11, 142
Molecular interaction experiment (MIMIx) 
protocol 108
Molecular network 107
Molecular Structure Databases 27, 29, 30
Multiple sequence alignment 36, 40–42, 48, 150
MUMmer 135
Murine caspase 6 57, 58
Mutational substitution 38
Mycobacterium tuberculosis 83
Mycoplasma genome 69
N
National Center for Biotechnology Information 
(NCBI) 14, 23, 46, 99, 127, 150
 – nucleotide database 48, 49
 – protein database 23
NCBI BLAST home page 138, 161
Needle application 149
Needleman and Wunsch algorithm 40
Neuraminidase inhibitors 86
Next-Generation Sequencing (NGS) 67–68
NGL Viewer 87
NiceSite view of Prosite database 24
Noncoding regions, comparative analysis 128
Northern blot analysis 98
Nuclear magnetic resonance (NMR) 111
Nucleic acids 2
 – composition 3
 – ribose/phosphoric acid residue structure 2
Nucleosome aggregation 92
Nucleotides 2, 11
 – mutational rate 36
Nucleotide sequence databases 43
 – DDBJ 17
 – EMBL 17
 – ENA 17, 19
 – GenBank 14, 16
O
Oligonucleotide arrays 96
Online Mendelian Inheritance in Man (OMIM) 
database 26, 153
Ortholog 36
Orthologous genes 135
Orthologous proteins 135
P
Pairwise sequence comparison 36, 40–42
Papainlike proteases 79
Paralog 36
Pattern-Hit Initiated BLAST (PHI-BLAST) 45
PeptideMass 120
Personalized medicine 65
Pfam database 25
Pharmaceuticals on molecular networks 107
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Pharmacogenetics 63–65
Pharmacometabonomics 65
Pharmacophore modeling 84
PhenomicDB database 26, 27, 115
Phenomics 93, 112–114
Phenylalanine 61, 70
Phenylalanine Hydroxylase Locus 
Knowledgebase 61
Phenylketonuria 61, 70, 154
Phrap program 56
Phylogenetic classification of proteins 135
Phylogenetic tree 41, 42, 49, 150, 162
Picorna virus proteases 79
Plasmodium falciparum 86
Polymerase chain reaction (PCR) 52, 53
Polypeptides 74
Position accepted mutation (PAM) 39
Position-Specific Iterated BLAST (PSI-BLAST) 45
Preproproteins 75
Preproteins 75
PRINTS database 24, 32, 146
Prodrugs 65
Prokaryotic gene information 5
Prosite 23, 24, 32, 146
Protein array technology 109, 110
Protein Data Bank (PDB) 27, 78, 79, 86, 87
Protein Information Resource (PIR) 20
Protein ionization technique 105
Protein sequence databases
 – NCBI 23
 – UniProt 20
Protein–protein interactions 83, 108, 110
 – database 119
Proteins 2
 – amino acid sequence 7
 – chemical properties 7
 – database 43
 – geometric properties 9
 – physiological conditions 7
 – quaternary structure 10
 – Ramachandran plot of transcription regulator 
protein GAL4 10
 – structure
 – high-throughput methods 78
 – modeling 78
 – primary 7, 12, 74, 143
 – Protein Structure Initiative 79
 – secondary 7, 9, 11, 12, 74, 143
 – tertiary 10, 74
Proteogenomics 68–69
Proteome 11, 93
 – description 142
Proteomics 92, 102
ProtEST databank 54
PubChem database 30, 148
 – PubChem BioAssay 30
 – PubChem Substance 30
PubMed database 31
Pyrosequencing 62, 67, 68
Q
Quality trimming 56
R
RCSB PDB database 147, 155
Reactome database 129
Reference proteins/templates 78
Relational database systems 14
Ritonavir (Norvir) 86
RNA 2, 11, 16, 27, 142
 – types 55–56
RNA interference (RNAi) technology 114, 115
RNA-Seq, see Whole transcriptome shotgun 
sequencing
S
Salmonella typhimurium 76
Sandwich assay 109
Saquinavir 86
Scoring matrices 36, 38
Sequence alignments
 – multiple 36, 39, 42
 – nucleotide and amino acid sequences 37
 – pairwise 36, 40, 42
 – quality measure determination 37
Sequence analysis software 46
Sequence-tagged sites (STSs) 52
Serial analysis of gene expression (SAGE) 101
Signal peptide 74–77, 87, 155
Signal peptide score (S-score) 76
SignalP program 75, 76, 87, 156
Similarity matrices 36
Single-nucleotide polymorphisms (SNPs) 61, 62
Small interfering RNA (siRNA) 115
Species-specific map 138
SPHGEN subprogram 80, 81
Splicing 12, 60, 61, 128, 142
stackPACK program 56
Stratified medicine 63
STRING database 108
Structural Classification of Proteins (SCOP) 29
Structural Genomics Consortium 79
Structurally conserved regions (SCRs) 78
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Structure-based rational drug design 80–84
 – docking
 – DOCK 80–82
 – GOLD software 83, 84
 – drug target 80
 – pharmacophore modeling 84–85
 – success 85–86
Substitution matrices 36, 39
Swiss2DPage 119
SWISS-MODEL server 78, 87, 157
Swiss-Prot database 20, 86, 87, 149, 156, 157
Systems biology 92, 115, 116, 118
Systems Biology Markup Language (SBML) 118
Sythesis, by sequencing 67
T
Tamiflu 86
Tandem affinity purification (TAP) 106
Tandem mass spectroscopy 106
tblastn 43
Thioguanine 63
Thiopurine-S-methyltransferase 63, 66
3D structure, receptor 84, 85
TMHMM program 77, 155, 157
Toxicological analysis 101
Transcription 5
Transcriptome 11, 93
 – description 142
Transcriptomics 92, 93
 – DNA microarray 94
Transduction pathway 36
Translated EMBL (TrEMBL) 20
Translation 5
Transmembrane helices 75–77, 146, 156, 157
Transmembrane proteins 77–78
Trypanosoma cruzi 86
Two-dimensional polyacrylamide gel electrophore-
sis (2D-PAGE) 103, 104
Tyrosine kinase inhibitor 86
U
UniGene database 54, 70, 153
UniProt Archive (UniPArc) 20
UniProt Knowledgebase (UniProtKB) 20, 144, 146, 
154, 155
UniProt Reference Clusters Database (UniRef ) 20, 23
Universal Protein Resource (UniProt) 20, 144, 157
V
Venn diagram 9, 142, 143
W
Whole transcriptome shotgun sequencing 54
Y
Yeast two-hybrid system 108
Y-score 76
Index
